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ABSTRACT
Adult bone marrow contains progenitor cells that can extricate 
themselves from their bone marrow cavity niche, and engraft within 
foreign tissues, whereupon they produce specific differentiated adult 
lineages. Bone marrow engraftment is upregulated with increasing 
regenerative pressure, which has triggered speculation as to the 
therapeutic potential of bone marrow cells. In this thesis, I describe for 
the first time, that transplanted adult bone marrow cells engraft within the 
intestines of mice and humans and give rise to a substantial proportion of 
the mesenchymal cells in the lamina propria, namely, the intestinal 
subepithelial myofibroblasts. I show that bone marrow contribution to 
intestinal myofibroblasts is significantly enhanced in a mouse model of 
colitis. Furthermore, I show that bone marrow cells form multiple vascular 
lineages in the mouse colon, with an enhanced propensity in colitis. 
These results have implications for the use of bone marrow in the 
treatment of inflammatory bowel disease, either by directly producing 
mesenchymal and vascular lineages, and/or possibly via the indirect 
regulation of intestinal epithelial cells.
I also report that transplanted bone marrow cells engraft into the skin and 
contribute to multiple epidermal lineages. These bone marrow-derived 
cells are commonly located within postulated epidermal stem cell niches, 
and can express putative epidermal stem cell markers. Bone marrow cell 
engraftment was significantly enhanced in the wounded epidermis, and 
bone marrow-derived epidermal cells can proliferate in vivo, and form 
colonies in vitro. I found no evidence that bone marrow cells fuse with 
indigenous epidermal cells to form heterokaryons.
These results highlight the potential of bone marrow cells in the treatment 
of diseases of the gastrointestinal tract and skin.
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CHAPTER I
General Introduction
1.1) Adult stem cells
Adult stem cells are primitive, morphologically indistinct cells that lack 
markers of lineage commitment, and are thus generally defined by their 
functional characteristics. All adult stem cells, referred to as stem cells 
herein, share two main properties. Firstly, all stem cells can undergo self­
renewal by dividing to produce an identical daughter cell, thereby forming 
and maintaining the foundations of a tissue and ensuring stem cell 
longevity within the tissue. Indeed, stem cells are often defined by their 
capacity for clonogenic self-renewal throughout the lifetime of their host. 
Secondly, stem cells can divide to produce daughter cells that evolve, or 
"differentiate", to form the entire specialised adult cell repertoire within 
their tissue of origin. This ability to produce cells of more than one 
lineage is known as “multipotentiality”. Stem cells divide to produce a 
partly-differentiated intermediate cell, known as a "transit amplifying" cell. 
These cells are committed to the formation of terminally-differentiated 
adult cell lineages, typically believed to be confined to a particular cellular 
pathway, although emerging data indicates that the classical pathways of 
stem cell differentiation are not as definitive as previously believed 
(section 1.13).
Fundamentally, stem cells preserve the steady-state functioning of a 
tissue and maintain homeostasis by replenishing cells that are lost due to 
damage or disease. In tissues with a rapid cell turnover rate, such as the 
gastrointestinal tract and the skin, cells are constantly being shed and 
replaced by the differentiating cells beneath them, and concurrently, the
16
rate of stem cell production of transit amplifying cells is higher in these 
tissues. Likewise, the rate of stem cell division fluctuates in response to 
regenerative demand dictated by tissue disease and injury.
The onset of neoplastic change within a tissue generally occupies a 
significant time span, as a number of mutations must accumulate within a 
cell before neoplasia is invoked. Therefore in tissues such as the skin 
and gastrointestinal tract, wherein the differentiated adult cells are 
distinctly short-lived, it is likely that the stem cells are the carcinogen 
target cells, due to their prolonged existence within these tissues. The 
gradual accumulation of mutations within a stem cell is believed to lead to 
the formation of a “cancer stem cell”, which divides to produce a clone of 
mutated daughter cells and leads to tumour formation (Al-Hajj et al., 
2004; Park et al., 2004; Reya et al., 2001). Elucidation of the genetic 
adaptations that lead to the formation of cancer stem cells will pave the 
way to a clearer understanding of the processes of tissue disease and 
repair, and hopefully the development of effective future therapies.
17
1.2) The stem cell niche
Stem cells are located within a specialised regulatory microenvironment, 
or niche, which provides an optimal milieu for stem cell survival and 
function. The “stem cell niche” hypothesis was defined by Schofield in 
1978 (Schofield, 1978), and proposes that specific signals from the niche 
cause the stem cells to undergo self-renewing divisions, thereby 
preventing their maturation. When stem cell progeny migrate outwith the 
niche they differentiate to become transit-amplifying cells, demonstrating 
that stem cells may be regulated by their environment, rather than by 
intrinsic programming.
Due to their indistinct phenotype, stem cells within most mammalian adult 
tissues have proven difficult to identify, and consequently, 
characterisation of the components comprising the stem cell niche that 
govern and support the stem cells is equally arduous. The mammalian 
stem cell niche is thought to be formed by the stromal cells and their 
secreted extracellular matrix (ECM), which surround the stem cells. Due 
to the hierarchical migratory nature of differentiating transit amplifying 
cells, the stem cell niche is most likely to be situated at the origin of 
cellular flux, as associations between the stem cells and the cells of the 
niche are vital for the maintenance of tissue turnover. The "conceptual" 
stem cell niche should consist of three primary components: the localised 
signalling cells and their secreted extracellular matrix factors, the cells 
which comprise the niche; the target range influenced by the signalling 
factors of the niche, the expanse governed by the so-called niche; and 
the target of the signalling factors, the stem cells (Lin, 2002).
As we strive to unravel the pathways of cellular differentiation and 
proliferation within a tissue, we implicitly consider the stem cell as the 
governing body of these processes. Although stem cells are essentially 
the most important of all cells within a regenerating tissue, if we consider
18
their primitive, unspecialised characteristics, it is feasible that 
understanding the inner mechanics of a stem cell may be less important 
than elucidation of the nature of the cells which interact and regulate their 
behaviour i.e. the niche.
19
1.3) Cells of the small intestine and colon
1.3.1) Epithelial cells
Throughout the small intestine and colon, the internal luminal surface is 
lined by a simple, columnar epithelial mucosa with an underlying 
vascularised lamina propria, and muscularis mucosa. The nature and 
distribution of each cell type varies throughout each different functional 
region of the small intestine and colon, although each cell is believed to 
derive from a stem cell originating in the endoderm during embryogenesis 
(Maunoury et al., 1988). The epithelial mucosa has various structural 
specialisations, which considerably increase the luminal surface area to 
support the absorption and digestion of food.
In the small intestine and colon, frequent concave indentations known as 
"crypts" extend through the lamina propria down to the muscularis 
mucosae. In the small intestine, finger-like structures known as "villi" 
project into the lumen and expand the surface area. The fully- 
differentiated cells of the crypts and villi are situated towards the luminal 
surface, and are continually being shed into the lumen and replaced by a 
constant stream of proliferating progenitor cells. The columnar cells, 
termed "enterocytes" in the small intestine and "colonocytes" in the colon, 
are the most abundant epithelial cell type in the mucosa, responsible for 
secretion and absorption. Columnar cells are polarised cells with a basal 
nucleus and an apical brush border composed of microvilli, which 
increase the surface area further. The "goblet" cells, so-called due to 
their characteristic shape, are dispersed throughout the small intestinal 
and colonic epithelium and secrete mucus into the intestinal lumen to 
lubricate the mucosa and to trap and expel microorganisms. The 
gastrointestinal tract is the largest endocrine organ in the body, and 
hence the "endocrine", "neuroendocrine" or "enteroendocrine" cells are 
abundant throughout the epithelium, although in the small intestine are
20
more common to the crypts than the villi. To date, approximately 10 
different endocrine cells have been described in the mammalian small 
intestine (Solcia et al., 1998), defined by their hormonal content, which is 
secreted from basally sited dense core or neurosecretory granules. The 
"Paneth" cells are almost exclusive to the crypt base of the small intestine 
and ascending colon. These cells maintain a sterile environment in the 
crypt via phagocytosis and the secretion of various antibacterial 
substances, including lysozyme, and antibacterial peptides called 
defensins or cryptdins from large apical secretory granules (Darmoul et 
al., 1997; Ouellette et al., 1994; Ouellette et al., 2000). Other less 
common cell lineages are also present, such as caveolated cells 
(Nabeyama and Leblond, 1974), and M- (membranous- or microfold-) 
cells which function in antigen transport, and are found in the small 
intestine within specialised lymphoid follicles, known as "Peyers patches" 
(reviewed in (Kerneis and Pringault, 1999)).
1.3.2) The lamina propria
The lamina propria is a layer of loose connective tissue, which lies 
immediately subjacent to the epithelial mucosa throughout the 
gastrointestinal tract. The lamina propria is composed of mesenchymal 
cells and their secreted basement membrane factors, and is highly 
vascular with lymphatic capillaries and nervous tissue (reviewed in 
(Kedinger et al., 1998; Powell et al., 1999a)). The lamina propria 
contains two intestinal myofibroblast populations: the interstitial cells of 
Cajal (ICC), and the intestinal subepithelial myofibroblasts (ISEMFs). 
The ICC are pacemaker cells located in an intramuscular space between 
the submucosa and muscularis propria, which regulate gastrointestinal 
smooth muscle motility and neurotransmission (Sanders, 1996). Other 
cell lineages present in the lamina propria include: fibroblasts and 
fibrocytes, vascular endothelial and smooth muscle cells, blood cell 
lineages such as granulocytes, mast cells, macrophages, T and B 
lymphocytes and plasma cells, verifying the role of the lamina propria as 
a key player in immune responses (Hunyady et al., 2000). The number
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and distribution of cell types in the lamina propria, and their secretion of 
regulatory factors, varies in accordance to changing physiological 
conditions in the gastrointestinal tract (Hunyady et al., 2000).
1.3.2.1) The intestinal subepithelial myofibroblasts
ISEMFs display cytologic characteristics of both fibroblasts and smooth 
muscle cells, and are immunoreactive for a-smooth muscle actin (SMA), 
vimentin, and smooth muscle myosin antigens; though do not express 
desmin under normal circumstances (reviewed in (Powell et al., 1999a)). 
This antigenic phenotype permits their distinction from the vimentin- 
negative fibroblasts and the strongly desmin-positive smooth muscle 
cells. ISEMFs exist as a cellular syncytium in the subepithelial lamina 
propria, and are most prominently expressed around the lower two-thirds 
of the crypts. The cellular processes of ISEMFs have been shown to 
merge with the pericytes that surround the blood vessels (Joyce et al.,
1987), and can encircle the capillaries that extend throughout the lamina 
propria in the small intestinal villi (Komuro and Hashimoto, 1990). 
ISEMFs proliferate and migrate upward along the crypt-villus axis until 
they reach the tip of the crypt or villi where they are then shed into the 
intestinal lumen, a process taking approximately 2 - 4  days in the mouse 
small intestine (Marsh and Trier, 1974b) and rabbit colon (Pascal et al., 
1968). The pattern and timeframe of this myofibroblast migratory pattern 
is very similar to that of murine epithelial cells (Wright and Alison, 1984). 
ISEMFs are adjoined to epithelial cells via gap and adherens junctions, 
which permit epithelial: mesenchymal interaction (Powell et al., 1999b). 
ISEMFs have a broad range of functions including the regulation of 
epithelial cell homeostasis, mucosal protection and wound healing, 
contraction and motility of small intestinal villi and water and electrolyte 
transport in the colon (reviewed in (Powell et al., 1999b)).
The origin of the ISEMFs is unresolved, with reports of transdifferentiation 
between different mesenchymal cell types including resident tissue 
fibroblasts (Gabbiani, 1996) or smooth muscle cells (Ronnov-Jessen et
22
al., 1995), or a putative stem cell population in the lamina propria near the 
crypt base (Bockman and Sohal, 1998; Marsh and Trier, 1974a; Marsh 
and Trier, 1974b; Mayer-Proschel et al., 1997; Pascal et al., 1968; 
Sappino et al., 1989). However, more recent data from in vitro studies, 
indicates that cells in the BM can differentiate to produce myofibroblast­
like cells (Ball et al., 2004; Emura et al., 2000; Kadner et al., 2002).
In normal, healthy tissue the ISEMF is present as a spindle-shaped, 
transiently differentiated cell. However, in inflamed tissue, ISEMFs 
become activated and assume a round, flattened morphology. Activated 
ISEMFs display an accelerated proliferation rate (McKaig et al., 2002), 
increased expression of cytokines, chemokines, growth factors and 
adhesion molecules, and have an enhanced secretion of soluble 
mediators of inflammation and extracellular matrix factors (reviewed in 
(Powell et al., 1999a; Powell et al., 1999b)). For example, activated 
ISEMFs stimulate epithelial cell hyperplasia in inflammatory bowel 
disease (IBD) by upregulating their secretion of the epithelial cell mitogen, 
keratinocyte growth factor (KGF) (Bajaj-Elliott et al., 1997). Furthermore, 
overactivation and persistence of activated ISEMFs causes tissue fibrosis 
and scarring in Crohn’s disease (Aigner et al., 1997; Graham, 1995; Isaji 
et al., 1994; Kinzler and Vogelstein, 1998; Martin et al., 1996).
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1.4) Intestinal epithelial stem cells
The adult epithelial cells of the intestinal mucosa are constantly under 
high regenerative pressure due to the rapid rate of cell turnover in this 
tissue. For example, the lining of the gastrointestinal tract is replaced 
every 2 - 3  days in rodents and other mammals (Wright and Alison,
1984). To regulate homeostasis, a vital balance between cell apoptosis, 
senescence and the proliferation and differentiation of new cells must be 
maintained. This role is attributed to the intestinal stem cell although, 
despite its significance as the most important regulatory element of 
intestinal function, limited evidence exists to definitively substantiate the 
location, quantity, regulatory pathways or function of this elusive cell.
1.4.1) Intestinal epithelial stem cell location
Since the polarised orientation of the differentiated cells in the intestinal 
crypts and villi is well characterised, it is presumed that a pool of 
progenitor cells exist at the origin of cellular migration and are responsible 
for this continuous cellular flux. The epithelial cells of the small intestine 
originate in the lower regions of the crypt, and undergo proliferation and 
differentiation as they travel upwards to be shed into the intestinal lumen, 
with the exception of the Paneth cells, which migrate downward to their 
location in the crypt base. It is therefore generally accepted that the 
epithelial stem cell compartment is in the crypt base of the colon, and at 
approximately cell position 4 - 5 in the small intestinal crypts, just superior 
to the Paneth cells (Figure 1.1; (Potten et al., 1997)).
1.4.2) Intestinal epithelial stem cell niche
As with stem cells of most adult tissues, it is thought that the intestinal 
epithelial stem cells are located and maintained within a mesenchymal 
niche, situated near the base of the intestinal crypts. However, as the
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stem cells remain unidentified, it is not possible to localise the niche that 
underlies them and thus, our knowledge of the intestinal niche is 
fundamentally based upon circumstantial evidence and speculation. 
Ablation studies of specific epithelial cell lineages have failed to identify 
which cells comprise and are targeted by the intestinal niche. For 
example, targeted ablation of Paneth cells (Garabedian et al., 1997), and 
three different endocrine cell lineages in the mouse small intestine (Rindi 
et al., 1999), had no effect on the rate of epithelial cell proliferation. It is 
more conceivable that epithelial stem cells are regulated by non-epithelial 
components i.e. the mesenchymal cells and ECM factors in the subjacent 
lamina propria, which fits with the classical view of the composition of the 
stem cell niche (Ohlstein et al., 2004; Spradling et al., 2001), and is 
further supported by evidence of interactions between the ISEMFs and 
epithelial cells of the mucosa. For example, ISEMFs play vital roles in 
epithelial cell restitution, remodelling, fibrosis and immunological and 
inflammatory responses (reviewed in (Powell et al., 1999b), in their 
secretion of specific growth factors and inflammatory cytokines (Dignass 
and Sturm, 2001; Dignass et al., 1994; Podolsky, 1997; Polk, 1998; 
Riegler et al., 1996). This epithelial:mesenchymal interaction highlights 
the ISEMF as a candidate component of the intestinal epithelial stem cell 
niche, although it is not clear if mesenchymal signals act directly upon the 
stem cells or the transiently-differentiated daughter cells.
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1.4.3) Intestinal stem cell number/ clonal origins of intestinal crypts
1.4.3.1) Mouse
The number of stem cells within the gastrointestinal niche is a subject of 
ongoing debate. Investigations into the clonal origins of intestinal crypts 
have attempted to deduce whether they are monoclonal populations 
derived from a single stem cell, or whether multiple stem cells proliferate 
to produce polyclonal crypts. The "Unitarian hypothesis" states that a 
single intestinal stem cell can clonally expand to produce the entire adult 
cell repertoire in the intestinal crypts (Cheng and Leblond, 1974). This is 
supported by evidence that a single surviving stem cell can recreate 
entire monoclonal crypts following irradiation damage (Ponder et al.,
1985), although these studies of damaged epithelium do not confirm that 
intestinal crypts are monoclonal under normal circumstances.
Mouse aggregation chimeras, wherein one parental strain bears a 
specific marker for the tissue of interest, have been used to investigate 
the Unitarian hypothesis. The binding capacity of the Dolichos biflorus 
agglutinin (DBA) lectin to the cells of the intestinal epithelium can be 
abolished by spontaneous mutation of the Dlb-1 locus on chromosome 1, 
or by treatment with the chemical mutagen, ethylnitrosourea (ENU). The 
SWR mouse has a carbohydrate polymorphism of Dlb-1 , and 
consequently, DBA binds to sites on the C57BI/6J-derived, but not SWR- 
derived cells in heterozygous C57BI/6J(B6)«->SWR mouse embryo 
aggregation chimeras. Intestinal crypts in neonatal B6<-»SWR mice were 
polyclonal for the first two weeks after birth, suggesting that multiple stem 
cells exist during development (Schmidt et al., 1988). However, all crypts 
eventually become monoclonal, possibly due to the positive selection of a 
single dominant clone or by the segregation of lineages due to the 
division of crypts by “crypt fission”, which occurs frequently during this
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developmental period (section 1.5.1;(Bjerknes and Cheng, 1999; Park et 
al., 1995)). The epithelial cells in the crypts remain monoclonal in the 
adult mouse intestine, confirming the existence of a single, sustainable 
stem cell (Bjerknes and Cheng, 1999; Ponder et al., 1985; Winton and 
Ponder, 1990). Similarly, ENU treatment in B6<-*SWR mice results in 
loss of DBA binding in mutated cells, and revealed that small intestinal 
crypts are initially partially, and then entirely negative for DBA staining 
(Winton et al., 1988). It is proposed that ENU causes mutation of the Dlb- 
1 locus in a stem cell, which then expands stochastically to produce a 
clone of cells that cannot bind DBA and remain unstained (Winton et al.,
1988). If this is the case then a single stem cell can give rise to all the 
epithelial lineages within the small intestinal crypts.
In female mice with a heterozygous polymorphism of the X-linked gene, 
glucose-6-phosphate dehydrogenase (G6PD), individual X chromosomes 
are distinguished by their natural "mosaic" pattern of G 6 P D  
immunohistological staining. Use of this model to investigate clonality in 
the intestinal crypts, excludes the possibility that crypts derived from 
distinct strains in chimeric mice segregate differentially during 
organogenesis. The monophenotypic origin of murine intestinal crypts 
was confirmed following histochemical analyses in these mice, although 
the small intestinal villi showed a polyclonal derivation, and are 
presumably formed by the upwards migration of epithelial cells from 
multiple crypts (Thomas et al., 1988). This is concordant with 
observations that crypts, although smaller than villi, are 7-fold more 
numerous in the mouse duodenum, and 4-fold in the ileum (Wright and 
Alison, 1984).
In both chimeric mice and the G6PD mouse model, the time taken for the 
decrease in partially-mutated crypts and emergence of entirely negative 
crypts to reach a plateau was approximately 4 weeks in the small 
intestine and 12 weeks in the large intestine, which was initially thought to 
be due to tissue differences in cell cycle duration. However, an 
alternative explanation can be found in the “stem cell zone” hypothesis,
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which was conceived following a series of microscopic morphometry and 
autoradiography-labelling studies of the mouse small intestine (Bjerknes 
and Cheng, 1981a; Bjerknes and Cheng, 1981b; Bjerknes and Cheng, 
1981c; Bjerknes and Cheng, 1981d; Bjerknes and Cheng, 1981e). In this 
hypothesis, multiple stem cells occupy the crypt base at cell positions 1 -  
4, and can undergo proliferation but do not differentiate until they have 
migrated to cell position 5. Paneth cells also appear initially at position 5, 
although these cells migrate downward to the crypt base (Bjerknes and 
Cheng, 1981a). Based upon this hypothesis, it was suggested that larger 
numbers of stem cells are present in the colon than in the small intestine, 
causing the difference in time taken for the mutant stem cells to expand 
stochastically and create monoclonal crypts (Williams et al., 1992).
Alternatively, the temporal differences in the appearance of 
monophenotypical crypts in specific regions of the gastrointestinal tract 
may be due to differential rates of crypt fission at the time of mutagen 
administration (Park et al., 1995). It was suggested that stem cell number 
fluctuates throughout the crypt cycle until a threshold number of cells is 
reached, thereby signalling for crypt fission to occur (Loeffler et al., 1997). 
Other reports state that between 4 - 6  stem cells located at cell position 4 
- 5 from the base of the crypt, just superior to the Paneth cells, comprise 
the small intestinal stem cell population (Cai et al., 1997; Potten, 1998; 
Potten et al., 1997), and others claim that up to 16 or more stem cells can 
exist in a single intestinal crypt (Roberts et al., 1995).
1.4.3.2) Human
In humans, the intestinal crypts appear to be monoclonal and the small 
intestinal villi are polyclonal, analogous to the situation in the mouse. The 
single cell-cloned human colorectal carcinoma cell line, HRA19, was 
derived from a primary adenocarcinoma of the rectum. A colony of single 
morphology was cloned and grown as a monolayer in vitro. When 
engrafted subcutaneously into nude mice, the clones produce tumours 
that were histologically identical to the founding tumour and contain each
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major epithelial cell type found in vivo (Kirkland, 1988). However, it is 
important to note that the results of this study of neoplastic cells cannot 
be directly applied to the normal human gastrointestinal epithelia.
Perhaps the best evidence for the clonal origin of human intestinal crypts 
comes from a study of the colon of a rare XO/XY patient who had 
received a prophylactic colectomy for familial adenomatous polyposis 
(FAP). Non-isotopic in situ hybridisation (NISH) using Y chromosome- 
specific probes showed that normal intestinal crypts were composed 
almost entirely of either Y chromosome-positive or Y chromosome- 
negative cells, with approximately 20% of crypts being XO. 
Immunostaining for neuroendocrine cell-specific markers was combined 
with NISH detection of the Y chromosome to show that these cells shared 
the same genotype as other crypt cells. The small intestinal villi epithelia 
were a mixture of XO and XY cells, in keeping with the notion that villi 
derive from stem cells of more than one crypt. Of the 12,614 crypts 
examined, only 4 crypts were composed of XO and XY cells, which was 
explained by non-disjunction with loss of the Y chromosome in a crypt 
stem cell. These observations agree with previous findings in chimeric 
mice that intestinal crypts are monoclonal and derive from a single 
multipotential stem cell.
Clonality studies are not strictly sustainable if they overlook the vital 
consideration of “patch size”, wherein a “patch” is described as the 
number of cells of a single genotype within an area of tissue that is 
derived from either a single clone or from the coalescence of multiple 
clones of the same lineage (Garcia et al., 2000; Schmidt et al., 1985). 
Clonality must be determined at the patch edge, as it is not possible to 
decipher whether cells within the centre of a patch are truly clonal or 
simply monophenotypic, formed from several stem cells of the same 
genotype. Heterozygosity for the G6PD Mediterranean mutation (563 C 
-*  T) is present in 17% of Sardinian females, permitting analyses of patch 
size by G6PD immunohistochemical staining. Of 10,538 colonic crypts 
analysed from 9 patients carrying the G6PD Mediterranean mutation,
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patch size in the colon was observed to be relatively large, containing up 
to 450 crypts. No evidence of any crypts with a mixed phenotype was 
observed in 2,260 crypts located at the periphery of a patch, indicating 
that colonic crypts are indeed monoclonally-derived (Novelli et al., 2003). 
The Unitarian hypothesis, that all the differentiated epithelial lineages 
within the gastrointestinal tract share a common cell of origin, appears to 
apply to both mice and humans.
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1.5) Methods of identifying intestinal stem cells
The maintenance of homeostasis of the intestinal epithelium is an 
intricate and complex interplay of multiple regulatory mechanisms. It is 
therefore of great interest to uncover the molecular and cellular pathways 
that are required for normal intestinal function, starting, of course, with the 
ongoing quest to identify the intestinal epithelial stem cell and its niche.
1.5.1) Crypt fission and the crypt cycle
The intestinal crypts divide and replicate by a branching process known 
as “crypt fission”. In this process, the intestinal crypts undergo basal 
bifurcation and budding, leading to longitudinal division and the formation 
of identical daughter crypts. Elucidation of the process of crypt 
multiplication, led to the notion that the intestinal crypts have a “crypt 
cycle” and finite lifespan, which was subsequently shown to be 
approximately 2 years in the mouse small intestine (Loeffler et al., 1997; 
Totafurno et al., 1987). As crypt fission begins at the bottom of the crypt 
i.e. the location of the putative stem cells, it is possible that the stem cells 
initiate and regulate the formation of new crypts. Indeed, evidence is 
emerging that crypt fission may occur in the intestine when a maximal 
crypt size is reached (Park et al., 1997), possibly when a threshold 
number of stem cells becomes exceeded (Loeffler and Grossmann,
1991).
A stochastic state dependent model of stem cell growth, proposes that 
there are 3 possible outcomes when stem cells divide, described as; “r”, 
wherein a stem cell divides asymmetrically to produce one stem cell that 
is retained within the niche and one daughter cell that leaves the niche 
and becomes committed to differentiation; “p”, wherein 2 stem cells are 
produced following symmetrical stem cell division and; “q”, where stem 
cells divide symmetrically to produce two daughter cells that leave the
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niche and become transit amplifying cells (Figure 1.2; (Loeffler et al.,
1993)).
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Figure 1.2) Possible outcomes of stem cell division.
A stem cell (s) can divide asymmetrically to produce one stem cell that is 
retained within the niche and one transit amplifying (TA) cell that leaves 
the niche and becomes committed to differentiation (a). Alternatively, a 
stem cell can undergo symmetrical division to produce two identical stem 
cells, or two TA daughter cells (b). Diagram courtesy of MJ Lovell.
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1.5.2) DNA-labelling studies
A recent study of the mechanisms of stem cell division in the mouse small 
intestine has revealed that during asymmetrical division, stem cells retain 
an innate mechanism of genome protection. By labelling DNA template 
strands of the intestinal stem cells with tritiated thymidine ([3H]TdR) 
during development or in tissue regeneration, and by bromodeoxyuridine 
(BrdUrd)-labelling the newly synthesized daughter strands, both DNA 
strands can be visualised during cell division. Results showed that the 
original template DNA is retained within the stem cell, and the newly 
synthesised Brdllrd-labelled strands are passed-on to the daughter cells 
that leave the stem cell niche and become committed to differentiation. 
By discarding the newly transcribed DNA during asymmetrical cell 
division the intestinal stem cell utilises an inherent mechanism of genome 
protection, as this strand is more prone to replication-induced mutation 
(Potten et al., 2002). This study supports the hypothesis of Cairns 
(Cairns, 1975), which suggests that selective retention of the template 
DNA strand during stem cell division provides a means of protection 
against DNA replication errors (Figure 1.3).
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Figure 1.3) The segregation of template and newly-synthesised DNA 
strands in a chromosome during cell division, according to the 
Cairn’s hypothesis.
Template DNA strands are selectively retained by the stem cell during 
cell division, whereas the newly-synthesised DNA strands are segregated 
to the daughter cell destined to enter the dividing transit compartment and 
be shed from the tissue after a few days, thus removing any replication- 
induced errors. Label introduced into the newly-synthesised DNA takes 
two divisions to be removed from the stem cells, whereas label in the 
template strand would persist in the stem cell line. (Adapted from (Potten 
et al., 2002)).
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1.5.3) DNA mutation studies
An insight into stem cell organization in the crypts was gained from 
studies of the methylation pattern of non-expressed genes in the colon. 
Phylogenetic analyses of random sequence variations in methylation tags 
of three neutral loci in cells of human colonic crypts can predict stem cell 
division histories and map cell fate. Cells in separate, unrelated crypts 
show variations in these methylation patterns, as expected, and cells 
closely opposed within one crypt display identical or closely related 
sequential methylation tags. This indicates that human colonic crypts 
contain multiple stem cells, which are constantly lost and replaced, 
eventually leading to a "bottleneck" effect wherein all cells are related to 
the closest stem cell ascendant and are monoclonally-derived (Yatabe et 
al., 2001).
Both inherited and spontaneous mutations occur frequently in the human 
mitochondrial genome, and are implicated in the progression of many 
diseases, with a role in ageing and carcinogenesis (Brierley et al., 1998; 
Coller et al., 2001; Michikawa et al., 1999). Mathematical models indicate 
that the high frequency of mitochondrial DNA (mtDNA) mutations, and 
their accumulation within individual cells is a result of clonal expansion by 
genetic drift (Chinnery and Samuels, 1999; Coller et al., 2001), and can 
produce a defect in oxidative phosphorylation (Sciacco et al., 1994). 
Cells demonstrating >50% cytochrome-c oxidase enzyme function and 
normal succinate dehydrogenase (SDH) activity generally have increased 
numbers of mtDNA mutations (Johnson et al., 1993). The biochemical 
function of samples of both normal and cancerous human colonic mucosa 
was deduced by sequencing their mtDNA, and by histological analysis of 
cytochrome-c oxidase and SDH function. The results were inconsistent, 
as crypts were composed either entirely, or partially, of cells with mtDNA 
mutations, suggesting that a single stem cell exists in the wholly mutated 
crypts, and that multiple stem cells co-exist in the mixed crypts (Taylor et 
al., 2003). Mitochondrial DNA mutations accumulate in stem cells in the 
colonic crypts in an age-dependent fashion and can produce a
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biochemical deficiency dependent on the site and severity of the 
mutation. This study has implications for the role of mtDNA mutations in 
the onset of cancer, and presents a link between mutations in mtDNA and 
the resultant aberrant oxidative phosphorylation in cancer cells, as 
accumulating mutations occur within crypt stem cells, which then undergo 
clonal expansion (Taylor et al., 2003).
1.5.4) Molecular markers of intestinal stem cells
1.5.4.1) Musashi and Hairy and Enhancer-of-split proteins
Musashi-1 (Msi-1) is the mammalian homologue of a Drosophila protein 
required for asymmetric division of sensory neural precursor cells 
(Nakamura et al., 1994; Okabe et al., 2001), and is highly expressed in 
mammalian neural stem cells (Sakakibara et al., 1996). The 
transcriptional repressor Hairy and Enhancer-of-split (Hes)-1 is essential 
for neural stem cell self-renewal and suppression of neural stem cell 
differentiation (Akazawa et al., 1992; Nakamura et al., 2000; Sasai et al.,
1992). Msi-1 positively regulates transcription of Hes-1, suggesting a 
close interaction between the 2 proteins (Imai et al., 2001). This is 
supported by their co-expression in cells just superior to the Paneth cells 
in the small intestine, the postulated stem cell zone. Hes-1 expression in 
the mouse small intestine is more widespread than Msi-1 expression, as 
Hes-1 is also expressed, albeit in reduced levels, in epithelial cells 
migrating toward the villus tip. It is suggested that co-localisation of Msi-1 
and Hes-1 in cells just superior to the Paneth cells is indicative of the 
stem cell population in the mouse small intestine, and that Hes-1 
expression alone represents proliferating cells committed to differentiation 
that have migrated outwith the stem cell niche (Kayahara et al., 2003). 
Musashi-1 mRNA and protein expression has also been confirmed in the 
putative stem cells in neonatal and adult intestinal crypts in mice (Potten 
et al., 2003), and has recently been demonstrated in the human colon in 
epithelial cells located between position 1-10 in the crypts (Nishimura et
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al., 2003). These studies implicate Musashi-1 as a possible 
gastrointestinal epithelial stem cell marker.
1.5.4.2) Repression of E-cadherin
E-cadherin is a cell adhesion molecule with a well-established role in 
tumour suppression. Downregulation of E-cadherin expression is 
implicated in a number of pathological conditions in the gut, which involve 
increased cell proliferation, loss of cell polarity and/or differentiation, 
including IBD and cancer (Del Buono and Pignatelli, 1999; Gagliardi et 
al., 1995; Gassier et al., 2001; Hanby et al., 1996). E-cadherin is 
expressed in high levels in the intestinal epithelium, and has been shown 
to regulate intestinal cell polarity and differentiation both in vitro 
(Schreider et al., 2002) and in vivo, via the p-catenin/Tcf/LEF signalling 
pathway (Gottardi et al., 2001; Stockinger et al., 2001), which is vital for 
normal intestinal epithelial cell function (section 1.6.1). A recent 
publication claims that differential E-cadherin expression in the epithelial 
cells along the human small intestine crypt-villus axis provides an insight 
into the nature of the hierarchical polar distribution of these cells, and can 
be used to locate the intestinal epithelial stem cells. E-cadherin is absent 
from the cells in the base of the human small intestinal crypts, at 
approximately cell position 5 - 7  i.e., the stem cell zone. Forced 
expression of E-cadherin in those cells caused a decrease in 
proliferation, and promoted cell junction formation thereby inhibiting cell 
migration. It is therefore proposed that E-cadherin represents a marker of 
intestinal epithelial stem cells, and plays an important role in regulating 
stem cell behaviour. However, the inability of E-cadherin to induce 
terminal differentiation of enterocytes indicates that it acts in conjunction 
with other proteins (Escaffit et al., 2005).
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1.6) Pathways of cellular differentiation in the intestine
An increasing number of genes and their ligands and receptors are being 
identified that are expressed by epithelial and mesenchymal cells in the 
gastrointestinal tract, and are involved in the regulatory molecular 
pathways of epithelial cell function in both the normal and neoplastic 
gastrointestinal mucosa. The ongoing elucidation of these molecular 
pathways is key to providing an insight into the location and the behaviour 
of the intestinal epithelial stem cell.
1.6.1) The Wnt/p-catenin signalling pathway
The central player in the canonical Wnt signalling pathway is the 
cytoplasmic protein beta (p)-catenin, whose stability is regulated by the 
APC tumour suppressor complex. When Wnt receptors are not engaged, 
APC forms a subcellular, trimeric complex with axin and glycogen 
synthase kinase-3p (GSK3P), which triggers the phosphorylation, 
ubiquitination and proteosomal degradation of p-catenin. Wnt stimulation 
activates the cytoplasmic phosphoprotein “dishevelled” through its 
receptor “frizzled”, causing inhibition of GSK3p and a resultant 
accumulation of cytosolic p-catenin (Kinzler and Vogelstein, 1996). Beta- 
catenin then translocates into the nucleus and interacts with members of 
the T cell factor/lymphoid-enhancing factor (Tcf/LEF) family of DNA- 
binding proteins, transiently converting them from transcriptional 
repressors to activators, and signalling the activation of downstream 
target genes that increase cellular proliferation. When the Wnt signal is 
removed, APC extracts p-catenin from the nucleus and the transcriptional 
repressor function of Tcf is restored (reviewed in (Bienz, 2002; Sancho et 
al., 2004)).
The Wnt/p-catenin pathway plays a role in malignant transformation, as 
85% of human sporadic colorectal tumours are reported to have an APC
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mutation (Kinzler and Vogelstein, 1996). This APC mutation renders the 
GSK3p/Axin/APC complex incapable of destabilising p-catenin, leading to 
an accumulation of nuclear p-catenin/Tcf/LEF complexes, and an 
increase in target gene transcription and cell proliferation which can 
cause tumour formation (Figure 1.4; (Mei et al., 1999; Wielenga et al., 
1999)).
41
Frizzled
- \  ./"
Ubiquitin- 
mediated Q  
proteolysis Of\ O
o o
AXIN J O
TCF I [JfltOfflS 
9SS//X
Nucleus
Frizzled
Nucleus
Figure 1.4) The canonical Wnt/p-catenin signalling pathway.
In the absence of active Wnt signalling (a.), APC forms a complex with 
axin and GSK-3, which triggers the degradation of p-catenin, and 
maintains prospective target genes in a repressed state. Wnt signalling 
(b.), activates the cytoplasmic phosphoprotein DSH, through its receptor 
“Frizzled”, to reduce p-catenin degradation. As p-catenin accumulates, it 
enters the nucleus and interacts with members of the T-cell factor (TCF) 
and lymphoid-enhancing factor (LEF) family of transcription factors to 
activate the transcription of target genes. APC, adenomatous polyposis 
coli; p-cat, p-catenin; DSH, dishevelled; GSK-3, glycogen synthase 
kinase-3p; P, phosphorylation; TCF, T-cell factor. (Adapted from (Moon 
et al., 2004)).
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1.6.2) The Tcf/LEF DNA-binding protein family
There are four known members of this family of transcription factors, Tcf- 
1, LEF1, Tcf-3, and Tcf-4. Tcf-4 is expressed in high levels in the 
developing intestine from embryonic day (E) 13.5, and in the epithelium of 
the adult small intestine and colon and in colon carcinomas (Barker et al.,
1999). In patients with a loss of function of the APC or p-catenin genes, 
the nuclear accumulation of p-catenin/Tcf-4/LEF complexes in colonic 
epithelial cells implicates Tcf-4 in the ensuing uncontrolled target gene 
transcription, and subsequent upregulation of cell proliferation that can 
often lead to tumourigenesis (Barker et al., 1999). In the absence of p- 
catenin, the Tcf/LEF family recruit the co-repressor proteins “Groucho” 
and CREB-binding protein (CBP) to the downstream Wnt target genes 
and inhibit their transcription (reviewed in (Barker et al., 2000)). The Tcf- 
4 knockout mouse is devoid of proliferating cells in the small intestine, 
and is presumed to lack a functional stem cell compartment. It is 
postulated that Tcf-4 is vital for the establishment of the intestinal stem 
cell population, and is activated by a Wnt signal from the underlying 
stroma (Korinek et al., 1998), further evidence that mesenchymal cells in 
the lamina propria comprise the intestinal stem cell niche.
TCF target genes include; c-myc, tcf-1, cydin D1, c-Jun, Fra-1, 
urokinase-type plasminogen activator receptor (uPAR), fibronectin, CD44, 
and the matrix metalloproteinase matrilysin, many of which have 
carcinogenic potential in the gastrointestinal tract (reviewed in (Bienz and 
Clevers, 2000; Polakis, 1999)). Two important Tcf-4 target genes are the 
tyrosine kinase guidance receptors EphB2 and EphB3 , which are 
expressed along a gradient with the highest levels found in the crypt 
base, whereas levels of their ligand ephrin-B1 increase in a counter­
gradient along the crypt-villus axis. In mice with targeted deletion of 
EphB2 and EphB3 genes, differentiated epithelial cells lose their
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polarised organisation resulting in a random distribution of mucosal cells 
(Batlle et al., 2002).
1.6.3) Cdx-1 and Cdx-2 homeobox genes
The mammalian homeobox proteins Cdx-1 and Cdx-2 also play an 
important role in intestinal epithelial stem cell transcriptional regulation, 
with a particular influence on gastrointestinal metaplasia. Cdx-1 is 
expressed throughout the proliferative compartment of the developing 
and adult mouse intestinal crypt epithelium (Subramanian et al., 1998), 
and both Cdx-1 and Cdx-2 mRNAs show restricted expression in the 
epithelial mucosa of the human small intestine and colon (Mallo et al., 
1997; Mizoshita et al., 2001). The Tcf-4 knockout mouse, mentioned 
above, does not express Cdx-1 in the small intestinal epithelium, implying 
that Cdx-1 is a direct downstream target of the Tcf-4/p-catenin complex in 
the Wnt signalling pathway, and is employed in development of the 
epithelial stem cell niche (Lickert et al., 2000). Expression of Cdx-1 is 
reduced in proliferating epithelial cell nuclei in colonic crypts concurrent 
with their progression to adenomas and adenocarcinomas (Lickert et al.,
2000) although, as no colonic tumours develop in the Cdx-1 null mouse, 
this molecule does not appear to have direct tumour suppressing 
properties (Subramanian et al., 1998). Cdx-2 is expressed in all epithelial 
cell nuclei in the upper regions of the crypts of the descending colon to 
the rectum, with decreasing expression parallel to an increasing degree 
of dysplasia in these cells (Ee et al., 1995). Region-specific genes such 
as Cdx-1, Cdx-2 and Tcf-4 appear to define the morphological features of 
the specialised regions of the intestinal epithelium and regulate stem cell 
function.
1.6.4) The forkhead family of transcription factors
The forkhead, or winged helix family of transcription factors, of which 
there are nine members identified in mice, produce the Fox (forkhead 
box) proteins (reviewed in (Kaestner et al., 2000)). Mice with a
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heterozygous targeted mutation of the forkhead homologue 6 (fkh-6), or 
Fox1 gene, which is ordinarily expressed by gastrointestinal 
mesenchymal cells, display an atypical gastrointestinal epithelium with 
branched and elongated glands in the stomach, elongated villi, 
hyperproliferative crypts and goblet cell hyperplasia due to increased 
epithelial cell proliferation. These Fox1 mutants have increased levels of 
heparin sulfate proteoglycans (HSPGs), causing overactivation of the 
Wnt/p-catenin pathway and an increase in target cell proliferation, 
demonstrating an indirect regulation of the Wnt/p-catenin pathway by 
Fox1-mediated HSPG production (Kaestner et al., 1997).
1.6.5) The TGF-p/Smad signalling pathway
The transforming growth factor TGF-p family of growth factors are known 
inhibitors of gastrointestinal epithelial cell proliferation, and are 
predominantly expressed in the differentiated compartments of the gut 
(Winesett et al., 1996). Under normal circumstances, TGF-p forms a 
multimeric complex with two serine-threonine kinase surface receptor 
molecules, TGF-p type I (TGFpRI) and type II (TGFpRII). The 
intracellular messengers of the TGF-p signalling pathways are the 
cytoplasmic Smad proteins, and Smad2 and Smad3 are phosphorylated 
upon activation of the TGF-p receptors, and form a heteromeric complex 
with Smad4. This complex then translocates to the nucleus, where it 
interacts with transcriptional coactivators and corepressors to regulate 
TGF-p target gene transcription (Fiocchi, 2001; Miyazono, 2000).
Disruption of TGF-p/Smad signalling causes intestinal epithelial cell 
hyperproliferation, and Smad2, Smad4 and TGFpRII are frequently 
inactivated in human cancers confirming their function as tumour 
suppressor genes (Grady et al., 1999; Markowitz et al., 1995; Massague, 
1998). Lack of TGF-p signalling in the intestine appears to contribute to 
the progression of early pre-existing lesions (reviewed in (Sancho et al., 
2004)). For example, mice with targeted heterozygous mutations in the
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Smad4 and APC genes develop adenomatous polyps in the small 
intestine and colon due to loss of heterozygosity (LOH) of the APC and 
Smad4 wild type alleles. These lesions rapidly progress to form 
adenocarcinomas with an increased malignant nature than those formed 
in mice with a heterozygous mutation of the APC allele only (Takaku et 
al., 1998). This implies a reciprocal interaction between the TGF-p and 
Wnt signalling pathways in the progression of intestinal carcinogenesis, 
wherein LOH of genes from both pathways is required before malignant 
transformation can occur (Takaku et al., 1998).
1.6.6) The Notch signalling pathway
Notch encodes a large, single transmembrane receptor, of which there 
are four mammalian isoforms (Notch 1 - 4 )  and five corresponding 
ligands (Delta-like 1, 3, and 4; Jagged 1 and 2) (reviewed in (Sancho et 
al., 2004)). The Notch-signalling pathway regulates gastrointestinal 
epithelial cell fate and the differentiation of the four specialised epithelial 
lineages of the gastrointestinal tract. This pathway supports the Unitarian 
Hypothesis, that a single stem cell gives rise to all mature intestinal 
epithelial cell lineages (Cheng and Leblond, 1974). Increased levels of 
Notch protein negatively regulate the transcription of the Mathl gene, a 
basic loop-helix transcription factor, via an upregulation of the Hes1 
transcriptional repressor. Mice with a targeted deletion of the Mathl gene 
fail to develop goblet, Paneth and enteroendocrine cell lineages in the 
small intestine, and these Mathl-negative epithelial cell progenitors solely 
form enterocytes (Yang et al., 2001). Conversely, a reduced Notch 
expression and subsequent accumulation of its ligand, Delta, increases 
Mathl expression by blocking Hes1, causing cells to transdifferentiate to 
form goblet, Paneth and enteroendocrine lineages in the small intestine 
(van Den Brink et al., 2001). Hes1 knockout mice display an elevated 
Mathl expression with a concurrent increase in the numbers of goblet, 
Paneth and enteroendocrine cells and a reduced enterocyte population 
(Jensen et al., 2000). These results suggest that the absorptive versus 
secretory cell fate decision is established through the Notch-Hes1
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pathways, although aberrant Notch signalling in intestinal tumourigenesis 
has not been described to date (reviewed in (Sancho et al., 2004)).
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1.7) Cells of the epidermis
The mammalian epidermis is the outer covering of the skin, composed of 
a stratified squamous, keratinised epithelium and its associated 
appendages, the hair follicles, sebaceous glands and sweat glands. The 
epidermis is subdivided into a basal layer, spinous layer, granular layer 
and the peripheral stratum corneum, which is in contact with the outer 
environment. The keratinocytes are the principal epithelial cell lineage in 
the epidermis, so-called because of the family of filamentous proteins, the 
keratins, which comprise its distinctive cytoskeleton. Other cells in the 
epidermis are the Langerhans cells, which provide immunological 
protection, the melanocytes that function in their absorption of ultraviolet 
light, and the Merkel cells, which act as sensory mechanoreceptors 
(reviewed in (Leigh et al., 1994)). The basal epidermis rests on a 
basement membrane, which overlies the dermis, a dense fibroelastic 
connective tissue composed of collagen and elastic fibres that encloses 
the vasculature and the nervous system of the skin.
1.7.1) Keratinocytes
The basal layer of the epidermis contains the epidermal stem cells and 
their transit amplifying cell progeny, which leave the niche and travel to 
the surface of the skin, giving rise to the entire differentiated keratinocyte 
repertoire during this hierarchical migration. Basal cells are distinguished 
by an intracellular cytoskeleton composed of a relatively dispersed, but 
extensive, network of keratin filaments. The spinous layer, or stratum 
spinosum, is 4 - 8 cells wide in humans. The keratinocytes in this layer 
contain large, dense bundles of keratin intermediate filaments, which 
extend to the cell periphery and form desmosomal cell junctions between 
adjacent cells, thereby imparting mechanical strength to the tissue. The 
spinous cells gradually become more flattened as they migrate upward, 
and express lamellar granules that secrete specific lipids and enzymes,
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which contribute to the barrier function of the epidermis by filling the 
intercellular spaces of the stratum corneum. The granular layer, or 
stratum granulosum, is generally comprised of 2 -  3 cell layers in 
humans, although this is markedly increased in the “ridged” skin of the 
palms and soles. The keratinocytes in this layer are post-mitotic and are 
distinguished by the presence of keratohyalin granules. Granular cells 
also synthesise and crosslink a number of structural proteins to form the 
cornified cell envelope of the terminally differentiated, non-viable stratum 
corneum. The human stratum corneum consists of 15 -  20 layers of flat, 
hexagonal-shaped anucleate cells, or squames. When keratinocytes 
enter the stratum corneum, the process of “keratinisation” is complete, 
and cells are eventually sloughed from the epidermal surface. The time 
taken for a keratinocyte to differentiate from stem cell to squame is 
approximately 8 -  9.5 days in mice (Potten et al., 1987), and between 28 
-  60 days in humans (Hunter et al., 1995).
1.7.2) Non-keratinocyte lineages
The melanocytes, Langerhans and Merkel cells comprise the non- 
keratinocyte component of the mammalian epidermis, accounting for less 
than 20% of all epidermal cells. These cells assume a non-random 
distribution amongst the keratinocytes throughout the epidermis; 
melanocytes and Merkel cells are typically present in the basal layer, 
whilst the Langerhans cells are found suprabasally in the spinous and 
granular layers. The melanocytes are dendritic-like cells, which are easily 
distinguished from keratinocytes by their lack of keratin intermediate 
filament bundles and by the presence of small, membrane-bound melanin 
pigment-containing melanosomes. Melanocytes are present in a 
constant ratio of 1 melanocyte to 36 keratinocytes, the “epidermal 
melanin unit” (Fitzpatrick and Breathnach, 1963; Jimbow et al., 1976), 
and function in their transfer of melanin to keratinocytes via dendritic 
processes. The Langerhans cells also have a dendritic phenotype and 
are specialised in the uptake, processing and presentation of specific 
antigens. These cells are distinguished by their lack of keratin
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intermediate filament bundles and the presence of “Birbeck granules”, 
which form by invagination of the plasma membrane to enclose bound 
antigen (Takahashi and Hashimoto, 1985). The Merkel cells are the 
hormone-secreting cells of the epidermis, which function as slow- 
adapting mechanoreceptors (Halata et al., 2003). Merkel cells contain 
small, membrane-bound dense core granules and can synthesise keratin 
intermediate filaments, although unlike the bundles of intermediate 
filaments in keratinocytes, these are loosely distributed within the 
cytoplasm. Merkel cells are the least common non-keratinocyte lineage 
in the epidermis, although are expressed in higher numbers in the palms, 
buccal mucosa, lips and soles i.e., regions of high touch sensitivity 
(Lacour et al., 1991).
I.7.3) The pilosebaceous hair follicle
II .3 .1 )  The hair follicle
Hair follicles are the major appendage in mammalian skin, and are 
comprised of an epithelial core surrounded by a mesenchymal sheath. 
The epithelial core is composed of several specialised layers including, 
the outer root sheath (ORS), which is continuous with the overlying 
interfollicular epidermis (IFE), and the inner root sheath (IRS) that 
includes, from centre to periphery, the cuticle and Henle and Huxley’s 
layers. The lower portion of the hair follicle protrudes into the dermis and 
is dilated into a bulb of epithelium enclosing the dermal papilla, a 
specialised pocket of mesenchymal cells. The hair shaft is enclosed 
within the IRS, and develops from progenitor cells located in the matrix 
region surrounding the dermal papilla (reviewed in (Goldsmith, 1991)).
Hair follicles undergo a constant cycle of alternating growth (anagen), 
regression (catagen) and rest (telogen). In the mouse, anagen lasts 
approximately 3 weeks, and the first 3 cycles are relatively synchronous. 
In humans, anagen can last for several years in hair follicles in the scalp, 
whereas the growth period for the eyelashes and eyebrows is around 1 -
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4 months, although the hair cycle is not synchronous in the skin of 
humans as each follicle maintains an independent rhythm of growth and 
rest (reviewed in (Alonso and Fuchs, 2003)).
1.7.3.2) The sebaceous glands
The sebaceous glands are attached to the upper permanent portion of 
the hair follicle where they are unaffected by the hair cycle and epidermal 
wounding. Sebaceous glands are associated with hair follicles all over 
the body, with the exception of the palms and soles, which are devoid of 
hair. Glands can be unilobular or multilobular, and vary greatly in size 
independent of their location, although the greatest density of glands are 
on the face and scalp. As the sebaceous cells, or sebocytes, migrate 
from the basal layer toward the centre of the gland, they accumulate a 
lipid-rich fluid, or sebum, that is eventually secreted onto the epidermal 
surface via the sebaceous duct. As sebocytes approach the sebaceous 
duct they become distended due to their high sebum content, and their 
nuclei and other intracellular structures disappear. The cells eventually 
rupture and release their contents into the duct by holocrine secretion 
(reviewed in (Thiboutot, 2004)).
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1.8) Epidermal stem cells
The cells of the adult epidermis and its associated appendages undergo 
continual renewal and remodelling throughout life, and therefore a strict 
balance between cell proliferation and differentiation must be maintained 
by the endogenous stem cells. Most adult stem cells divide infrequently 
and thus have a long cell cycle time e.g., stem cells of the skin and gut 
have a cell cycle time approximately 2-fold slower than their transit 
amplifying cell progeny, although cell cycle time is dramatically reduced 
following damage or disease e.g., mouse stem cell cycle times can be 
reduced from 200 hours to 12 hours following epidermal wounding 
(reviewed in (Potten and Booth, 2002)). The stochastic state-dependent 
model of intestinal stem cell growth proposed by Leoffler et al., (section 
1.5.1; (Loeffler et al., 1993)), can also be applied to the epidermal stem 
cells, wherein three possible outcomes are possible following stem cell 
division. Stem cells can undergo symmetrical division to produce two 
identical stem cells that are retained within the stem cell niche, or can 
divide asymmetrically to produce one identical stem cell and one 
daughter cell that leaves the niche and becomes committed to 
differentiation, or can undergo a third type of division to produce two 
daughter transit amplifying cells that leave the niche and differentiate to 
form specific epidermal lineages (reviewed in (Brouard and Barrandon, 
2003)).
A well-established model of DNA labelling can be used to localise the 
stem cells within a tissue, taking advantage of their long cell cycle. It is 
possible to label all the dividing cells in the developing or regenerating 
epidermis by a repeated or continuous supply of either Brdllrd or 
[3H]TdR, followed by a long chase period. The transit amplifying cells 
divide to dilute and eventually lose their label during the chase period, 
and only the cells that have a very slow cycle retain the label i.e., the 
stem cells.
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The epidermal stem cells reside in the basal layer of the epidermis, and 
are believed to inhabit stem cell niches in two separate locations, the 
“bulge” region of the hair follicles in both mice and humans, and the 
epidermal proliferative units (EPUs) in the rodent IFE, and in the basal 
epidermis at the top of the rete ridges in human IFE (Figure 1.5).
53
Figure 1.5) The epidermis and its postulated stem cell zones.
Stem cells are believed to be located at the top of the rete ridges in the 
basal layer of the interfollicular epidermis (IFE), and in the bulge region of 
the hair follicle beneath the sebaceous gland. The outer root sheath 
(ORS) is contiguous with the basal layer of the IFE and, together with the 
inner root sheath (IRS), forms a channel for the hair shaft. The dermal 
papilla is a cluster of specialised mesenchymal cells in the hair follicle 
bulb. Diagram courtesy of MJ Lovell.
1.8.1) Stem cells in the bulge region
It was originally believed that the relatively undifferentiated cells in the 
lower part of the hair follicle bulb were the epidermal stem cells (Hardy, 
1992; Reynolds and Jahoda, 1991). However, excision of the hair bulb 
and dermal papilla in both mice and humans established that this region 
is not required for regeneration of the hair follicles, as the remaining intact 
upper portion of the hair follicles could renew the entire follicle and 
therefore was proposed to contain a potent stem cell population (Jahoda 
etal., 1996; Oliver, 1966).
In a seminal paper by the Cotsarelis laboratory (Cotsarelis et al., 1990), 
repeated labelling with [3H]TdR revealed a subpopulation of epidermal 
cells in the “bulge” region of the hair follicle that retained their DNA label 
for a long period of time, and were proposed to constitute a population of 
epidermal stem cells. Furthermore, no label-retaining cells were 
observed outwith the bulge, which was defined as the lowest point of the 
upper permanent portion of the follicle at the level of attachment of the 
arrector pili muscle immediately subjacent to the sebaceous gland 
(Cotsarelis et al., 1990). With the discovery of these putative stem cells 
arose the “bulge activation hypothesis”, which states that the stem cells in 
the bulge form all epidermal lineages upon stimulation by associated 
mesenchymal cells (Cotsarelis et al., 1990). In support of this hypothesis, 
bulge cells are in contact with the mesenchymal dermal papilla of the bulb 
during telogen, and are the first cells to undergo proliferation at the onset 
of hair growth during early anagen (Wilson et al., 1994), possibly due to 
paracrine signalling by the cells in the dermal papilla via their epithelial: 
mesenchymal contacts.
The potential of cells in the bulge to proliferate and form new 
keratinocytes was confirmed in mice following BrdUrd injection twice daily 
for 3 days, and a subsequent 8-week chase period, as label-retaining 
cells were restricted to the bulge region. After this 8-week chase period 
all follicles were in telogen, although when the chase was extended to IQ-
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weeks, some follicles in the anagen growth phase were observed that 
contained labelled cells in their lower regions, and were therefore directly 
descended from cells in the bulge (Taylor et al., 2000). Further evidence 
for a population of stem cells in the bulge was shown by dissection of rat 
whisker hair follicles and evaluation of their clonogenicity in vitro, which 
revealed that 95% of clonogenic cells are located in the bulge (Kobayashi 
et al., 1993; Oshima et al., 2001).
A novel double-labelling technique was devised to investigate the 
migration of bulge-derived cells in the adult mouse epidermis. Cells of 
the normal adult mouse epidermis have a low proliferative index (2 - 4% 
of cells) and a long cell cycle time (72 -  100 hours) (Loeffler et al., 1987; 
Potten and Loeffler, 1987). To overcome the experimental limitations 
posed by a long cell cycle, epidermal wounds were created on the dorsal 
epidermis of 7-week-old mice when the hair follicles were in telogen, to 
stimulate stem cell proliferation and shorten the cell cycle (Wilson et al.,
1994). The first pulse of BrdUrd was administered 21 hours post- 
wounding when epidermal regeneration was at its peak, followed by 
several chase intervals of 1 -  18 hours and a second injection of 
[3H]TdR. In the wounded epidermis, a 10-hour interval between BrdUrd 
and [3H]TdR administration resulted in the double labelling of 
keratinocytes in the upper regions of the follicles. Subsequent chase 
periods of 10, 20 and 30 hours resulted in a progressive decline in 
double-labelled cells of the upper follicles, and a concurrent marked 
increase in double-labelled cells in the IFE. These DNA-labelling studies 
advocate the “bulge activation hypothesis”, and confirm that the progeny 
of stem cells in the bulge can undergo at least two independent pathways 
of migration and differentiation, moving downward to form cells in the 
lower follicle, and upward migration to form cells in the upper follicle and 
IFE (Taylor et al., 2000).
Barrandon and colleagues (Oshima et al., 2001) dissected fragments of 
bulge regions obtained from whisker (vibrissal) follicles of adult ROSA26 
mice, which constitutively expressed a lacZ reporter gene under the
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control of “SV40” promoter, and implanted them into the vibrissal follicles 
of wild type mice that had had their own bulge region partially amputated. 
Cells derived from the transplanted bulge regions were detected by 
immunohistochemical staining for p-galactosidase, which revealed that 
cells from the bulge migrate to the upper and lower regions of the hair 
follicles and generate all epidermal lineages of the hair follicle including 
the IRS, ORS, hair shaft, and the sebaceous glands. Furthermore, 
fragments of the ROSA26 bulge region from vibrissal follicles were 
implanted onto the back skin of wild type mouse embryos, and when the 
embryos were born, the implanted regions were then transferred onto the 
back of adult athymic mice to prevent graft rejection. Transplanted bulge 
regions produced entire hair follicles, although these follicles were both 
morphologically and functionally typical of back hair, or pelage, follicles 
(Oshima et al., 2001). Therefore, epidermal stem cells in the bulge do 
not appear to be pre-programmed to form definitive lineages, and instead 
it seems that the fate of their cell progeny is influenced by external cues 
from the surrounding environment i.e., the stem cell niche.
As stem cells cycle more slowly than their differentiating counterparts, 
and thereby retain incorporated DNA label for lengthy periods, 
classification of stem cells as label-retaining cells is an effective means of 
their identification. However, it is surprising that stem cell in the bulge 
appear to retain their DNA label for several weeks, as the estimated stem 
cell cycle time in the adult mouse epidermis is approximately 8 days 
(reviewed in (Potten, 2004; Potten and Booth, 2002)). Therefore, a slow 
cell cycle is unlikely to be the apposite explanation for the prolonged label 
retention of the epidermal stem cells in the bulge. The Cairn’s hypothesis 
(Cairns, 1975), describes the selective retention of the template DNA 
strand by a stem cell during division, thereby protecting against DNA 
replication-associated errors, which are more frequent in the newly 
transcribed daughter DNA strand and can lead to carcinogenesis via the 
cancer stem cell hypothesis (see sections 1.1 and 1.5.2). Therefore, 
when new stem cells are being made i.e., during development or in tissue 
regeneration after wounding, DNA label would be incorporated into the
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permanent template strand, which is selectively retained throughout 
subsequent stem cell divisions. Retention of template DNA by stem cells 
in the intestine has recently been confirmed in a double-labelling study 
(Potten et al., 2002) but, although this would account for the prolonged 
expression of DNA label by cells in the bulge region, has not yet been 
established in the epidermis.
1.8.2) The epidermal proliferative unit
Early histological analyses of the stratum corneum of the mouse dorsal 
epidermis revealed that this layer is assembled into discrete plate-like 
columns of approximately 10 cells that can be traced downward to the 
basal layer. It was proposed that progenitor cells in the basal layer divide 
and migrate upward to produce the differentiated cells of the entire 
column, thus compensating for cells that are shed from the skin surface 
during keratinisation (Mackenzie, 1970; Potten, 1974). This 10-cell basal 
structure was named the epidermal proliferative unit (EPU), and was 
proposed to consist of a single central stem cell surrounded by its transit 
amplifying cell progeny (Figure 1.6; (Christophers, 1971; Mackenzie, 
1969; Potten, 1974)). Accordingly, subsequent irradiation and kinetic 
studies showed that epidermal stem cells comprise approximately 10% of 
the cells of the basal layer in the mouse epidermis (Clausen and Potten, 
1990; Kolodka et al., 1998; Mackenzie, 1997; Potten and Morris, 1988; 
Withers, 1967), although other studies have suggested that only 2% 
(Morris et al., 1985) and 4% (Bickenbach and Chism, 1998) of the basal 
cells in mice are stem cells, and therefore, the exact number of stem cells 
in the epidermis remains indeterminate.
In the human epidermis, the structural organisation of the stratum 
corneum resembles that of the mouse, implying that a basal proliferative 
compartment similar to the mouse EPU exists, although it has not yet 
been possible to trace the boundaries of each column to the basal layer 
and thus identify a definitive stem cell zone (reviewed in (Potten, 2004; 
Potten and Booth, 2002)). High levels of Pi integrin expression are
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believed to be a feature of epidermal stem cells (section 1.9.1; (Jones et 
al., 1995; Mackenzie, 1970)). The basal cells with the highest Pi integrin 
expression are localised in evenly spaced clusters within projections of 
the IFE into the dermis, known as rete ridges. Furthermore, keratin-19 is 
a potential marker of human epidermal stem cells (section 1.9.2) and is 
co-localised with Pi integrin-expressing slowly-cycling cells in deep rete 
ridges in the human IFE (Michel et al., 1996). Therefore, although a 
definitive stem cell-containing, EPU-like structure has not been identified 
in the human epidermis, the bulk of evidence suggests that these stem 
cells are located within rete ridges above the mesenchymal dermal 
papilla.
Substantial evidence supports the notion that stem cells in the IFE are 
less potent and less numerous than those in the bulge (Cotsarelis et al., 
1990), and that cells in the bulge have a longer lifespan than those in the 
IFE (Morris and Potten, 1999; Taylor et al., 2000). When cultured in vitro, 
bulge keratinocytes yield larger colonies than those from other skin sites, 
which has led to speculation that stem cells in the IFE may be the 
progeny of the bulge stem cells (Morris et al., 2004). It is well 
documented that the bulge stem cells are multipotent, capable of forming 
all the differentiated lineages of the hair follicles and the IFE. However, 
cells derived from the stem cells in the IFE appear to be unipotent, 
forming only the keratinocyte lineages found in the IFE itself (reviewed in 
(Alvarez-Dolado et al., 2003)).
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Figure 1.6) The epidermal proliferative unit (EPU).
EPUs are semi-independent units of cells, found in slowly-proliferating 
rodent epidermis. The stratum corneum is composed of flattened, 
hexagonal cells (surface view shown in upper part of A; C). The 
underlying stratum granulosum and stratum spinosum layers are aligned 
into columns, which project downward and encompass approximately 10 
cells in the basal layer (lower part of A; B). Mitotic cells are located at the 
edges of the basal layer, and are believed to derive from a central basal 
stem cell(s) and undergo lateral and then suprabasal migration 
throughout each epidermal layer until they are shed at the skin surface. 
(A, from (Leigh et al., 1994); B, C from (Wright and Alison, 1984)).
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1.9) Epidermal stem cell markers
1.9.1) Integrin expression by epidermal stem cells
Integrins are heterodimeric transmembrane receptors consisting of an a 
and a p subunit, which bind to specific ECM proteins and can transduce 
signals via the formation of cell:cell contacts. The known associations 
between the basal keratinocytes and their underlying basal lamina have 
generated an interest in specific integrin expression by the epidermal 
stem cells. Isolation of human keratinocytes on the basis of their surface 
p1 integrin expression showed that cells expressing the highest levels of 
p1 integrins had a high colony forming efficiency in culture and rapidly 
adhered to ECM proteins, and therefore may comprise a stem cell 
population (Jones and Watt, 1993). Immunohistochemical analyses of 
human skin showed that pi integrin expression is restricted to discrete 
patches of cells in the basal layer, and differentiating cells located 
suprabasally do not express pi integrins (Jones et al., 1995). However, 
high pi integrin expression was observed in approximately 20 -  45% of 
basal cells, which is at least double the proportion that are estimated to 
be stem cells in vivo (Jones et al., 1995).
The pi integrin gene knockout mouse is early embryonic lethal. 
Therefore, to investigate the consequences of epidermal-specific p1 
integrin deletion, mice with floxed pi alleles were crossed with mice 
expressing the Cre-recombinase enzyme under the control of either a 
keratin-14 or keratin-5 promoter, both of which proteins are constitutively 
expressed in basal keratinocytes. These animals show severe defects in 
basement membrane assembly and organisation and have impaired 
keratinocyte proliferation and ineffective cell migration, although 
proliferation and terminal differentiation of keratinocytes does occur 
(Brakebusch et al., 2000; Grose et al., 2002; Raghavan et al., 2000). It 
appears that p1 integrin is essential for the migration of keratinocytes,
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possibly via interactions with the basement membrane, although it is not 
essential for keratinocyte proliferation and differentiation.
Studies of a p1 integrin-deficient embryonic stem cell line showed that 
these cells fail to form keratinocytes in vitro, although will differentiate to 
produce keratinocytes in vivo when allowed to form teratomas by 
subcutaneous injection in mice, and following injection into the skin of pi- 
null/wild type chimeric mice. Additionally, ECM assembly was impaired in 
ES cell cultures, but not in the teratomas or chimeric mouse epidermis. 
(Bagutti et al., 1996). It was initially proposed that a lack of regulatory 
signals from the basement membrane in the culture environment 
prevents keratinocyte differentiation (Bagutti et al., 1996). This is fitting 
with the theory that stem cells are regulated by signals from their 
underlying niche, which is believed to comprise the underlying 
mesenchymal cells and their associated basement membrane factors 
(section 1.2). However, keratinocyte differentiation was not induced in 
co-cultures of pi integrin-deficient ES cells with epidermal basement 
membrane factors (Bagutti et al., 2001).
A later study has also highlighted a6 integrin as a stem cell marker in the 
human epidermis. Approximately 10% of basal epidermal cells express 
a6 integrin and exhibit an enhanced regenerative capacity (Li et al.,
1998). However, the use of a6 integrin in identifying epidermal stem cells 
remains controversial, as previous studies found little correlation between 
the level of a6|34 integrin expression and proliferative potential (Jones et 
al., 1995; Jones and Watt, 1993). Additionally, mice lacking the a6p4 
integrin heterodimer display severe epidermal blistering, but do not 
demonstrate reduced proliferation or differentiation of keratinocytes 
(DiPersio et al., 2000).
1.9.2) Keratin protein expression by epidermal stem cells
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The keratins are a multigene family of intermediate filament proteins that 
are differentially expressed in specific epithelial tissues, including the 
skin. In the epidermis, keratin (K) 5 and K14 are generally found in the 
undifferentiated cells of the basal layer, and K1 and K10 are found 
suprabasally in more differentiated keratinocytes (Bailleul et al., 1990; 
Byrne and Fuchs, 1993; Ramirez et al., 1994; Vassar et al., 1989). The 
switch in keratin expression between the proliferating and differentiating 
compartments of the epidermis indicates that changes in keratin filament 
organisation, and the ensuing changes in cellular adhesion may influence 
keratinocyte function (reviewed in (Fuchs, 1990)).
Unlike K14, which is ubiquitously expressed by all cells in the basal 
epidermis, K15 is restricted to patches of label-retaining cells in this layer 
in the human hair follicle bulge region, and thus K15 has been nominated 
as a marker of human epidermal stem cells (Lyle et al., 1998; Porter et 
al., 2000; Waseem et al., 1999). Moreover, label-retaining cells in the 
bulge have recently been shown to co-express both K15, and the 
primitive stem cell marker, CD34 (Trempus et al., 2003).
Liu and colleagues (Liu et al., 2003) cloned the promoter region of the 
mouse K15 gene with a downstream lacZ reporter gene, and generated a 
K15/lacZ transgenic reporter mouse in which K15 activity was detected 
by p-galactosidase expression. Transgenic mice were injected with 
[3H]TdR twice a day for 3 days, followed by a chase period of 50 days, to 
label DNA in slowly cycling cells. In adult transgenic mice, lacZ 
expression was strikingly localised to label-retaining bulge cells 
throughout all stages of the hair cycle (Liu et al., 2003). As a continuation 
to these results, a second transgenic mouse was produced that 
expressed CrePRI fusion protein, under control of the K15 promoter 
(Ktr1-15-CrePR1). CrePRI consists of a Cre-recombinase enzyme and a 
truncated progesterone receptor that binds the progesterone antagonist, 
RU486. In Ktr1-15-CrePR1 mice, CrePRI is inactive in K15-positive cells 
except during RU486 treatment, wherein CrePRI enters the nucleus and 
causes recombination. Ktr1-15-CrePR1 mice were further crossed with
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R26R mice to produce Ktr1-15-CrePR1;R26R transgenic mice, which 
ubiquitously express lacZ under the control of the ROSA26 promoter 
following Cre-mediated removal of an inactivation sequence. Treatment 
of Ktr1 -15-CrePR1 ;R26R mice with RU486 resulted in permanent 
expression of lacZ in the bulge region, and also in their progeny, thus 
demonstrating that bulge stem cells are K15-positive, have a high 
proliferative potential and are long-lived. These studies unequivocally 
demonstrate that bulge stem cells are multipotent and can form three 
differentiated epidermal lineages, as lacZ-labelled cells were seen in hair 
follicles, IFE and in the sebaceous glands, although the major flux of cells 
appeared to contribute to generation of the new hair follicle during the 
hair cycle, and it is postulated that separate populations of stem cells 
exist within the IFE and sebaceous glands (Morris et al., 2004). In the 
same study, the K15 promoter region was cloned upstream of eGFP and 
transgenic mice were created wherein the K15/eGFP-positive cells in the 
bulge could be isolated by fluorescence-activated cell sorting (FACS). 
These cells possessed several characteristics of epidermal stem cells as 
they co-expressed a6 and p1 integrins and CD34, and they also had a 
high proliferative potential and formed large colonies in vitro. 
Furthermore, the multipotency of these cells was confirmed as isolated 
stem cells can regenerate the entire epithelium when combined with 
neonatal mouse dermal cells in culture (Morris et al., 2004).
The aforementioned study by the laboratory of Cotsarelis (Morris et al., 
2004), is one of two recent papers that have made a considerable 
advancement in the isolation of a multipotent epidermal stem cell. The 
second paper comes from the Fuchs laboratory, and outlines the 
transcriptional profile of a population of label-retaining cells isolated from 
the stem cell niche (Tumbar et al., 2004). In this study, transgenic mice 
were engineered to express histone H2B-green fluorescent protein (GFP) 
controlled by a tetracycline (tet)-responsive regulatory element (TRE), 
and were further crossed with mice expressing a K5 promoter, driven by 
the tet repressor, VP16. Administration of tet induced K5 expression in 
the epidermis, and in the absence of tet the epidermis was GFP-positive.
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Four-week-old mice were administered tet for 4 weeks, and following a 4 
month chase period, less than 1% of bulge cells retained GFP 
fluorescence i.e., had not differentiated to express K5. At the onset of 
anagen, GFP-positive cells initiate new follicle formation and migrate 
downward from the bulge to produce multiple epidermal lineages 
including cells in the IRS, ORS, matrix and hair shaft. The GFP-positive 
cells also repopulated the wounded epidermis in vivo, and had high 
proliferative capacity in vitro. The authors confirm the co-expression of 
epidermal stem cell markers in the bulge including, K15, K19, a 6 and (31 
integrins, and CD34, and defined the mRNA expression profile of these 
cells which interestingly revealed expression of three genes that are also 
common to HSCs, ES cells and neural stem cells, namely Eps8, Col18a1, 
Pkd2 (Tumbar et al., 2004).
K19 is another keratin protein that has been proposed as a stem cell 
marker, although recent evidence suggests that K15 is perhaps a more 
convincing candidate (Morris et al., 2004; Tumbar et al., 2004). K19 co- 
localises with the label-retaining cells in the bulge region of hair follicles in 
adult human skin (Lane et al., 1991; Stasiak et al., 1989). K19
expression within label-retaining cells in the skin was confirmed in a later 
study combining [3H]TdR labelling with K19 immunodetection, although 
K19 was not expressed on all label-retaining cells and therefore may not 
be present in all stem cells (Michel et al., 1996). K19-positive cells also 
co-express high levels of the putative epidermal stem cell marker (X3P1 
integrin, strongly implicating K19 as a marker of epidermal stem cells 
(Michel et al., 1996). Interestingly, the numbers of K19-positive cells 
appeared to decrease with age, suggesting a decline in stem cell number 
from birth to adulthood (Michel et al., 1996).
1.9.3) p63 expression by epidermal stem cells
Another factor associated with epidermal stem cells is the transcription 
factor p63, a homologue of the tumour suppressor gene p53 (Lohrum and
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Vousden, 2000). Mice with a targeted deletion of the p63 gene locus 
have major defects in their limb and craniofacial development, as well as 
a striking absence of stratified epithelia (Celli et al., 1999; Yang et al.,
1999). Immunohistological analyses of human skin revealed that p63 
protein expression was restricted to clusters of slow-cycling, 
undifferentiated cells in the basal epidermis, implicating p63 as a marker 
of distinction between epidermal stem cells and their transit amplifying 
progeny (Pellegrini et al., 2001; Yang et al., 1998).
1.9.4) Melanoma-associated chondroitin sulfate expression by 
epidermal stem cells
Keratinocytes synthesise a number of proteoglycans that are differentially 
expressed depending on the proliferative status of the cell. Melanoma- 
associated chondroitin sulfate (MCSP) is a high molecular weight 
proteoglycan that is highly expressed in human melanomas and in 
cultured melanoma cell lines (Pluschke et al., 1996). MCSP has a 
restricted pattern of expression in small clusters of basal cells in the 
human IFE, and is co-localised with Pi integrin in these cells (Kupsch et 
al., 1995). In the human hair follicles, MSCP expression is relatively 
widespread in the ORS, although co-expression of both MCSP and K15 
is restricted to basal cells in the centre of the ORS (Kupsch et al., 1995). 
Moreover, MCSP is co-localised with other putative epidermal stem cell 
markers, keratin-19, Pi and a6 integrins, within a subset of cells in this 
region of the ORS (Ghali et al., 2004). These data suggests that MCSP, 
when co-expressed with other specific antigens, may provide a good 
marker of human epidermal stem cells in both the IFE and the bulge 
region of the hair follicles.
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1.10) The epidermal stem cell niche
It is generally accepted that a population of stem cells exists in the bulge 
region of the hair follicles and in specialised clusters in the IFE, although 
the stem cell niches for these stem cells are as yet undefined and 
consequently the mechanisms that regulate epidermal stem cell 
behaviour are unclear. The bulge activation hypothesis states that 
signals from mesenchymal cells in the dermal papilla of the hair bulb 
stimulate the multipotent differentiation of the keratinocyte stem cell 
(section 1.8.1). During catagen, the lower two-thirds of the hair follicle 
regress and the dermal papilla moves upward to the level of the bulge, 
where it remains throughout telogen. When a new hair cycle is initiated 
with the onset of anagen, cells derived from the bulge move downward 
and proliferate and differentiate to form a new hair shaft, and other bulge 
cell derivatives move upward to maintain the upper follicle and sebaceous 
gland and to replenish cells in the IFE. Therefore, the dermal papilla 
appears to be the most likely component of the epidermal stem cell niche, 
and mesenchymal: epithelial interaction between the cells in the dermal 
papilla and in the bulge are responsible for stimulating the stem cells to 
divide and leave the niche and undergo differentiation. Although the 
bulge activation hypothesis was established based upon circumstantial 
evidence, a number of studies have shown that proliferation and 
differentiation of epidermal cells is dependent on direct contact between 
the epithelial bulge and the mesenchymal dermal papilla. For example, if 
the dermal papilla is mechanically separated from the growing hair 
follicle, follicle growth ceases (Link et al., 1990). Moreover, mice that do 
not express bone morphogenetic protein-4 (BMP-4), which is normally 
produced in the dermal papilla cells, show complete loss of all hair due to 
reduced or absent keratinocyte differentiation and dysregulated cell 
proliferation (Kulessa et al., 2000).
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1.11) Signalling pathways of epidermal cell differentiation
Signals that initiate and regulate the defined pathways of epidermal stem 
cell differentiation are not clear. However, recent advances have been 
made to identify the molecules and pathways that regulate stem cell fate.
1.11.1) The Wnt/p-catenin signalling pathway
As described in section 1.6.1, members of the T cell factor/lymphoid- 
enhancing factor (Tcf/LEF) family of DNA-binding proteins are 
transcriptional regulator molecules, which are bound by p-catenin in 
response to canonical Wnt signalling, and activate the transcription of 
genes that induce cell proliferation. In the epidermis, p-catenin and 
Tcf/LEF family members are expressed in both mesenchymal cells of the 
dermal papilla and in keratinocytes (Alonso and Fuchs, 2003; DasGupta 
and Fuchs, 1999; Zhou et al., 1995). Mice with a homozygous germ-line 
mutation in the LEF-1 gene showed sparse hair growth and complete loss 
of whisker follicles (van Genderen et al., 1994), and transgenic mice that 
mis-express LEF-1 display striking abnormalities in their hair follicle 
orientation and patterning during development (Zhou et al., 1995). 
Transgenic mice that lack p-catenin binding site expression in basal 
keratinocytes showed progressive hair loss and formed dermal cysts 
derived from cells in the base of the hair follicles. These cysts expressed 
markers of differentiation common to cells in the IFE and thus p-catenin 
appears to regulate keratinocyte differentiation into specific lineages 
(Niemann and Watt, 2002). Transgenic mice that express a truncated 
stabilised form of p-catenin under the control of an epidermal keratin 
promoter display signs of de novo hair follicle morphogenesis. These hair 
follicles induce LEF-1, causing hyperproliferation of keratinocytes (Gat et 
al., 1998). Therefore, p-catenin appears to regulate keratinocyte stem 
cell proliferation via regulation of LEF-1 gene transcription.
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1.11.2) c-Myc regulation of epidermal stem cell function
The c-Myc oncogene is a downstream target of the p-catenin/Tcf/LEF 
pathway, and can suppress the proliferation of normal human epidermal 
stem cells in culture, and stimulate pathways of terminal differentiation in 
these cells (Gandarillas and Watt, 1997). To study the function of c-Myc 
in vivo, an inducible system was generated in which c-Myc was fused to 
the oestrogen receptor (c-MycER), and was then targeted to the basal 
keratinocytes using the K14 promoter. In this system, c-Myc is held in an 
inactive state until the addition of 4-hydroxytamoxifen (4-OHT). The 
effects of c-Myc on keratinocytes in vivo, were not consistent with the in 
vitro observations described above. In heterozygous transgenic mice, 4- 
OHT treatment stimulated proliferation of cells in the IFE, leading to a 
thickened epidermis and an increased number of differentiated cell 
layers. However, the hair follicles showed an abnormal morphology and 
contained increased numbers of sebocytes. Therefore, c-Myc appeared 
to promote sebocyte differentiation at the expense of hair differentiation 
(Arnold and Watt, 2001). In a similar study, expression of c-Myc in the 
basal keratinocytes produced a 50% decrease in (31 integrin-expressing 
label-retaining cells, concomitant with a loss of hair in these animals 
(Waikel et al., 2001). These data suggest that c-Myc activation depletes 
the epidermal stem cell population in the hair follicles, possibly by down- 
regulation of pi integrins, which in turn impairs keratinocyte migration.
1.11.3) Bone morphogenetic proteins
The bone morphogenetic proteins (BMPs), part of the TGFp superfamily, 
have known roles in the regulation of cell proliferation, differentiation and 
apoptosis in many tissues, including skin (reviewed in (Massague and 
Chen, 2000)). BMPs activate signal transduction via their type I (BMPR- 
IA and BMPR-IB) and type II (BMPR-II) serine/threonine kinase 
receptors. A number of BMP antagonists have been described, including 
Noggin, which binds BMP-2 and BMP-4 with a high affinity, and binds
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BMP-7 with a lower affinity (reviewed in (Botchkarev, 2003)). Upon BMP 
binding to its receptor, specific Smad proteins are phosphorylated and 
translocate to the nucleus to regulate transcription of BMP target genes. 
BMP signalling is believed to be vital for hair follicle induction, and BMP-2 
and BMPR-IA are present in the epithelial cells of the hair follicle, and 
BMP-4 is expressed by the cells in the dermal papilla of mice (Botchkarev 
et al., 1999; Lyons et al., 1989; St-Jacques et al., 1998). In mice with a 
targeted deletion of the BMP-neutralisation protein Noggin, hair growth is 
significantly retarded (Botchkarev et al., 1999). It is proposed that Noggin 
neutralises the inhibitory action of BMP-4 on anagen, and stimulates hair 
growth by upregulating the transcriptional repressor molecule LEF1, 
which is supported by the observed active hair growth in mice in vivo 
following administration of Noggin protein (Botchkarev et al., 2001). 
Therefore, it appears that cross-talk between the BMP and Wnt/p-catenin 
signalling pathways are critical for the normal hair cycle to occur. 
Interactions between the Wnt and BMP signalling pathways were recently 
confirmed in mice with a Cre-mediated mutation of BMPR-IA. These 
mice had a lack of external hair and the IRS failed to differentiate. 
Nuclear p-catenin was absent from the epithelium of severely mutated 
hair follicles. These data suggest that activation of the Wnt pathway is a 
downstream effect of BMPR-IA signalling, both of which are essential for 
normal differentiation and proliferation of postnatal hair follicles (Andl et 
al., 2004). The downstream target molecules of BMP signalling are not 
yet fully understood, although the transcription factor Msx-2 is expressed 
on hair matrix keratinocytes and mediates the effects of BMP on LEF-1, 
Foxnl and Hoxc13 transcription factors, which in turn regulate the 
expression of keratin genes by keratinocytes (reviewed in (Botchkarev, 
2003; Fuchs, 2001)).
1.11.4) Sonic hedgehog
The sonic hedgehog (Shh) signalling cascade is one of the key pathways 
in development of the epidermis and hair follicles and in skin
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tumourigenesis. The transmembrane receptor Patched (Ptc), is activated 
by Shh and triggers a signalling cascade modulated by Smoothened 
(Smo), which in turn elicits nuclear translocation of the transcription factor 
Gli and the transcription of downstream target genes, including members 
of the Wnt and TGFp family (Ingham, 1998; Ingram et al., 2002). Shh is 
expressed in the developing epidermis and hair follicles, and Ptc 
expression is in the adjacent mesenchymal cells (Bitgood and McMahon, 
1995; Iseki et al., 1996; Motoyama et al., 1998; Oro et al., 1997). The 
anagen-inducing properties of Noggin are mediated, at least partly by 
Shh signalling in the hair follicle. Shh is upregulated in the hair follicle 
following Noggin administration, whereas BMP-4 downregulates Shh 
expression (Botchkarev et al., 2001). In Shh knockout mice formation of 
follicles, hair shafts and sebaceous glands was inhibited, although the 
epithelial cells undergo terminal differentiation to keratinocytes. Shh'7' 
mice lacked a dermal papilla, demonstrating a paracrine regulation of 
development of the mesenchymal components of the hair follicle by Shh 
in the epidermis (Chiang et al., 1999). Therefore, Shh regulates the 
development of the mesenchymal components of the hair follicle, and the 
absence of dermal papillae in Shh-deficient mice prevents hair follicle 
morphogenesis. The differentiation of keratinocytes in the absence of the 
stem cell niche, supports the “stem cell niche” hypothesis (Schofield, 
1978).
The Wnt, TGFp, and Shh signalling pathways appear to reciprocally 
modulate the epidermal stem cells, with some overlap in each pathway. 
For example, normal signalling via both the Wnt and BMP pathways are 
vital for induction of follicle growth and the terminal differentiation of 
keratinocytes, whereas the Shh pathway is vital for the proliferative 
expansion of the hair follicles, but is not required during hair lineage 
differentiation. The BMP signalling pathway is also required to induce 
hair growth, and is a probably candidate for a downstream target of the 
Wnt pathway. Moreover, ectopic differentiation of sebocytes was 
observed in separate studies where either the Shh pathway (Allen et al.,
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2003), or the BMP pathway (Guha et al., 2004) was dysregulated, 
suggesting that both pathways are essential for normal lineage 
differentiation in the sebaceous glands.
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1.12) Bone marrow stem cells
1.12.1) Haematopoietic stem cells
The pluripotent haematopoietic stem cell (HSC) can reconstitute the 
entire cell repertoire of the blood (Lagasse et al., 2001; Morrison and 
Weissman, 1994; Weissman, 2000), and is one of the few adult stem 
cells for which definitive markers have been identified. HSCs are most 
commonly isolated by FACS using specific antibodies to cell surface 
proteins e.g., all adult HSCs express c-Kit and Sca-1, though lack, or 
express very low levels of markers of lineage differentiation (Lin“/l0) 
(Uchida and Weissman, 1992). Specific cell surface proteins are 
gradually expressed as HSCs mature and their self-renewal potential 
becomes limited, and known markers of lineage differentiation in HSCs 
include Thy-1, Flk2, B lymphocytes (CD45), T lymphocytes (CD3), 
granulocytes (Ly-6G), monocytes (CD11) and erythrocytes (TER-119) 
(reviewed in (Kondo et al., 2003)). The sialomucin CD34 was originally 
identified as the definitive HSC marker, although CD34 expression 
appears to fluctuate as subpopulations of CD34-positive (+) and CD34- 
negative (-) HSCs have been identified in both human and mouse bone 
marrow (BM), (reviewed in (Kondo et al., 2003)). The glycoprotein 
AC133 (CD133) may be a more primitive marker of human HSCs, as it is 
expressed on both CD34+ and CD34- BM fractions and is down- 
regulated as HSCs differentiate, and virtually all mature haematopoietic 
lineages lack CD133 expression (Gallacher et al., 2000; Yin et al., 1997). 
Human-derived CD133+ cells have been shown to repopulate the sheep 
BM (Yin et al., 1997).
1.12.2) Side populations cells
Both murine and human BM express a highly-enriched HSC population, 
the side population (SP) cells, which are identified by their ability to efflux
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the DNA binding dye Hoechst 33342 on flow cytometric analysis. Murine 
SP cells represent approximately 0.1% of the whole BM, although can 
reconstitute the entire haematopoietic system in lethally irradiated 
recipients (Goodell et al., 1996). Recent analyses of CD34- and CD34+ 
subpopulations of murine SP cells has revealed that CD34- SP cells 
contain the greatest enrichment of primitive stem cells (Parmar et al.,
2003).
1.12.3) Mesenchymal stem cells
Mesenchymal stem cells (MSCs) in the adult BM support haematopoiesis 
via cell signalling and the secretion of specific growth factors and 
cytokines (Cherry et al., 1994; Guerriero et al., 1997; Moreau et al., 
1993), and are progenitor cells for each of the differentiated lineages 
found in the connective tissue such as bone, fat, muscle, tendon and 
cartilage (reviewed in (Barry and Murphy, 2004; Roufosse et al., 2004). 
MSCs comprise approximately 0.001 -  0.01% of the total number of 
nucleated cells in the BM, although, similar to HSCs, can be enriched in 
vitro. MSCs were first isolated from the haematopoietic component of rat 
BM in 1966, using standard cell culture techniques (Friedenstein et al., 
1966), and it is now well documented that MSCs present in vitro as 
fibroblastic-like, adherent cells capable of extended proliferation. 
Attempts to characterise the cell surface antigens expressed by MSCs 
has proven difficult due to the low numbers of MSCs in adult BM. In the 
mouse, CD34+, CD45+, CD11b+ fractions of BM are believed to be 
enriched for MSCs (Baddoo et al., 2003; Ortiz et al., 2003). In the human 
BM, CD34 (Simmons and Torok-Storb, 1991a), CD166 (activated 
leukocyte-cell adhesion molecule) (Bruder et al., 1998), CD105 
(transforming growth factor receptor, endoglin) (Barry et al., 1999), CD73 
(Barry et al., 2001) and the stromal progenitor (Stro-1) antigen (Simmons 
and Torok-Storb, 1991b) are all expressed on MSCs, although are not 
MSC-specific, and thereby do not qualify as definitive stem cell markers 
(reviewed in (Barry and Murphy, 2004)).
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1.12.4) Multipotent adult progenitor cells
A subpopulation of MSCs, the multipotent adult progenitor cell (MAPC), 
has been isolated from the BM of both rodents (Jiang et al., 2002) and 
humans (Reyes et al., 2001). MAPCs were initially separated by their 
negative expression of the haematopoietic markers, CD45 and 
glycophorin-A (GlyA). Human MAPCs are characteristic of classical 
MSCs as they lack expression of CD44, major histocompatibility complex 
(MHC) class I, and p2-microglobulin (Pittenger et al., 1999), and also do 
not express the HSC markers CD34, CD45 and c-Kit. Murine MAPCs 
have a similar phenotype to the human MAPC as they do not express 
CD34, CD44, CD45, c-Kit, MHC class I and II, have a low level of 
expression of Flk-1, Sca-1 and Thy-1, and express high levels of CD13 
and stage-specific antigen I (SSEA-1). The morphology and phenotype 
of MAPCs was stable for over 50 population doublings in humans (Reyes 
et al., 2001), and 120 population doublings in the mouse (Jiang et al., 
2002). Both human and mouse MAPCs can differentiate to form all 
mesenchymal cell lineages and endothelial lineages, and mouse MAPCs 
can contribute to the epithelium of the liver, lung and gut (Jiang et al., 
2002). The MAPCs are similar to embryonic (ES) stem cells in their 
phenotype, nature and differentiation potential (Jiang et al., 2002), 
although MAPCs are readily accessed from BM and thus do not carry any 
ethical stigma. Furthermore, ES-derived cells often develop into 
teratomas (Thomson et al., 1998), whereas MAPC progeny do not (Jiang 
et al., 2002).
1.12.5) Endothelial progenitor cells
Vasculogenesis is the de novo formation of blood vessels from vascular 
precursor cells, or angioblasts, originating in the primitive mesoderm 
(Risau and Flamme, 1995). Angioblasts give rise to endothelial cell 
channels, which form the lining of the blood vessels and are surrounded 
by a layer of smooth muscle “mural” cells, although to date a mural cell 
progenitor cell has not been identified. Traditionally, vasculogenesis was
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believed to be confined to early embryogenesis, and postnatal blood 
vessel formation was attributed to "angiogenesis", wherein fully- 
differentiated endothelial cells in pre-existing blood vessels detach from 
the vessel wall, and migrate and proliferate to remodel the existing 
primary vascular network e.g., within injured vasculature and in tumour 
formation (Folkman, 1992). However, accumulating evidence suggests 
that circulating cells exist in the adult BM and peripheral blood that can 
form new blood vessels by neovasculogenesis, leading to the novel 
paradigm of "postnatal vasculogenesis".
A population of circulating endothelial precursor cells (EPCs) was initially 
isolated in 1963 by the endothelialisation of Dacron grafts by cells in the 
peripheral blood (Stump et al., 1963). EPCs were first characterised 
based on their expression of vascular endothelial growth factor receptor-2 
(VEGFR-2, Flk-1 in mouse) and CD34, which are also expressed by 
angioblasts and HSCs (Asahara et al., 1997; Shi et al., 1998). These 
BM-derived EPCs have a high proliferative capacity, form homogenous 
monolayers in vitro with typical "cobblestone" cell morphology, produce 
nitric oxide, incorporate acetylated low-density lipoprotein (Ac-LDL) and 
express several endothelial markers including, von Willebrand factor 
(vWF), VEGFR-2, CD31 (PECAM), CD105, E-selectin and vascular cell 
adhesion moleulce-1 (V-CAM-1) (Asahara et al., 1997; Quirici et al., 
2001; Shi et al., 1998).
However, distinction of EPCs from mature endothelial cells may be 
complicated by the expression by both cell types of several antigens 
including, VEGFR-2 (Flk-1) (Flamme et al., 1995), Tie-1 (Sato et al., 
1993; Sato et al., 1995), Tie-2 (Schnurch and Risau, 1993) and vascular 
endothelial (VE)-cadherin (Ali et al., 1997; Peichev et al., 2000; Vittet et 
al., 1996). Furthermore, EPCs share a common expression of a number 
of HSC markers including VEGFR-1, CD34, platelet endothelial cell 
adhesion molecule (PECAM), Tie-1, Tie-2 and vWF, and both cell types 
can incorporate Ac-LDL (reviewed in (Peichev et al., 2000)). Human 
EPCs have recently been shown to express CD133 (Peichev et al.,
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2000), which is suggested to be a primitive HSC marker (Gallacher et al., 
2000; Yin etal., 1997).
Recent studies have shown that CD14+/CD34- human mononuclear 
cells, which are phenotypically distinguishable from MSCs and HSCs, 
express endothelial cell-specific markers in vitro including, vWF, VEGFR- 
1, VE-cadherin, CD105, CD31, Tie2 and endoglin (Fernandez Pujol et al., 
2000; Fujiyama et al., 2003). Additionally, these CD14+ cells form 
functional endothelial cells in ischaemic models (Fujiyama et al., 2003; 
Harraz et al., 2001). It is therefore possible that the CD34-/CD14+ 
fraction of BM contains a potent source of EPCs (Fujiyama et al., 2003).
It is now well documented that EPCs in the mouse and human BM play 
an important role in vasculogenesis in both mouse and human. The 
isolated subpopulations of EPCs, and their contribution to vasculogenesis 
in specific models of injury or disease is summarised in Table 1.1.
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Table 1.1) Examples of the contribution of BM-derived cells to vascular 
lineages in the mouse and human.
■
C D 3 4 + , F lk-1  + 
cells (human)
Hindlimb ischaemia 
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(A sahara
1997)
et a l.,
Low -density BM 
mononuclear cells 
(mouse)
Tum our im plant, 
epidermal wounding, 
hindlimb ischaemia, 
myocardial 
ischaemia (mouse)
Neovasculogenesis,
BM-derived
endothelium
(A sahara
1999)
et al.,
C D 34+ cells (G-
CSF-stimulated;
human)
Myocardial infarction 
(mouse)
Neovasculogenesis 
and angiogenesis
(Kocher et al., 2001)
Lin-, c-kit+ cells 
(mouse)
Myocardial infarction 
(mouse)
Endothelial cells, 
sm ooth  m u scle  
cells
(Orlic, 2002; Orlic et 
al., 2001a)
C D 34+ , C D 45+ , 
C D 1 3 3 +  c e lls  
(human)
Myocardial infarction 
(human)
Myocardial
regeneration
(Assm us
2002)
et a l.,
C D 1 4 + , C D 3 4 -  
(human)
De-endothelialisation 
of carotid artery
Neovasculogenesis,
BM-derived
endothelium
(Fujiyam a
2003)
et al.,
Peripheral blood 
mononuclear cells 
(human)
Ischaemic hindlimb 
(mouse)
Neovasculogenesis (Iw agu ro
2002)
e t a l.,
Lin-, c-kit+, Sca-1 + 
(mouse)
Atherosclerosis
(mouse)
Neovasculogenesis, 
endothelial cells, 
sm ooth  m uscle  
cells
(Sata et al., 2002)
Lin- HSCs (mouse 
or human)
Retinal degeneration 
(mouse)
Endothelial cells in 
recovered retinal 
vasculature
(Otani et al., 2004; 
Otani et al., 2002)
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HSCs (mouse) Choroidal
neovascularisation
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Grant et al., 2002; 
Sengupta et a l., 
2003)
CD133+ (including 
CD34-
subpopulation;
human)
Myocardial infarction 
(human)
Enhanced
ventricular function, 
angiogenesis
(Stamm et al., 2003)
SP cells (C D 34- 
/low, c-kit+, Sca- 
1+; mouse)
Myocardial infarction 
(mouse)
Endothelial cells in 
small vessels
(Jackson et al., 
2001)
BM (mouse) Cerebral infarction 
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Hess et al., 2002)
HSC (Lin-, CD34-, 
c -k it+ , Sca-1  + ; 
mouse)
Cerebral infarction 
(mouse)
BM-derived 
perivascular cells
(Hess et al., 2004)
BM (mouse) Choroidal
neovascularisation
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Tomita et al., 2004)
HSCs( c-kit+, Sca- 
1+, Lin-; mouse)
N/A BM-derived 
endothelium (liver, 
lung, heart, skeletal 
m u s c l e  a n d  
intestine)
(Bailey et al., 2004)
C D 1 1 7 +  cel l s  
(mouse)
Hindlimb ischaemia 
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Li et al., 2003)
BM (mouse) Choroidal
neovascularisation
(mouse)
BM-derived 
endothelia l cells  
a n d  s m o o t h  
muscle-like cells
(Espinosa-Heidmann 
et al., 2003)
Sca-1+, Flk-1+, c- 
kit+ cells (mouse)- 
treated with HGF
Emphysema
(mouse)
BM-derived 
endothelial cells, 
pulmonary 
regeneration
(Ish izaw a  et al., 
2004)
Lin- H SCs and  
whole BM (mouse)
p-cell injury (mouse 
pancreas)
Neovasculogenesis,
BM-derived
endothelium
(M athew s et al., 
2004)
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Lin-, c-kit+, Sca-1 + 
HSCs, or whole 
BM (mouse)
Choroidal
neovascularisation
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Takahashi et al., 
2004)
BM (mouse) Choroidal
neovascularisation
(mouse)
Neovasculogenesis,
BM-derived
endothelium
(Csaky et al., 2004)
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1.13) Adult Stem Cell Plasticity
An expanse of evidence regarding the surprisingly flexible potential of 
adult stem cells in their differentiation repertoires has recently challenged 
the classical belief that tissue stem cells are restricted to the production of 
adult lineages within their tissue of residence. Consequent to this 
discovery, stem cells now represent an entire new field of regenerative 
medicine, and may hold the key to the treatment of a number of diseases 
such as cancer, cardiovascular disease, neurodegenerative disease and 
diabetes. Recently, a vast number of reports have emerged showing that 
adult stem cells retain a large degree of plasticity and can differentiate to 
form many functional adult cells within extraneous tissues. Much of this 
research has focussed on the adult BM as an easily accessible source of 
cells that have the potential to cross lineage boundaries, and transplanted 
adult BM cells have been shown to form adult cell types in many different 
tissues including the liver, kidney, heart, CNS, gastrointestinal tract, lung, 
and skin (reviewed in (Poulsom et al., 2002); see also Table 1.2). These 
pathways can be bi-directional as muscle (Jackson et al., 1999) and 
neuronal stem cells (Bjornson et al., 1999) can also form BM, though the 
latter pathway is disputed by some (Morshead et al., 2002).
It appears that selection pressure induced by target organ damage can 
intensify the efficacy of this process e.g., increased numbers of cells of 
BM origin were observed in murine models of cerebral infarction (Hess et 
al., 2002), myocardial infarction (Jackson et al., 2001; Orlic, 2002; Orlic et 
al., 2001b), and in gastrointestinal epithelia of BM-transplanted humans 
with graft-versus-host-disease (GvHD) or intestinal ulceration (Okamoto 
et al., 2002). It is proposed that BM cells respond to specific signals from 
damaged or diseased tissues whereupon they migrate to, and engraft 
within this tissue, and aid regeneration and remodelling by contributing to 
differentiated adult cells.
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It is important to demonstrate that BM-derived adult cells are functional 
with a capacity to restore diseased or damaged tissues, and thus convey 
a possible clinical relevance. The fumarylaceto-acetate hydrolase- 
deficient (Fah'7') mouse model of the human metabolic liver disease, Type 
1 tyrosinaemia, was used to confirm the functional significance of BM cell 
plasticity (Lagasse et al., 2000). Fah'7' mice were transplanted with as 
few as 50 purified HSCs, which travelled to the liver and restored enzyme 
levels to normal by forming Fah-expressing hepatocytes, thereby 
rescuing the mice from their fatal deficiency (Lagasse et al., 2000). A 
recent publication also showed amelioration of disease by BM cells, as 
Cu/Zn superoxide dismutase (SOD1) mice, which develop a lethal 
neurodegenerative disease similar to amyotrophic lateral sclerosis (ALS) 
in humans, show a considerable delay in the onset of ALS and have a 
significantly extended lifespan following BM transplant (Corti et al., 2004). 
Fully differentiated neurons, skeletal muscle fibres and cardiomyocytes of 
BM origin were observed in these mice (Corti et al., 2004). BM cells have 
also been shown to produce functionally competent endocrine p-cells in 
the pancreatic islets of mice, demonstrating a potential cell-based therapy 
for diabetes mellitus (lanus et al., 2003).
1.13.1) BM contribution to the cells in the adult intestine
There are a growing number of reports that BM cells can repopulate both 
epithelial and mesenchymal lineages in the gastrointestinal tract of 
animals and man. A seminal paper by Krause and colleagues (Krause et 
al., 2001) demonstrated the remarkable plasticity of a single purified BM 
cell. Eleven months after injection of a male mouse HSC and 2 x 104 
supporting female haematopoietic progenitor cells into a female mouse, 
multiple tissues were analysed for the presence of the Y chromosome by 
fluorescent in situ hybridisation (FISH). Y chromosome-positive epithelial 
cells were found in the lung, the skin and throughout the gastrointestinal 
tract, including the oesophagus, stomach, small intestine and colon. A 
highly purified population of MSCs, termed MAPCs (section 1.12.4), were
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isolated from ROSA26 mice which constitutively express p-galactosidase. 
Following 55 -  65 population doublings, 1 or 10 -  12 MAPCs were 
microinjected into 3.5-day-old mouse blastocysts, which were then 
transferred to foster mothers and allowed to develop and be born. 
Chimeric animals were killed at 6 - 20 weeks, and BM-derived epithelial 
cells were observed in many somatic tissues, including the small intestine 
(Jiang et al., 2002). In biopsies from female patients who had undergone 
sex-mismatched HSC transplantation, in situ hybridisation for a Y 
chromosome-specific probe combined with immunohistochemical staining 
for cytokeratins, demonstrated mucosal cells of donor origin in the gastric 
cardia (Korbling et al., 2002). Similarly, in gastrointestinal biopsies from 
four long-term BM transplant survivors who had developed GvHD or 
intestinal ulceration, epithelial cells of BM origin were detected up to 8 
years post-transplantation in the oesophagus, stomach, small intestine 
and colon (Okamoto et al., 2002), and a further recent paper describes 
the presence of donor-derived epithelial cells in colonic biopsies from 8 
patients that received a sex-mismatched BM transplant (Spyridonidis et 
al., 2004). This study excluded the possibility that BM-derived intestinal 
epithelial cells are merely intraepithelial lymphocytes in close proximity 
with epithelial cells, by using a rigorous three dimensional confocal 
detection technique on tissue sections that were triple stained for donor- 
specific, epithelial-specific and haematopoietic-specific markers 
(Spyridonidis et al., 2004). It is important to note that donor-derived 
intestinal epithelial cells are single cells randomly interspersed throughout 
the crypts and villi, and the incidence of BM-derived intestinal epithelial 
cells post-transplant are variable and are generally low, ranging from 
0.04% (Spyridonidis et al., 2004) to approximately 10% (Jiang et al., 
2002). However, BM contribution to epithelial cells in human intestinal 
biopsies was increased between 5 -  50-fold in tissue damaged by GvHD, 
compared to intact epithelium (Okamoto et al., 2002; Spyridonidis et al.,
2004), although the low levels of engraftment and the lack of donor- 
derived cell clusters in crypts or villi indicate that it is unlikely that the BM 
cells form intestinal epithelial stem cells or undergo proliferation.
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BM cells also contribute to mesenchymal lineages in the mouse and 
human gastrointestinal tract. Transplanted BM cells contribute to large 
proportions of myofibroblasts and fibroblasts in the mouse lung, stomach, 
oesophagus, skin, kidney and adrenal glands. Indeed, following lethal 
irradiation and whole BM transplant, up to 64% of ISEMFs in the mouse 
stomach were BM-derived 6 weeks post-transplant (Direkze et al., 2003). 
Analysis of liver biopsies from patients with fibrosis showed that a 
significant proportion of myofibroblasts were BM-derived, and BM can 
maintain differentiated cell production within a damaged tissue for 
extensive lengths of time e.g., in one patient, approximately 23% of 
myofibroblasts in the fibrotic liver were BM-derived 2 years post­
transplant (Forbes et al., 2004).
1.13.2) BM contribution to vascular lineages
As discussed in section 1.12.5, it is well documented that the BM 
contains progenitor cells that can differentiate to form both endothelial 
cells and smooth muscle mural cells of blood vessels, particularly in 
situations where vascular remodelling and regeneration is required (see 
Table 1.1). A recent paper showed that transplanted BM forms 
endothelial cells in the human skin, stomach and small intestine, which 
were observed up to 7 years post transplant (Jiang et al., 2004). Levels 
of BM engraftment were low, with BM contributing to only 2.3% and 1.7% 
of endothelial cells in blood vessels of the skin and gut, respectively 
(Jiang et al., 2004).
1.13.3) BM contribution to cells in the adult epidermis
Similar to the situation in the gastrointestinal tract, there are several 
reports of a BM origin of several differentiated adult lineages in the 
mouse and human epidermis. Following transplantation of a single 
purified HSC, cytokeratin-positive cells of donor derivation were observed 
in the mouse epidermis, including the postulated stem cell zone, although 
these cells did not appear to undergo clonal expansion and are therefore
84
unlikely to be epidermal stem cells (Krause et al., 2001). The contribution 
of transplanted BM cells to differentiated keratinocyte lineages is 
significantly increased in the regenerating mouse epidermis (Badiavas et 
al., 2003; Borue et al., 2004), supporting the notion that non- 
haematopoietic cell production by BM is enhanced in response to signals 
from damaged or diseased tissues. BM-derived epidermal cells are also 
seen in human skin, as female recipients of a male HSC transplant 
showed BM-derived epidermal cells as late as 354 days post­
transplantation (Korbling et al., 2002). In a recent “skin reconstitution 
assay”, adult BM cells were transplanted directly onto the wounded 
mouse epidermis and within 3 weeks epidermal keratinocytes, follicular 
epithelial cells, sebaceous gland cells, dendritic cells and endothelial cells 
of BM origin were observed (Kataoka et al., 2003).
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Table 1.2) The contribution of BM to adult lineages in non-haematopoietic 
tissues.
Liver (rat) BM Oval cells 
Hepatocytes
Not
investigated
(Petersen et al., 
1999)
Liver (human) BM Myofibroblasts Not
investigated
(Forbes et al., 
2004)
Liver (human) BM Hepatocytes Not
investigated
(Alison et al., 
2000; Theise et 
al., 2000)
Liver (mouse) HSC Hepatocytes Not
investigated
(Lagasse et al., 
2000)
Liver (m ouse, 
human)
BM Endothelium Not
investigated
(Gao et al., 2001)
Liver (mouse) HSC Hepatocytes Fusion (Camargo et al., 
2004; Wang et al., 
2003; Willenbring 
et al., 2004)
Liver, gut, skin 
(human)
HSC
(peripheral
blood)
Epithelial cells No fusion (Korbling et al., 
2002)
Kidney (mouse, 
human)
BM Tubular
epithelium,
glomeruli
Not
investigated
(Poulsom et al., 
2001)
Kidney (mouse) BM Mesangial cells, 
endothelium
Not
investigated
(Cornacchia et al., 
2001)
Kidney (human) BM Endothelium No fusion (Lagaaij et al., 
2001)
Heart (mouse) BM Cardiomyocytes Not
investigated
(O rlic  e t a l., 
2001b)
Heart (mouse) SP cells Cardiomyocytes,
endothelium
Not
investigated
(Jackson et al., 
2001)
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CNS, heart, liver 
(mouse)
BM Purkin je  cells,
cardiomyocytes,
hepatocytes
Fusion (Alvarez-Dolado et 
al., 2003)
CNS (mouse) BM Purkinje cells Fusion (Weimann et al., 
2003a; W eimann  
et al., 2003b)
CNS (mouse) BM Neurons Not
investigated
(Brazelton et al., 
2000; M ezey et 
al., 2000)
CNS (mouse) BM Microglia Not
investigated
(S im a rd  and  
Rivest, 2004)
CNS (mouse) BM Endothelium,
neurons
Not
investigated
(Hess etal., 2002)
CNS (mouse) BM M icro g lia  and  
astrocytes
Not
investigated
( E g l i t is  an d  
Mezey, 1997)
CNS (human) HSC Neurons,
astrocytes,
microglia
No fusion (C o g le  et al., 
2004)
Gastrointestinal 
tract (human)
BM Epithelial cells Not
investigated
(Okamoto et al., 
2002)
Colon (human) HSC Colonocytes No fusion (Spyridonidis et 
al., 2004)
Intestine (mouse 
and human)
BM Myofibroblasts Not
investigated
(Brittan et al., 
2002)
Skin (mouse) BM Keratinocytes No fusion (Brittan et al., 
2004)
Skin (mouse) BM Keratinocytes No fusion (B orue  et a l., 
2004)
Cheek
epithelium
(human)
BM Buccal cells No fusion (Tran et al., 2003)
Liver, lung, gut 
(mouse)
MAPC Epithelial cells Not
investigated
(Jiang et al., 2002)
Liver, lung, gut, 
skin (mouse)
Single
HSC
Epithelial cells Not
investigated
(Krause et al., 
2001)
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Lung, stomach, 
oesophagus, 
skin, k idney, 
adrenal (mouse)
BM Myofibroblasts Not
investigated
(D irekze et al., 
2003)
Liver, lung, skin 
(mouse)
BM Epithelial cells No fusion (H arris  et a l., 
2004)
Pancreatic 
tumour (mouse)
BM Myofibroblasts,
fibroblasts
Not
investigated
(D irekze et al., 
2004)
88
1.14) Stem cell plasticity: de novo cell generation or 
heterokaryon formation
Before any clinical application can be considered, it is vital to understand 
the mechanisms that regulate stem cell plasticity, and the processes that 
occur within a stem cell in order for it to assume a new, differentiated 
phenotype. It is becoming increasingly apparent that two separate 
mechanisms of stem cell plasticity exist; de novo cell generation through 
BM cell differentiation, and fusion of BM cells with pre-existing cells to 
form a cell with multiple, genetically-variant nuclei, a heterokaryon. The 
first evidence for cell fusion was shown in co-cultures of embryonic stem 
(ES) cells, with either neural stem cells (Ying et al., 2002), or BM stem 
cells (Terada et al., 2002), wherein the adult stem cells appeared to fuse 
with the ES cells when extracted from their niche environment. However, 
these studies observed genetically-modified cells in culture, and are not 
directly analogous to in vivo observations of adult stem cell plasticity. 
Furthermore, these reported fusion events were too infrequent to account 
for reported BMSC plasticity in vivo in some tissues (2-11 hybrid clones 
were formed per 106 BM stem cells (Terada et al., 2002)).
The classic “gold standard” proof of principle model for adult stem cell 
plasticity was demonstrated by the rescue of the Fah'7' mouse from its 
fatal metabolic disease by BM stem cell transplantation (Lagasse et al., 
2000) (section 1.4), which definitively showed that BM-derived 
hepatocytes were functionally normal. However, cytogenetic analyses 
showed that almost all the newly formed, Fah-synthesising hepatocytes in 
these transplanted mice expressed a karyotype indicative that fusion had 
occurred between a transplanted BM cell and a host hepatocyte 
(Vassilopoulos et al., 2003; Wang et al., 2003). It is important to consider 
that hepatocytes are frequently polyploid and express multiple sets of 
chromosomes, and it is thereby possible that the liver presents a unique
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environment for the formation of fused hybrid cells (reviewed in (Alison et 
al., 2004)).
Transplanted BM stem cells have been shown to fuse with Purkinje cells 
in brains of both mice (Weimann et al., 2003b), and humans (Weimann et 
al., 2003a). In the SOD1 mouse, which develops a lethal form of human 
ALS, BM cells can form adult cells in the CNS, heart and skeletal muscle, 
thereby prolonging animals’ survival (Corti et al., 2004) (section 1.13). 
Examination of nuclear content by FISH analyses suggested that BM- 
derived neurons may be a result of cell fusion, although in the brains of 
some male mice that had received a female BM transplant, neurons were 
seen that did not express a Y chromosome, which could be explained by 
de novo cell formation by transplanted female BM cells, or alternatively 
may simply be a result of incomplete detection by the FISH technique 
(Corti et al., 2004). Conversely, in the human brain, transplanted BM 
cells appear capable of neurogenesis and contribute to approximately 1% 
of all neurons for up to 6 years post-transplant. Analyses of autopsy 
brain specimens from 3 female patients that received a male BM 
transplant showed no evidence of fusion, as only one X chromosome was 
present in all male-derived neurons (Cogle et al., 2004).
Whilst studies of sex chromosomal content may prove ambiguous due to 
artefacts created by the in situ hybridisation technique, the Cre/lox 
recombinase system provides an elegant means of studying the 
mechanism of adult stem cell plasticity, using mice of the Z/EG Cre- 
reporter strain. The Z/EG transgenic mouse expresses a transgene 
cassette consisting of the chicken p-actin promoter driving expression of 
a p-galactosidase/neomycin-STOP reporter gene. This is flanked by two 
loxP sites and followed downstream by enhanced green fluorescent 
protein (eGFP) expression. Expression of p-galactosidase alone is driven 
by the p-actin promoter until Cre mediated recombination occurs, at 
which point the p-galactosidase-STOP DNA is excised and the 
downstream eGFP is expressed instead. BM from male Z/EG mice was
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transplanted into female mice that ubiquitously expressed Cre, and cells 
within multiple tissues were analysed for eGFP or p-galactosidase 
expression i.e., any cell resulting from the fusion of a BM cell with a host 
cell should express eGFP, and any cell which expresses p-galactosidase 
is the product of BM cell differentiation. However, recent reports using 
the Cre/lox recombinase system have also proved inconsistent, as BM- 
derived epithelial cells in the mouse liver, lung and skin were shown by 
this method to form without cell fusion (Harris et al., 2004), whereas 
results of Alvarez-Dolado and colleagues (Alvarez-Dolado et al., 2003) 
using a similar system, clearly demonstrated that BM cells spontaneously 
fuse with hepatocytes in the liver, Purkinje cells in the CNS and 
cardiomyocytes in the heart, with no evidence of de novo generation.
Evidence of heterokaryon formation following stem cell transplantation in 
the gastrointestinal tract or skin has not been reported to date, and 
gastrointestinal epithelial cells derived from transplanted mobilised 
peripheral blood stem cells were reported to contain a normal ratio of sex 
chromosomes (Korbling et al., 2002). Furthermore, keratinocytes of BM 
origin were frequently observed in the mouse epidermis, which were 
shown to form with no evidence of cell fusion (Borue et al., 2004). An 
important observation was made in that in some reported incidences of 
spontaneous cell fusion, the original stem cell markers are repressed and 
the transplanted cells appear to reprogram their new "host" nuclei to 
produce a sustainable, functional cell (Weimann et al., 2003b). 
Additionally, the incidence of heterokaryons was shown to increase as a 
tissue ages, suggesting that BM-derived cells can divide (Weimann et al., 
2003b). The underlying principle, that transplanted BM cells have the 
capacity to rescue an otherwise fatal metabolic disease, is maintained 
and should not be overlooked, although it is irrefutable that before we 
overlook, or indeed overstate, the capacity of adult stem cells to 
regenerate damaged or diseased tissue, further clarification of the 
mechanisms involved in this apparent stem cell plasticity is essential.
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CHAPTER II
Materials and Methods
2.1) BM transplant
In order to investigate the contribution of BM to adult lineages in the 
gastrointestinal tract and skin, BM transplants were performed where the 
donor cells and their differentiated progeny could be identified by the 
presence of a specific chromosome or protein that was absent in the 
recipient tissues. The most commonly used marker of the transplanted 
BM marker was the Y chromosome, following a gender-mismatched BM 
transplant. Additionally, BM from transgenic mice that express the Green 
Fluorescent Protein (GFP) was transplanted into wild type mice, thereby 
providing an alternative method of detection of the donor-derived cells.
All animal procedures were carried out under UK Home Office procedural 
and ethical guidelines (Home Office Project Licence No. 70/5798). All 
mice were maintained in the Biological Resource Unit, Cancer Research 
UK, London Research Institute.
Six week old female recipient mice had their BM ablated by 12 Gray 
whole body irradiation in a divided dose, 3 hours apart, using an IBL 637 
gamma irradiator equipped with a caesium 137 source (Cis-Bio 
International). This was immediately followed by a tail vein injection of 
approximately 1 x 106 whole BM cells from age-matched male mice. BM 
was flushed from both tibias and femurs of donor mice with sterile PBS 
using a 5 ml syringe, and cells were centrifuged at 1500 rpm for 2 x 5 
minutes, supernatant discarded, and cells resuspended in 0.2 ml sterile
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PBS. The number of nucleated cells was calculated using a 
haemocytometer, by the dye exclusion test using 0.01% Trypan blue. 
Cells were stored at 4°C for no more than 2 hours before transplant. 
Following transplant, the mice were housed in sterile conditions and 
specific protocols were performed in accordance each defined study 
(section 2.2). All mice were killed by CO2 inhalation and exsanguination.
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2.2) Outline of individual experimental studies
2.2.1) BM contribution to intestinal lineages
2.2.1.1) Murine study
Donor mice were male C57/ Black 6 (n = 10), and recipient mice were 
female C57/ Black 6 (n = 30). Groups of ten mice were killed at 7 days, 
14 days and 6 weeks after BM transplant, colons and small intestines 
were harvested and fixed in NBF for 24 hours at room temperature. 
Colons and small intestines from male and female wild type mice, to be 
used as controls, were harvested and fixed in for 24 hours in NBF at 
room temperature.
2.2.1.2) Human study
Tissue from three female patients who had received unprocessed BM 
transplants from male donors was analysed. These patients had 
subsequently had one or more gastrointestinal biopsies for suspected 
graft versus host disease (Table 2.1). Biopsies were formalin fixed, 
routinely processed and paraffin wax embedded. All tissue, including 
male and female control intestinal tissues were obtained from the 
archives of Hammersmith Hospital, London, and all procedures were in 
accordance with local ethical guidelines.
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Table 2.1) Details of patients’ used in this study. All patients were 
female, and received an unprocessed BM transplant from a male donor.
Patient 1 (39) Gastric antrum 3 months
Patient 2 (37) Duodenum (D2) 26 months
Patient 3 (23) Rectum 38 days
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2.2.2) BM contribution to experimental colitis
Following reports that the contribution of BM to functional differentiated 
cells in non-haematopoietic tissues is heightened in damaged or 
diseased states, we used a well-established model of experimental colitis 
with similarities to Crohn’s disease, to investigate this claim in the mouse 
colon.
Donor mice were male Balb/C (n = 18), and recipient mice were female 
Balb/C (n = 50). Six weeks after BM transplantation, animals were 
sedated by a 0.2 ml intraperitoneal injection of Hypnorm (fentanyl citrate 
0.315 mg/ml plus fluanisone 10 mg/ml; Janssen Animal Health), diluted 1 
in 10 in injectable water. TNBS (2 mg in 50% ethanol; Sigma) was 
administered intrarectally, with control groups given 50% ethanol only. 
Animals’ body weights were recorded daily, and five animals from both 
the TNBS-treated group and the ethanol-treated control group were killed 
on days 1, 4, 6, 8 and 14. Colons were fixed in NBF for 24 hours at room 
temperature.
2.2.3) BM contribution to the normal and wounded epidermis
Donor mice were male TgN(GFPU)5Nagy (GFP; n = 20; Jackson 
Laboratories Strain #003115129) and recipient mice were female Sv/C57 
Black/6 (n = 60). In the GFP mice, expression of GFP protein is driven by 
the chicken beta-actin promoter and CMV intermediate early enhancer, 
with ubiquitous transgene expression within all nucleated tissues 
(Hadjantonakis et al., 1998).
2.2.3.1) Spontaneous fusion
In the spontaneous fusion study, which aimed to investigate whether 
transplanted BM cells transform to produce non-haematopoietic lineages 
or whether they fuse with indigenous cells within a tissue to form a
96
heterokaryon, the same BM transplant procedure was applied using male 
GFP transgenic donors (n = 7) and male Sv/C57 Black/6 recipients (n = 
20).
22.3.2) Cutaneous wounds
Six weeks post-transplantation, two full-thickness circular wounds, each 3 
mm in diameter, were made to the mouse dorsal skin of 45 of the 
transplanted mice. Fifteen mice were killed at 4, 7 and 30 days post- 
wounding, and approximately 2 cm2 sections of unwounded and wounded 
skin were fixed in NBF for 24 hours at room temperature. Mice were 
injected intraperitoneally with 5-bromo-2’-deoxyuridine (BrdUrd; 0.1 ml/10 
g body weight of 10 mg/ml stock in distilled water; Sigma) 2 hours prior to 
killing, to label cells in S-phase.
2.2.3.3) Wholemount preparation from tail epidermis
The tail skin from mice killed at 4 and 7 days post-wounding, was split 
lengthways using a scalpel, peeled from the tail, and cut into 
approximately 5 mm2 segments. Sections were incubated in 5 mM EDTA 
(CRUK) in PBS at 37°C for four hours, or until the epidermis could be 
peeled intact from the dermis. Epidermal sheets were fixed in 4% formal 
saline (Sigma) for 2 hours at room temperature, rinsed in PBS, and 
stored in PBS + 0.2% sodium azide (Sigma) in 24-well plates (Integra 
Biosciences Inc.) at 4°C prior to immunohistological analyses.
2.2.3.4) Harvesting and cultivation of mouse keratinocytes
Wild type Sv/C57 Black/6 mice (n = 8), GFP transgenic mice (n = 8), and 
the remaining 15 Sv/C57 Black/6 mice that were transplanted with GFP 
BM 6 weeks previously, were shaved and the dorsal skin was swabbed in 
70% ethanol, washed in distilled water, and further rinsed in 2 x 
antibiotics solution (penicillin/streptomycin; Sigma) in PBS. 2 cm squares 
of skin were floated on 0.25% trypsin (Gibco BRL) for 16 hours at 4°C, or
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until the epidermis could be peeled as an intact sheet from the dermis. 
Epidermal keratinocytes were resuspended in keratinocyte growth 
medium, filtered through a 70 fxm cell strainer (BD Biosciences) to 
remove cornified sheets, and plated onto 35 mm tissue culture dishes 
pre-seeded with a mitomycin C-treated (4 i^g/ml for 2-3 hours at 37°C; 
Sigma) J2 fibroblast feeder layer. Three weeks post-seeding, 
approximately 20 - 50 keratinocyte colonies were observed per dish, 
which were then stained by immunofluorescence (section 2.3.10).
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2.3) Immunohistochemistry and in situ hybridisation
Immunohistochemistry for various antigens was used to establish cell 
phenotype, and in wild type mice transplanted with GFP BM, GFP protein 
could be identified immunohistochemically. In tissues of female mice that 
received a BM transplant from a male mouse donor, in situ hybridisation 
for the Y chromosome was used to distinguish the transplanted cells. 
Therefore, combined immunohistochemistry and in situ hybridisation 
permitted both lineage tracing and phenotypical analyses.
Information regarding primary and secondary antibodies is presented in 
Tables 2.2 and 2.3, respectively. For all immunohistochemical and in situ 
hybridisation protocols, appropriate positive and negative controls were 
used. Prior to routine use of any newly acquired antiserum, a serial 
dilution was tested on positive control sections of fixed tissue in order to 
establish the optimal dilution of each antibody. Normal sera and 
secondary antibodies were used at the highest concentration (i.e., lowest 
dilution factor) recommended by the manufacturer. To eliminate 
background staining, the primary antibody was further diluted, or if 
unsuccessful, a serial dilution series of the secondary antibody was 
performed.
2.3.1) Tissue embedding and sectioning
Fixed tissue was transferred to 70% ethanol and embedded in paraffin 
wax by the CRUK Histopathology Unit. Embedded tissue blocks were 
sectioned at either 4 \im or 10 pm using a Jung Biocut 2035 microtome, 
depending on whether the chosen method of image acquisition was light 
or confocal microscopy, respectively. Tissue sections were placed on 
frosted glass microscope slides (Thermo Shandon c o l o r f r o s t ® )  and 
dried overnight at 37°C. Sections were stored for up to one month at 
room temperature in sealed slide boxes.
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2.3.2) Dewaxing and blocking of endogenous peroxidases - paraffin 
sections
Tissue sections were dewaxed by a 5 minute immersion in sulphur-free 
xylene (BDH) and rehydrated by 3 minute incubations in decreasing 
concentrations of ethanol (100%, 95%, 80%, 70% and 50%) in distilled 
water. Sections were then treated with 30% hydrogen peroxide (BDH) in 
methanol to block endogenous peroxidases, rinsed in tap water, and 
washed in PBS.
2.3.3) Immunohistochemical staining protocol - paraffin sections
With the exception of the anti-Brdllrd primary antibody (section 2.3.5), 
antigen retrieval was performed either by microwave treatment in 
preheated sodium citrate buffer for 10 minutes at 700 W, or by incubation 
in bovine trypsin (BDH) for 15 minutes at 37°C. Sections were then 
rinsed in tap water, washed in PBS, and pre-incubated in normal serum 
(DAKO) from the donor species of the secondary antibody for 15 minutes, 
diluted at 1:25 in PBS. Without rinsing, all sections were then incubated 
in primary antibody, followed by incubation in a species-specific 
biotinylated secondary antibody. A tertiary layer of either streptavidin- 
hydrogen peroxidase (strep-HRP) diluted to 1:500, or streptavidin-alkaline 
phosphatase (strep-AP) diluted to 1:50, was finally applied. Primary, 
secondary and tertiary layers were all diluted in PBS and incubated for 
approximately 45 minutes at room temperature. Tissue sections were 
washed for 3 x 5 minutes in PBS between each antibody layer, and 
following the tertiary layer.
Strep-HRP was detected by DAB (Sigma) for 2 -  10 minutes, until the 
brown colour of the DAB could be detected macroscopically. Sections 
were then washed in PBS for 2 x 5 minutes, rinsed in tap water and 
counterstained lightly with haematoxylin and eosin (section 2.3.4).
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Strep-AP was detected using the Vector Red Alkaline Phosphatase 
Substrate Kit 1 (Vector Laboratories), prepared according to the 
manufacturers’ instructions and applied to the tissue for 10 -  30 minutes, 
or until a red colour could be detected macroscopically. Sections were 
then washed in PBS prior to the in situ hybridisation protocol (section
2.3.8).
2.3.4) H & E Counterstain
A light H & E counterstain was applied to tissue sections by immersion in 
Coles’ haematoxylin (Pioneer Research Chemicals) for 10 minutes, 
followed by a thorough rinse in flowing tap water and immersion in acid 
alcohol (1% v/v concentrated HCI in 70% ethanol) for approximately 10 
seconds. Following a second rinse in tap water, sections were immersed 
in Scott’s tap water (30 mM NaHC03, 160 mM MgS04) for 10 seconds, 
and were rinsed in tap water for a final time. Sections were then rapidly 
dehydrated through graded alcohols to xylene (BDH), and mounted in 
DPX (Sigma).
2.3.5) Acid hydrolysis pretreatment to detect BrdUrd
BrdUrd is a thymidine analogue that is incorporated into newly replicated 
DNA during the cell cycle. Therefore, the proportion of cells that 
incorporate BrdUrd is a measure of the percentage of cells that are in S- 
phase at the time of BrdUrd administration.
Tissue sections to be stained for BrdUrd immunoreactivity required acid 
hydrolysis prior to application of the primary antibody to remove histone 
proteins and partially denature the DNA, thereby rendering the 
incorporated BrdUrd accessible to the primary antibody. Sections were 
dewaxed and endogenous peroxidases were blocked (section 2.3.2), 
followed by an incubation in 2 M HCI for 5 minutes at 37°C. Sections 
were then rinsed well in tap water prior to immunohistochemical staining.
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2.3.6) Immunofluorescence staining protocol - paraffin sections
2.3.6.1) Double-labelling protocol
For co-localisation experiments using a double immunofluorescence 
method, tissue was subject to antigen retrieval and incubation in normal 
serum, as above, and was then stained with two primary antibodies 
derived from distinct species. The primary antibodies were subsequently 
probed with species-specific secondary antibodies conjugated to different 
fluorophores. The antibodies were applied in the following sequence: first 
primary; first secondary; second primary; second secondary. All 
antibodies were diluted in PBS and incubated for 1 hour at room 
temperature, with 3 x 5  minute PBS washes between each antibody 
layer.
For co-localisation experiments wherein both primary antibodies of 
interest were raised in the same species e.g. rabbit anti-GFP and rabbit 
anti-K14 antibodies, an identical protocol was followed to that above, with 
the exception that the second primary antibody was directly conjugated to 
a monofunctional fluorescein dye (section 2.3.7), thereby eliminating the 
necessity for a secondary antibody layer to detect this antibody and 
preventing cross-reaction of secondary antibodies derived from the same 
species.
2.3.6.2) Triple-labelling protocol
The use of a primary antibody conjugated to a monofunctional fluorescein 
dye permitted triple-labelling of tissue sections. For this, the double 
labelling protocol for primary antibodies from two distinct species was 
followed as above. This was proceeded by incubation in a third primary 
antibody conjugated to a fluorescein dye (section 2.3.7), which fluoresced 
at a separate wavelength than the two secondary antibodies already 
applied to the tissue. Our first primary antibody was rabbit anti-GFP,
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which was detected by the AlexaFluor®594 goat anti-rabbit IgG, and the 
second primary antibody was mouse anti-Brdllrd, which was detected by 
the AlexaFluor®488 goat anti-mouse IgG. The third primary antibody 
was anti-K14 which was directly conjugated to a Cy5 dye (section 2.3.7). 
All antibodies were diluted in PBS and incubated for 1 hour at room 
temperature, with 3 x 5  minute PBS washes between each antibody 
layer.
Following immunofluorescence staining, tissue sections were either 
mounted in Citifluor (Citifluor Ltd.) and observed using a Zeiss LSM 510 
confocal microscope (section 2.4), or were rinsed in PBS prior to the in 
situ hybridisation protocol (section 2.3.8).
2.3.7) Labelling of anti-K14 antibody with a monofunctional 
fluorescent dye
The mouse anti-K14 antibody was concentrated to 10 and the buffer 
was exchanged for 100 mM bicine (pH 8.5; Sigma) using a Centricon- 
30™ centrifugal concentrating device (Millipore). Monofunctional Cy3™ 
dye (Amersham International) was dissolved in dry N,N- 
dimethylformamide (Sigma) at a concentration of 10 mM. To initiate 
protein labelling, a 30-fold molar excess of dye relative to protein was 
added to 100 i^g of the antibody. After 30 minutes at room temperature 
with occasional mixing, labelled antibody was separated from 
unconjugated dye by using a 6 kDa molecular weight cut-off disposable 
chromatography column (Biorad) equilibrated with PBS.
2.3.8) Combined immunohistochemistry and in situ hybridisation
2.3.8.1) Mouse tissue
Following immunohistochemistry, tissue sections were analysed by in situ 
hybridisation for detection of the Y chromosome. Sections were
103
incubated in 1M sodium thiocyanate (NaSCN; Sigma) in distilled water for 
10 minutes at 80°C, washed in PBS, and digested in 0.4% w/v pepsin 
(Sigma) in 0.1 M HCI at 37°C for varying times between 30 seconds and 
25 minutes. The protease was quenched in 0.2% glycine (Merck and Co. 
Ltd.) in double concentration PBS, the sections were rinsed in PBS, post­
fixed in 4% paraformaldehyde for 2 minutes, dehydrated through graded 
alcohols and air dried. A FITC-labelled Y chromosome paint (Star-FISH, 
Cambio) in the supplier’s hybridisation mix was added to the sections, 
sealed under a glass coverslip, heated to 60°C for 10 minutes, and 
incubated overnight at 37°C. Slides were washed in 50% formamide / 2 x 
SSC ( 3 x 5  minutes), 2 x SSC ( 3 x 5  minutes), and 4 x SSC / 0.05% 
Tween-20 (Q-Biogene) for 10 minutes, all at 37°C. Slides were washed 
with PBS and sections to be viewed by direct fluorescence were mounted 
in Citifluor (Citifluor Ltd.) and observed using a Zeiss LSM 510 confocal 
microscope (section 2.4). Tissue sections that were to be viewed 
indirectly by a light microscope, were incubated with peroxidase- 
conjugated anti-fluorescein antibody (Boehringer Mannheim) diluted to 1: 
250 in PBS, for 60 minutes. Slides were developed in DAB for 1 -  2 
minutes, counterstained lightly with haematoxylin and eosin (section
2.3.4), and mounted in DPX.
2.3.8.2) Human tissue
For Y chromosome detection in human tissues, an identical protocol to 
mouse tissue was used, with a FITC-labelled human Y chromosome paint 
(Star-FISH, Cambio). Tissue sections were heated to 80°C for 10 
minutes to hybridise the probe, and then incubated overnight at 37°C.
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2.3.9) Immunofluorescence staining protocol: epidermal 
wholemounts
Protocol was performed in 24-well plates (Integra Biosciences Inc.). All 
antibodies were diluted in PB buffer, and incubated overnight with gentle 
agitation. Tissue was washed for 4 hours in PBS + 0.2% Tween-20 (Q- 
Biogene) between each antibody layer. Epidermal wholemounts were 
blocked and permeabilised by incubation in PB buffer for 30 minutes 
before immunofluorescence double-labelling. Anti-GFP primary antibody 
was applied to tissues, and was detected by the AlexaFluor®593 goat 
anti-rabbit IgG. Anti-K14 antibody directly conjugated to a 
monofunctional Cy5 dye (section 2.3.7) was then applied to the 
wholemounts, prior to rinsing in distilled water and mounting in Gelvatol 
(Monsanto Chemicals) containing 0.5% 1, 4-Diazabicyclo[2.2.2]octane 
(DABCO; Sigma). Wholemounts were then observed using a Zeiss LSM 
510 confocal microscope (section 2.4).
2.3.10) Immunofluorescence staining protocol: keratinocyte 
colonies
Approximately 3 weeks after harvesting and cultivation of keratinocyte 
colonies from wild type (Sv/C57 Black/6) mice, GFP transgenic mice, and 
wild type mice transplanted with GFP BM 6 weeks previously (section
2.2.3), a double-labelling immunofluorescence method was performed. 
The culture medium was discarded from each 35 mm plate and cells 
were rinsed in PBS and fixed in 4% formaldehyde for 20 minutes at room 
temperature. Cells were then permeabilised in 0.1% Triton X-100 
(Sigma) in PBS for 4 minutes, and washed in PBS before 
immunostaining. Cultures were incubated in anti-GFP primary antibody, 
which was detected by a biotin-conjugated goat anti-rabbit IgG 
(Biosource). A streptavidin-fluorescein conjugate (Biosource) was 
applied as the tertiary layer at 1: 100, and cells were finally incubated in 
an anti-K14 antibody conjugated to a monofunctional Cy3 dye (section
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2.3.7). All antibodies were diluted in PBS and applied to the cultures for 2 
hours. Cultures were washed 2 x 5  minutes in PBS between each 
antibody layer. Finally cultures were mounted in Citifluor (Citifluor Ltd.) 
and images were captured using a Hamamatsu digital camera 
(Improvision) on a Zeiss Axioplan fluorescence microscope (Carl Zeiss 
Ltd.).
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2.4) Confocal Imaging
Fluorescent images of both wholemount tissue and immunofluorescence- 
stained paraffin sections were acquired with a Zeiss LSM 510 confocal 
microscope (Carl Zeiss Ltd.), using two argon lasers at 488 nm and 568 
nm and a helium-neon laser at 633 nm.
2.4.1) Wholemount tissue
In the wholemount tissue, epidermal sheets were scanned from the 
dermis to the epidermal surface, encompassing the hair follicle bulb to the 
basal interfollicular epidermis, to an approximate thickness of 40 -  80 \xm. 
Approximately 30 optical sections of each sheet were captured with a 
typical increment of 1 -  3 (Am, and scans were presented as z- 
projections.
2.4.2) Paraffin sections
Paraffin sections on glass microscope slides were scanned widthways to 
an approximate thickness of 10 jim. Approximately 20 optical sections 
were captured with a typical increment of 0.5 jim, and scans were 
presented as z-projections.
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2.5) Polymerase chain reaction (PCR)
We performed PCR on DNA isolated from keratinocyte colonies from 
female wild type mice transplanted with male GFP BM that were 
immunoreactive for both GFP and K14 (section 2.3.10). Therefore, the 
identification of both GFP- and Y chromosome-specific sequences in 
DNA isolated from the keratinocyte colonies would supplement the 
histological data. All reagents used were of molecular biology grade.
2.5.1) Isolation of colonies for DNA extraction
Keratinocyte colonies from female wild type mice transplanted with BM 
from GFP male transgenic mice, that were immunoreactive for both GFP 
and K14 antigens (section 2.3.10), were “picked” using a sterile needle 
and transferred to sterile T75 cell culture flasks containing keratinocyte 
growth medium. Positive and negative DNA control colonies were 
“picked” in the same way from GFP transgenic mice and from wild type 
mice that did not receive a BM transplant, respectively.
2.5.2) DNA extraction protocol
For the extraction of DNA from keratinocyte colonies, the following 
protocol was performed. Proteinase K (stock 20 mg/ml in distilled water; 
Sigma) was added to digest buffer to give a final concentration of 100 
pg/ml. Keratinocyte growth medium was removed from the T75 cell 
culture flasks containing the colonies, and replaced with 750 pi of the 
proteinase K solution. Flasks were incubated overnight at 56°C, and non­
adherent cells were scraped into the buffer and transferred to a 2 ml 
sterile eppendorf. Isopropanol (750 pi; Sigma) was added to precipitate 
the DNA and the tubes were vortexed briefly, and then centrifuged at 
2600 rpm for 20 -  30 minutes. Most of the supernatant was discarded, 
except a small volume containing the DNA sample, which was washed
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with 70% ethanol and dried overnight at 37°C. TE buffer (1.5 ml) was 
then added to dissolve DNA, and DNA was stored at -20°C, indefinitely.
2.5.3) PCR
The CRUK Oligonucleotide Service created all primers used in PCR. 
PCR for the GFP transgene was carried out using the following 
oligonucleotide primers to produce a 306-bp product:
GFP-1f (5-TGA ACC GCATCG AGC TGA AGG G-3'
GFP-2r (5-TCC AGC AGG ACC ATG TGAT CGC-3'
DNA loading was assessed using the following wild type primers:
B2-1 (5’-CAC CGG AGA ATG GGA AGC CGA A- 3’
B2-2 (5’-TCC ACA CAG ATG GAG CGT CCA G-3’
For each reaction, 1 \x\ of DNA was mixed with 0.5 \i\ of each primer; 
GFP-1f, GFP-2r, B2-1 and B2-2, 2 i^l dNTP (Takara Bio), 2.5 ptl 10X 
buffer (Takara Bio), 0.25 \x\ Takara Taq (Takara Bio), and 17.75 \i\
distilled water. PCR reaction conditions were as follows: denaturation at
96°C, 20 s; extension at 55°C, 20 s; and annealing at 72°C, 45 s. Thirty 
five amplification cycles were performed.
2.5.4) PCR using the incorporation of a radioactive label
The presence of the Sex Determining Region (SDR) of the Y 
chromosome was identified by radioactive PCR. The primers used to 
produce an 185-bp product were as follows:
5’- GAC TAG ACA TGT CTT AAC ATC TGT CC-3’
5’- CCT ATT GCA TGG ACA GCA GCT TAT G-3’
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The reaction mix was supplemented with nucleic acids labelled with 
radioactive phosphorous ([a32P]dCTP; Amersham International) to label 
the internal primers. For each reaction, 1 \i\ of DNA was mixed with 1 \i\ 
of each primer, 2 i^l dNTP (Takara Bio), 2 \x\ [a32P]d-CTP, 2.5 \x\ 10X 
buffer (Takara Bio), 0.25 \i\ Takara Taq (Takara Bio), and 15.75 \x\ 
distilled water. The PCR reaction conditions were as follows: 
denaturation at 94°C, 60 s; extension at 58°C, 60 s; and annealing at 
72°C, 60 s. Thirty amplification cycles were performed. Products were 
resolved on a 1.8% agarose gel (section 2.5.5), which was then rinsed 
briefly in tap water and then soaked in 20 x SSC for 20 minutes. The 
DNA was transferred from the gel to a Zeta probe membrane (Biorad) by 
capillary transfer overnight. This was followed by cross-linking the 
membrane with UV light to immobilise the DNA to the membrane. The 
membrane was then exposed to Kodak film at -80°C for 4 hours.
2.5.5) Electrophoresis
PCR products were separated on a 1.8% agarose gel. A 300 ml agarose 
gel was made by mixing 2.4 g ultra pure agarose (Gibco BRL) with 150 
ml distilled water, microwaving at high power for 3 -  5 minutes until the 
agarose was dissolved, and then adding 120 ml distilled water, 30 ml TE 
buffer and 5 \l\ of ethidium bromide (Sigma). The whole solution was 
poured in a large gel tank (Scotlab-Anachem Ltd.), whose sides were 
sealed with autoclave tape to generate a closed chamber, and 2 x 28-well 
combs were immersed in the agarose to create wells. The solution was 
left to set into a gel for approximately 30 minutes. The combs were 
removed, and 25 pil of amplified PCR products were then mixed with 5 l^ 
DNA loading buffer, loaded into the gel, and separated at 150 V for 1 -  2 
hours. 1kb and 100bp DNA ladders (NEB) were run alongside to 
determine fragment size. DNA bands were visualised under UV light and 
photographed using an EagleEye Still Video System (Stratagene).
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2.6) Statistical analyses
Data were analysed using GraphPad Prism version 4.0 (GraphPad 
software), using either Mann Whitney tests (two-tailed T-tests) or one­
tailed T-tests, with statistical significance defined as P<  0.05.
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Table 2.2) Details of primary antibodies used throughout the project.
SMA Smooth muscle 
actin
Mouse 1:4000 N/A Sigma
Desmin Desmin Mouse 1:20 Microwave Euro-Diagnostica
F4/80 Macrophages Rat 1:50 Trypsin Serotec
CD34 Haematopoietic
progenitors,
Keratinocyte
progenitors
Rat 1: 100 Microwave Cedarlane Labs. 
Ltd.
ICAM-1 Endothelial
cells
Rat 1:20 Microwave CRUK
GFP Green
fluorescent
protein
Rabbit 1: 1000 Microwave Molecular
Probes
K14 Basal
keratinocytes
Rabbit 1: 10,000 Microwave BAbCO
Ly6G Neutrophils Rat 1: 100 Microwave BD Biosciences
BrdUrd Cells in 
S-phase
Mouse 1:25 Acid
hydrolysis
BD Biosciences
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Table 2.3) Details of secondary antibodies used throughout the project.
Rabbit anti-mouse IgG biotin conjugate 1:250 DAKO
Rat anti-mouse IgG biotin conjugate 1: 100 Vector Labs.
Swine anti-rabbit biotin conjugate 1:500 DAKO
Goat anti-rabbit biotin conjugate 1:200 Biosource
International
Goat anti-rabbit IgG Cy™5 conjugate 1: 1000 ZyMax
Goat anti-mouse IgG Cy™5 conjugate 1: 100 ZyMax
AlexaFluor®594 goat anti-rabbit IgG 1: 100 Molecular
Probes
AlexaFluor®488 goat anti-rat IgG 1: 100 Molecular
Probes
AlexaFluor®488 goat anti-mouse IgG 1: 1000 Molecular
Probes
AlexaFluor®647 goat anti-rat IgG 1: 100 Molecular
Probes
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BUFFERS AND SOLUTIONS
Unless otherwise stated, distilled water refers to ‘Milli-Q Plus’ water 
produced by the reverse osmosis ‘ultra pure water system’ (Millipore).
Tissue Fixation
Neutral buffered formalin (pH 7.0) (NBF, CRUK)
Formalin, full strength (37-40% formaldehyde) 100 ml
Na2HP04 (BDH) 6.5 g
NaH2P04 (BDH) 4g
Distilled water 900 ml
4% Paraformaldehyde
Paraformaldehyde (Sigma) 16 g
PBS (CRUK) 400 ml
Paraformaldehyde dissolved in PBS at 70°C, cooled to room temperature 
before use.
Immunohistochemistry 
Phosphate buffered saline (PBS, CRUK)
NaCI (Sigma) 8.0 g
KCI (BDH) 0.35 g
Na2HP04 (BDH) 1.43 g
KH2P04(BDH) 0.25 g
Distilled water 1 L
Adjusted to pH 7.2 and autoclaved. 
TBS Buffer (pH 7.2)
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NaCI (Sigma) 
Hepes (Sigma)
0.9%
20 mM
PB Buffer
Skimmed milk powder 0.5%
Fish skin gelatin (Sigma) 0.25%
Triton-X-100 (Sigma) in TBS 0.05%
Bovine trypsin (pH 7.8)
Bovine pancreas trypsin (BDH) 
CaCb (Sigma)
Distilled water
Heated to 37°C.
Diaminobenzidine (DAB)
DAB (Sigma) 0.05%
Hydrogen peroxide (BDH) 0.001%
PBS 9 ml
In situ hybridisation
10X salt solution
NaCI (Sigma) 176.2 g
Na2HP04 (BDH) 14.2 g
1MTris-HCI (Sigma) 100 ml
0.2M EDTA (Sigma) 250 ml
The cf/-sodiumhydrogenphosphate was dissolved in water and adjusted to 
pH 6.8. The sodium chloride, Tris-HCI and EDTA were then added in 
order, and the volume was made up to 1 L with water and stored at room 
temperature.
100 mg 
100 mg 
100 ml
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20 X SSC (pH 7.5) (CRUK)
NaCI (Sigma)
Na citrate (Sigma)
Distilled water to 1L total volume.
Formamide buffer
10X salt solution
Formamide (non-deionised) (Sigma)
Distilled water to 2.5 L total volume.
Sodium citrate buffer (pH 6.0)
Tri-sodium citrate (Sigma)
Distilled water
Cell Culture
Keratinocyte growth medium (CRUK)
FAD powder (Imperial Labs.) consisting of 1 part of Ham’s F12 medium 
and 3 parts Dulbecco’s modified Eagle’s medium (CRUK), plus 0.18 mM 
adenine (final concentration; Sigma), was supplemented with 100 IU/L 
penicillin (Gibco BRL) and 100 pg/L streptomycin (Gibco BRL). FAD 
medium (CRUK) was bubbled with CO2 until acidic in pH, before 
sterilising by filtration through a 0.22 p,m filter (BD Biosciences). Medium 
was stored at 4°C until use.
Stock solutions of additives were prepared. 10'5 cholera endotoxin (ICN) 
was stored at -20°C. 10 ng/ml epidermal growth factor (Gibco BRL) was 
prepared by first dissolving in 1:10 volume of 0.1 M acetic acid (BDH) 
before adding to FAD medium containing 10% fetal calf serum (FCS, 
Imperial Labs.) and stored at -20°C. The additives were combined into a 
1000x cocktail (HICE): 1ml hydrocortisone, 100 i^l cholera endotoxin and 
1 ml epidermal growth factor stock solutions were added to 7.9 ml FAD 
medium with 10% FCS and stored at -20°C. The final concentrations in
175.5 g 
88 g
250 ml 
1.25 L
2.94 g 
1 L
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the medium were 10'10 M cholera endotoxin, 0.5 g/ml hydrocortisone and 
10 ng/ml epidermal growth factor. 1000x insulin stock solution (5 mg/ml 
in 5 mM HCI, Sigma) was stored at -20°C. The final concentration in the 
medium was 5 jig/ml insulin. Complete keratinocyte medium 
(FAD+FCS+HICE) was prepared by adding 10% (v/v) FCS cocktail and 
insulin solutions to the FAD medium prior to use, and stored at 4°C for up 
to 14 days.
Polymerase Chain Reaction
Tris/EDTA (TE) Buffer
1 M Tris (pH 7.5, Sigma) 1 ml
0.5 M EDTA (CRUK) 200 \i\
Distilled water 98.8 ml
DNA gel loading buffer (6x)
Bromophenol blue (Sigma) 0.25%
Xylene cyano (Sigma) 0.25%
Ficcol (Sigma) in distilled water 15%
Digest buffer
1M Tris-HCI (pH 8.5, Sigma) 25 ml
0.5 M EDTA (pH 8, CRUK) 2.5 ml
5 M NaCI (Sigma) 10 ml
20% Sodium dodecyl sulphate (SDS) 2.5 ml
Distilled water 210 ml
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Amersham International Buckinghamshire, UK.
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BDH Laboratory Supplies Inc., Hertfordshire, UK.
BD Biosciences New Jersey, USA
Bio-Rad Laboratories Inc., Hertfordshire, UK.
Biosource International Camarillo, CA, USA
Boehringer Mannheim UK Ltd., East Sussex, UK.
Cambio Ltd., Cambridge, UK
Carl Zeiss Ltd., Hertfordshire UK.
Cedarlane Laboratories Ltd., Ontario, Canada
Cis-Bio International Cedex, France
Citifluor Limited London, UK
DAKO A/S Cambridge, UK.
Euro-Diagnostica Malmo, Sweden
Gibco BRL/Life Technologies Ltd., Renfrewshire, UK.
GraphPad Software San Diego, CA, USA.
ICN Pharmaceuticals Ltd., Thame, Oxon, UK.
Imperial Laboratories (Europe Ltd) Hampshire, UK.
Improvision Coventry, UK.
Integra Biosciences Inc. Fareham, Hants, UK.
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Merck and Co. Inc. New Jersey, USA
Millipore Watford, UK
Molecular Probes Leiden, Netherlands
Monsanto Chemicals Massachusetts, USA.
New England Biolabs (NEB) New York, USA
Pioneer Research Chemicals Colchester, UK
Q-Biogene Carlsbad, CA, USA
Scotlab-Anachem Ltd., Strathclyde, UK
Serotec Oxford, UK
Sigma Chemical Co., 
Stratagene 
Takara Bio 
Vector Laboratories 
ZyMax
Dorset, UK 
La Jolla, CA, USA 
Gennevilliers, France 
Burlingame, CA, USA 
Cambridge, UK
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CHAPTER III
BM cells contribute to ISEMFs in the mouse and human 
small intestine and colon 
3.1) Introduction
3.1.1) BM contributes to gastrointestinal epithelial lineages
Several studies have shown that a population of progenitor cells exists in 
the BM and peripheral blood, which can give rise to cytokeratin- 
expressing epithelial lineages in the mouse and human gastrointestinal 
tract (Jiang et al., 2002; Korbling et al., 2002; Krause et al., 2001; 
Okamoto et al., 2002; Spyridonidis et al., 2004). However, the bulk of 
evidence indicates that BM is unlikely to have a therapeutic relevance in 
mucosal regeneration by the direct production of epithelial cells. Firstly, 
the reported incidence of gastrointestinal epithelial cells of BM origin is 
very low, ranging from 0.04% (Spyridonidis et al., 2004) to approximately 
10% (Jiang et al., 2002). Secondly, the observed donor-derived 
gastrointestinal epithelial cells are present as single cells within the 
gastric glands and intestinal crypts and villi, and there are no reports of 
cell clusters, thus implying that BM-derived gastrointestinal epithelial cells 
do not behave as stem cells and proliferate to produce differentiated cell 
progeny.
The paradigm that BM enhances its contribution to cells in non- 
haematopoietic tissues in damaged or diseased states (section 1.13) 
appears to also apply for the gastrointestinal epithelium, as numbers of 
BM-derived epithelial cells were increased between 5 - 50-fold in patients 
who had received a sex-mismatched BM transplant and had
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subsequently developed GvHD or intestinal ulceration (Okamoto et al., 
2002; Spyridonidis et al., 2004). However, the observed fraction of BM- 
derived epithelial cells in the human colon in GvHD was still relatively 
minor at only 0.22% (Spyridonidis et al., 2004). In a separate study, less 
than 4% of enterocytes in the small intestine were of BM origin in patients 
with GvHD, which regressed to less than 1% 2 years post-transplant 
when patients had recovered (Okamoto et al., 2002), further evidence 
that BM does not form a sustainable epithelial stem cell population in the 
gastrointestinal tract.
3.1.2) The crypt microcolony assay: a possible explanation for the 
lack of BM-derived intestinal epithelial stem cells
The ability of stem cells to regenerate epithelial cell populations of entire 
intestinal crypts and villi following cytotoxic treatment has been widely 
studied using the crypt microcolony assay, first described by Withers and 
Elkind in 1970 (Withers and Elkind, 1970). In this assay, crypt survival 
levels, the growth rate of surviving crypts and the number of clonogenic 
cells in each crypt of the mouse intestine are measured following whole 
body gamma irradiation. Four days after irradiation, the surviving 
clonogenic cells in a crypt divide to form microcolonies and regenerate all 
of the epithelial cell populations of that crypt, and the overlying small 
intestinal villi. The newly repopulated crypts are 1.5 - 2-fold bigger than 
normal crypts, and they divide by crypt fission to regenerate the entire 
intestinal mucosa (reviewed in (Roberts et al., 2003)). Crypts that have 
had their stem cells depleted by irradiation are reproductively sterile and 
consequently undergo apoptosis and disappear, but are identified by the 
radioresistant Paneth cells that remain in the crypt base. The number of 
clonogenic cells within a crypt following irradiation is variable and appears 
to be age-dependent, as older mice have fewer surviving crypts and 
display a two-fold increase in the level of crypt cell apoptosis, although 
having a greater number of clonogenic cells (Martin et al., 1998a; Martin 
et al., 1998b). The dose of irradiation and degree of mucosal damage 
also appears to influence clonogenic cell number, with reports of between
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5 and 10 clonogenic cells following low dose irradiation in the mouse 
colon, and up to 36 clonogenic cells per crypt in extremely damaged 
mucosa following high-dose irradiation in both the small intestine and 
colon of mice (Cai et al., 1997; Hendry et al., 1992). It is suggested that 
in severely damaged mucosa, stem cells recruit their daughter cells to the 
niche to increase clonogenic cell number (reviewed in (Roberts et al.,
2003)). However, Wright and colleagues showed that single stem cells 
are frequently retained within a crypt following severe radiation damage, 
and these cells can reproduce the entire repertoire of adult lineages in the 
intestinal epithelium, thereby forming a monoclonal crypt (Wright and 
Alison, 1984).
The results of these early assays may provide an explanation for the 
apparent lack of BM-derived epithelial stem cells in intestinal crypts 
following irradiation and BM transplantation in the aforementioned stem 
cell plasticity studies (section 3.1.1). The capacity of the intestinal 
epithelial stem cell(s) to undergo multipotent differentiation and 
regenerate the entire intestinal mucosa demonstrates the highly efficient 
nature of these cells, and indicates that a reserve population of stem cells 
located in the BM is not essential. Moreover, BM-derived epithelial cells 
are reportedly interspersed randomly within the intestinal crypts and villi 
in both mice and humans, and it can therefore be assumed that these 
cells are short-lived due to the high cell turnover in these tissues. The 
functional relevance of BM-derived intestinal epithelial cells is as yet 
unclear. They do not appear to contribute to sustainable epithelial stem 
cell populations in the intestinal crypts, although it is possible that they 
assist in the repair of damaged mucosa by producing low numbers of 
epithelial cells.
A very recent study supports the likelihood that BM contribution to 
gastrointestinal lineages occurs relative to the level of tissue damage. 
Wild type mice were transplanted with whole BM from p-galactosidase- 
expressing ROSA26 mice and were then either given gastric ulcers, or 
were infected with Helicobacter, a known carcinogen. In transplanted
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mice that received no further manipulation or developed acute gastric 
ulceration, no BM-derived epithelial cells were observed in the gastric 
glands. However, in mice that were infected with Helicobacter, less than 
5% of epithelial cells in gastric glands were BM-derived 5 weeks after 
infection, which increased dramatically to approximately 90% 1 year after 
infection in high-grade gastrointestinal intraepithelial neoplasia. In 
addition, a proportion of these cells incorporated BrdUrd and were 
therefore capable of proliferation, the first evidence that BM-derived cells 
in the gastrointestinal tract can undergo DNA synthesis (Houghton et al.,
2004).
Therefore, it is possible that the level of tissue regeneration induced by 
whole body irradiation, GvHD, or ulceration requires only a minimal 
contribution from cells in the BM, although in high-grade neoplasia it is 
likely that the endogenous intestinal stem cells are not sufficient to 
regenerate the damaged tissue and thus a supplementary stem cell 
population in the BM is employed.
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3.2) Aim
The aim of this section of the project was to investigate the contribution of 
BM cells to differentiated adult lineages of the mouse and human 
gastrointestinal tract. The role of BM cells in the formation of 
gastrointestinal epithelial cells has previously been demonstrated, 
although this appears to be minimal, and long term engraftment and 
proliferation of BM-derived gastrointestinal cells has only been shown in a 
model of gastric neoplasia (Houghton et al., 2004). The critical 
importance of epitheliakmesenchymal cell paracrine crosstalk in the 
regulation of intestinal function is well documented, in particular the close 
interactions between the intestinal epithelial cells and the ISEMFs 
(reviewed in (Powell et al., 1999a; Powell et al., 1999b)). Little is known 
about the origin of ISEMFs and I therefore decided to investigate the 
contribution of BM to mesenchymal cell types in the small intestine and 
colon of mice and humans. I now present further verification of the 
plasticity of adult BM cells, by showing that they provide a major 
contribution to the ISEMFs in the small intestine and colons of both mice 
and humans.
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3.3) Methods
Small intestines and colons were harvested from female mice that had 
received a lethal dose of irradiation and were immediately rescued by a 
whole BM transplant from male donors (section 2.1). Murine tissues were 
harvested at 1, 2 and 6 weeks post-transplant. Gastrointestinal biopsies 
were obtained from female patients that had developed GvHD following 
unprocessed BM transplant from male donors (Table 2.1). In both the 
mouse and human studies, the donor BM cells were male and the 
recipient tissues were female, which presented the Y chromosome as a 
marker of the transplanted cells. The Y chromosome was readily 
detected in paraffin-embedded tissue sections by in situ hybridisation, 
and this was combined with immunohistochemistry for various antigens to 
determine the phenotype of the donor-derived cells (section 2.3). Male 
and female control intestinal tissue from humans and mice were used as 
positive and negative controls for the Y chromosome in situ hybridisation 
protocol.
A more detailed description of the materials and methods used in this 
chapter is given in section 2.2.1.
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3.4) Results - murine studies
3.4.1) Male and female controls
As paraffin sections analysed by in situ hybridisation for Y chromosome- 
specific sequences were 4 urn thick, the Y chromosome was not present 
in all nuclear profiles and the observed proportion of donor-derived cells 
in female colons following a male BM transplant was therefore 
underestimated. In situ hybridisation for the Y chromosome in the colons 
of male control mice showed that approximately 69.2% of ISEMFs 
contained a Y chromosome, whereas there were no Y chromosome- 
positive cells in the female control colons (Figure 3.1). Accordingly, the 
observed values of donor cells in the female transplant tissues were 
divided by a factor of 0.692 to reflect total BM-derived cell populations.
3.4.2) BM-derived cells in the mouse intestine following BM 
transplant
Following transplantation of wild type male BM into irradiated wild type 
female mice, in situ hybridisation for Y chromosome expression showed 
frequent Y chromosome-containing cells within the small intestines and 
colons at all timepoints investigated (Figures 3.2 -  3.6). The vast majority 
of these cells were located within the lamina propria subjacent to the 
epithelial mucosa, and donor-derived cells were rarely seen within the 
intestinal crypts or villi.
3.4.3) Identification of ISEMFs derived from the BM
Several lines of evidence support the contention that many of the Y 
chromosome-containing cells in the female recipients were myofibroblast 
in nature. These cells were spindle-shaped and were located in the 
subepithelial lamina propria, often present as cellular columns spanning
126
from the base of the crypt to the intestinal lumen. Immunohistochemical 
analyses confirmed the ISEMF phenotype of the donor-derived cells, 
which were strongly SMA-positive and did not express desmin (Figure 3.7 
A). Furthermore, some BM-derived cells were clearly negative for the 
haematopoietic progenitor marker CD34 (Figure 3.7B), and the mouse 
macrophage marker F4/80 (Figure 3.7C), which excluded the possibility 
that these cells were merely infiltrating inflammatory lineages.
3.4.4) A significant number of ISEMFs in the mouse are derived from 
the BM
Based upon morphological criteria and the co-expression of a nuclear Y 
chromosome and cytoplasmic SMA expression, I detected BM-derived 
cells in the lamina propria of the mouse small intestine and colon. As 
early as 7 days post-BM transplant there was evidence of a few donor- 
derived ISEMFs in the lamina propria (Figure 3.2). These cells appeared 
to be single entities, randomly interspersed throughout the lamina propria, 
and rows or clusters of BM-derived ISEMFs were not seen at this stage. 
In both the small intestine and colon, the numbers of BM-derived ISEMFs 
appeared to intensify with increasing time elapsed after transplant. 
Numbers of BM-derived ISEMFs were calculated in tissue sections from 
the mouse colon at 2 and 4 weeks post-transplant. At 2 weeks post­
transplant, a vast increase in BM-derived ISEMFs was observed, and BM 
contributed to 49.5% of these cells at this stage (Table 3.1; Figure 3.3). 
This was further increased at 6 weeks post-transplant, as 57.6% of 
ISEMFs were of male origin in the mouse colon (Table 3.1; Figures 3.4,
3.5).
3.4.5) BM-derived ISEMFs form cellular columns, extending upward 
in the lamina propria
In the small intestine and colon at 2 and 6 weeks post-transplant, I 
frequently observed columns of BM-derived ISEMFs extending 
throughout the lamina propria from the pericryptal zone at the base of the
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crypt, forming a network as they projected upwards until reaching the 
intestinal lumen (Figure 3.5). This suggests that BM-derived ISEMFs are 
functionally competent and are interconnected within a cellular network, 
which proliferates and migrates upward to the intestinal lumen. It is 
possible that the BM-derived ISEMFs derive from a progenitor cell near 
the base of the crypt, although the lack of markers of proliferation in these 
tissues prevented the irrefutable demonstration of the proliferative 
capacity of these cells.
3.4.6) BM-derived ISEMFs appear to contribute to the epithelial stem 
cell niche
The intestinal epithelial stem cells are housed at the base of the crypts 
within the stem cell niche, which is composed of the underlying 
mesenchymal cells and their ECM substratum. Due to the prominent 
expression of ISEMFs in the lower two-thirds of the crypts (Neal and 
Potten, 1981), and their stringent regulation of epithelial cell function, it is 
postulated that ISEMFs comprise a major component of the intestinal 
stem cell niche. I frequently observed BM-derived ISEMFs in the lamina 
propria adjacent to the epithelial cells in the base of the crypts, thus 
indicating that BM may be a major source of the cells of the intestinal 
stem cell niche (Figure 3.6).
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3.5) Results - Human studies
In male control intestinal biopsy material, ISEMFs were positive for the Y 
chromosome. In the female intestinal control tissues, a Y chromosome 
was not detected within any cell nuclei (Figure 3.8).
In female patients who received a BM transplant from male donors, in situ 
hybridisation for the Y chromosome revealed that many cells of donor 
origin were present in the intestinal biopsy material. Some of these cells 
displayed positive immunoreactivity for SMA and thus, in addition to 
morphological criteria, were identified as ISEMFs (Figure 3.9). BM- 
derived ISEMFs were present in tissue biopsies from all patients 
examined, although the frequency of these cells varied between each 
patient. There was no distinct pattern of expression of these cells in the 
villous tips or crypt bases, and their expression appeared to be random 
throughout the lamina propria. In this small patient series, there was no 
obvious correlation between the degree of BM engraftment and the time 
elapsed between BM transplant and tissue biopsy.
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3.6) Discussion
This study verifies recent claims that cells in the adult BM exhibit a 
remarkable plasticity. I demonstrate that an organised network of 
myofibroblasts, the ISEMFs, can receive a major contribution from the 
BM in the colons and small intestines of both mice and humans. I believe 
that this is the first report that BM cells can contribute to such a highly 
organised system of myofibroblasts as the ISEMFs.
3.6.1) Evidence for a BM origin of myofibroblasts
The origin of the myofibroblasts in the gastrointestinal tract is not clear 
(section 1.3.2), with reports of transdifferentiation between other 
mesenchymal cell types (Gabbiani, 1996; Ronnov-Jessen et al., 1995), 
and claims of a myofibroblast stem cell population in the lamina propria 
near the base of the crypt (Bockman and Sohal, 1998; Marsh and Trier, 
1974a; Marsh and Trier, 1974b; Mayer-Proschel et al., 1997; Pascal et 
al., 1968; Sappino et al., 1989). There have been several reports that 
myofibroblasts in other tissues can derive from the BM. For example, 
Grimm et al., (Grimm et al., 2001) showed that approximately 30% of 
myofibroblasts in the kidney were of extra-renal origin. Although BM was 
not specifically documented as the origin of these cells, later observations 
strongly suggest that renal interstitial myofibroblasts can be so derived 
(Poulsom et al., 2001). There is emerging evidence to show that BM- 
derived MSCs have the potential to differentiate to form myofibroblasts in 
culture. For example, myofibroblasts will differentiate from human MSCs 
when they are co-cultured with colorectal carcinoma cell lines (Emura et 
al., 2000) or dermal fibroblasts (Ball et al., 2004). Furthermore, isolated 
human MSCs demonstrate characteristic myofibroblast antigen 
expression of SMA and vimentin, and can produce extracellular matrix 
proteins in vitro (Kadner et al., 2002).
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The data obtained from this part of the project clearly suggests that a 
large proportion of the intestinal myofibroblasts are derived from the BM 
in the mouse and human small intestine and colon. This has been 
supported by results from subsequent studies that have shown a BM 
origin of myofibroblasts in the mouse lung, stomach, oesophagus, skin, 
kidney and adrenal glands (Direkze et al., 2003), and in a mouse model 
of pancreatic insulinoma, approximately 25% of all myofibroblasts 
descend from transplanted BM. In the human, transplanted BM cells can 
form up to 45% of the myofibroblasts present in liver fibrosis (Forbes et 
al., 2004).
3.6.2) Contribution of BM stem cell subpopulations to 
myofibroblasts
Previous studies demonstrating BM engraftment in the mouse and human 
gastrointestinal tract have used either whole BM, or purified populations 
of HSCs or MAPCs (Jiang et al., 2002; Korbling et al., 2002; Krause et 
al., 2001; Okamoto et al., 2002; Spyridonidis et al., 2004). Although 
these studies report a low level of epithelial cell engraftment within the 
gastrointestinal tract, they do not observe BM colonisation of the 
pericryptal sheath. The reasons for these inconsistencies are unclear, 
although species differences, discrepancies in the number and phenotype 
of transplanted cells, detection techniques and time elapsed between BM 
transplant and analysis may influence the results. Reports of 
myofibroblasts of BM origin in other tissues have all been based upon the 
transplantation of whole BM (Direkze et al., 2003; Forbes et al., 2004; 
Poulsom et al., 2001), and therefore cell sorting experiments are 
essential to locate the defined ISEMF progenitor cells of the BM.
3.6.3) BM forms cellular columns of ISEMFs in the pericryptal sheath
Under normal circumstances, pericryptal myofibroblasts proliferate and 
migrate upward along the crypt-villus axis until they are shed into the 
intestinal lumen (Kaye et al., 1968; Parker et al., 1974; Pascal et al.,
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1968). Following irradiation in the rodent and human gastrointestinal 
tract, there is prominent loss of epithelial cells, and the pericryptal 
myofibroblasts also undergo apoptosis on a time-scale very closely 
associated with that seen in the epithelial cells (Thiagarajah et al., 2000; 
Wiernick and Perrins, 1975). The observations of rows of Y 
chromosome-positive ISEMFs indicate that transplanted BM cells can 
contribute to the turnover of the pericryptal myofibroblast sheath, 
presumably due to the regenerative demand incurred by irradiation 
damage at the time of BM transplant (Naftalin, 2004). These 
interconnected columns of BM-derived ISEMFs are suggestive evidence 
for clonal expansion, and I postulate that BM cells initially seed the lamina 
propria near the crypt base, and proliferate to produce daughter cells, 
which migrate upward along the crypt-villus axis. The extension of these 
cellular columns of donor-derived ISEMFs to the tip of the villi of the small 
intestine supports this theory of continuous migration by BM-derived cells.
Contrary to the results of earlier studies showing an upward migration of 
pericryptal myofibroblasts along the crypt-villus axis, Neal and Potten 
(Neal and Potten, 1981) suggested that intestinal myofibroblasts travel 
laterally in the lamina propria, and found no evidence of vertical migration 
of these cells in the mouse small intestine. The observations of BM- 
derived cellular columns may be explained simply by the engraftment of a 
number of transplanted cells in the lamina propria, and markers of 
proliferation are vital to unequivocally demonstrate the clonogenic status 
of these cells.
Unlike in the mouse colon, rows or clusters of BM-derived cells in the 
lamina propria of the human tissue were not observed, and the numbers 
of BM-derived ISEMFs varied widely between individual patients although 
were far less abundant than in the mouse. I experienced considerable 
difficulty in accurately quantifying the number of Y chromosome-positive 
cells in both the control male tissues and in the experimental transplant 
tissues, which may reflect differences in the degree of intestinal damage 
in each patient and/or technical factors such as tissue fixation.
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3.6.4) BM-derived ISEMFs contribute to the intestinal epithelial stem 
cell niche
The pericryptal myofibroblast sheath is closely associated with the 
epithelial cells of its crypt and is thought to influence epithelial behaviour 
by producing a number of growth factors and cytokines, the receptors for 
which are often located on the epithelial cell membrane (section 1.3.2; 
reviewed in (Powell et al., 1999a; Powell et al., 1999b)). Stem cells within 
many different tissues are believed to reside within a niche, which 
provides the optimal microenvironment for the stem cells to produce their 
differentiated progeny (section 1.2; (Schofield, 1978)). The epithelial cells 
in the lower regions of the intestinal crypts are the postulated stem cells, 
and the subjacent ISEMFs and their secreted basement membrane 
factors are proposed to form and maintain the stem cell niche. It is well 
documented that ISEMFs influence epithelial cell proliferation and 
regeneration through epithelial: mesenchymal crosstalk, and ultimately 
determine epithelial cell fate. BM-derived ISEMFs were frequently 
observed surrounding the epithelial cells in the base of the intestinal 
crypts, and I therefore propose that BM may contribute to the cells of the 
intestinal stem cell niche. This indicates that BM cells may have an 
indirect function in regulating intestinal epithelial cell proliferation, via the 
paracrine secretion of specific growth factors and cytokines.
3.6.5) Microchimerism
Microchimerism is defined as a small population of cells or DNA from one 
individual that is harboured in another individual. For example, during 
pregnancy cells can traffic between the foetus and the mother, and low 
levels of fetal cells have been shown to persist in the maternal circulation 
for up to 27 years postpartum (Bianchi et al., 1996). Persistent 
microchimerism can also follow a blood transfusion, or can occur from 
cell transfer between twins in utero (reviewed in (Lambert and Nelson, 
2003)).
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In a recent study by Spyridonidis et al. (Spyridonidis et al., 2004), 
showing BM-derived colonocytes in humans, microchimerism was 
considered by investigating the presence of a Y chromosome in 
colonocytes in colonic biopsies from female patients that had received a 
sex-matched BM transplant. A Y chromosome was not observed in cells 
in any of the tissue biopsies, despite 5 of the patients having a history of 
male childbirth, and all patients having a history of recent blood 
transfusion. This suggests that microchimerism may be very rare, 
although it is important to consider all possible origins of the donor- 
derived cells. In the murine studies there is no doubt that the BM was the 
origin of the new ISEMFs, although in the human tissues it was not 
possible to establish unequivocally that the donor BM is the source of the 
ISEMFs as the patients’ history of childbirth and blood transfusion were 
not known.
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3.7) Conclusion
Based upon the results of this part of the study, I conclude that an ISEMF 
progenitor population exists in the BM, which can contribute to the repair 
of the pericryptal sheath following irradiation. ISEMFs of donor origin 
were observed up to 6 weeks post-transplant when the intestinal mucosa 
and pericryptal sheath have fully regenerated, which suggests that BM- 
derived cells are sustained within the intestine. I suggest that BM-derived 
myofibroblasts contribute to the intestinal epithelial stem cell niche, and 
therefore can indirectly influence epithelial stem cell behaviour. I also 
speculate that BM-derived ISEMFs can proliferate and migrate upward 
along the crypt:villus axis, although this remains to be proven. Therefore, 
cells in the BM could potentially be used as vehicles for gene delivery to 
the gut, to modify both myofibroblast and epithelial cell behaviour.
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Table 3.1) BM contribution to ISEMFs in mouse colon at defined 
timepoints after whole BM transplantation.
14 days 49.5 ± 2.8
CDii
6 weeks 57.6 ±4.4°
(n = 5)
a Mean ± standard error of the mean percentage of ISEMFs that were 
BM-derived.
b Non-significant variances in mean percentage of ISEMFs at 14 days 
compared to 6 weeks (p = 0.103).
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Figure 3.1) In situ hybridisation for the Y chromosome in male and 
female wild type mouse controls.
Following in situ hybridisation for a Y chromosome-specific probe, the Y 
chromosome is identified as a dark brown spot in the cell nucleus. 
Subepithelial intestinal myofibroblasts (ISEMFs) were identified by their 
morphology, their location in the lamina propria, and by their 
immunoreactivity for smooth muscle actin (SMA; red cytoplasmic stain). 
Approximately 69.2% of all ISEMFs contained a Y chromosome in the 
male colons (A; arrows), and ISEMFs in female colons lacked Y 
chromosome expression (B).
137
Figure 3.2) BM-derived ISEMFs are present 7 days post-transplant.
As early as one week post-transplant, a few cells were present in the 
subepithelial lamina propria of the mouse small intestine and colon that 
were of BM origin. This figure shows Y chromosome-expressing ISEMFs 
in the female mouse colon at this early timepoint (arrows).
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Figure 3.3
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Figure 3.3) BM-derived ISEMFs are present 14 days post-transplant.
Numerous Y chromosome-positive cells that are immunoreactive for 
SMA, and are therefore believed to be ISEMFs of BM origin are present 
in female mouse small intestine and colon 14 days after male BM 
transplant. This figure shows a longitudinal section of mouse colon at this 
timepoint (e.g., arrows; high power insets). Approximately 49.5% of all 
ISEMFs in the mouse colon are of BM origin at this timepoint.
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Figure 3.4
Figure 3.4) ISEMFs in the lamina propria are frequently derived from 
the BM.
In female mice, transplanted with whole BM from male donors, 
approximately 57.6% of ISEMFs in the colon are of donor origin, 6 weeks 
after transplant (e.g. arrows; high power inset).
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Figure 3.5
Figure 3.5) BM-derived ISEMFs are often present in cellular columns 
in the subepithelial lamina propria
Y chromosome-positive ISEMFs stained with SMA in the mouse colon at 
6 weeks post-transplant. These cells were frequently present in rows, 
extending from the base of the crypt upward to the intestinal lumen 
(arrows).
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Figure 3.6
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Figure 3.6) BM-derived ISEMFs may contribute to the intestinal 
epithelial stem cell niche.
ISEMFs are predominantly located in the lower regions of the lamina 
propria surrounding the proposed intestinal epithelial stem cells in the 
crypt base. It is therefore postulated that myofibroblasts contribute to the 
intestinal epithelial stem cell niche (A; from {Spradling, 2001 #129}). BM- 
derived ISEMFs were often present in this region in the mouse small 
intestine and colon, 6 weeks after transplant, suggesting an indirect role 
for BM cells in the regulation of intestinal epithelial stem cell function (B; 
longitudinal section of mouse colon; arrows).
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Figure 3.7
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Figure 3.7) Some BM-derived cells do not express desmin, or 
haematopoietic or macrophage markers.
Desmin-immunoreactive cells within the lamina propria were not Y 
chromosome-positive (A). Y chromosome-positive cells in the lamina 
propria were often negative for the haematopoietic progenitor marker 
CD34 in the mouse colon, 6 weeks after transplant (B; arrows). Similarly, 
Y chromosome-positive cells in the lamina propria were often negative for 
the mouse macrophage marker F4/80 antigen (C; positively stained 
macrophages shown by arrows).
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Figure 3.8) In situ hybridisation for the Y chromosome in male and 
female human control intestines.
Following in situ hybridisation for a Y chromosome-specific probe, the Y 
chromosome is identified as a dark brown spot in the cell nucleus. 
Subepithelial intestinal myofibroblasts (ISEMFs) were identified by their 
morphology, their location in the lamina propria, and by their 
immunoreactivity for SMA (red cytoplasmic stain). This figure shows Y 
chromosome-expressing ISEMFs in the male duodenum (A; arrows), and 
ISEMFs in female duodenal control tissue that lacked Y chromosome 
expression (B).
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Figure 3.9
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Figure 3.9) BM-derived ISEMFs in the human gastrointestinal tract.
Human gastrointestinal biopsies from female patients who have received 
a BM transplant from a male donor, showing ISEMFs that are 
immunoreactive for SMA and positive for the Y chromosome probe (A -  
D; arrows).
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CHAPTER IV
In experimental colitis, the input of BM-derived ISEMFs is 
significantly increased, and BM plays an additional major 
role in neovasculogenesis.
4.1) Introduction
As discussed in Chapter III, following lethal irradiation and whole BM 
transplantation, a significant number of ISEMFs of donor origin were 
observed in the pericryptal sheath of the lamina propria in the mouse and 
human small intestine and colon. True to the nature of the indigenous 
ISEMFs, BM-derived ISEMFs are believed to form and maintain the 
intestinal epithelial stem cell niche, and thus contribute to the regulation 
of epithelial cell proliferation via mesenchymahepithelial cell interactions. 
Therefore, BM-derived ISEMFs may have an indirect role in the 
maintenance of intestinal homeostasis by regulating epithelial stem cell 
turnover (Brittan et al., 2002).
4.1.1) BM plasticity is enhanced with increasing regenerative 
demand
The contribution of BM cells to non-haematopoietic lineages in adult 
tissues is upregulated with increasing regenerative pressure induced by 
injury or disease (section 1.13). However, prior to this study, the role of 
BM cells in tissue remodelling in the inflamed gut was not known.
4.1.2) ISEMFs are activated in IBD
In the healthy gut, ISEMFs exist as transiently differentiated, quiescent 
cells. However, in inflamed tissue, they are activated to increase their
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proliferation rate (McKaig et al., 2002), upregulate their expression of 
cytokines, chemokines, growth factors and adhesion molecules, and to 
enhance their secretion of soluble mediators of inflammation and 
extracellular matrix factors (reviewed in (Powell et al., 1999a)). For 
example, activated ISEMFs increase their secretion of the epithelial cell 
mitogen, keratinocyte growth factor in IBD, thereby stimulating epithelial 
cell hyperplasia (Bajaj-Elliott et al., 1997). Furthermore, the pro- 
inflammatory cytokines interleukin-1 p and tumour necrosis factor-a 
(TNFa) are upregulated in Crohn’s disease (Mahida et al., 1989; 
Reinecker et al., 1993), and these have been shown to drive the 
proliferation of human colonic myofibroblasts in vitro (Jobson et al., 
1998). It is well documented that overactivation and persistence of 
ISEMFs in Crohn’s disease can result in tissue fibrosis and scarring 
(Aigner et al., 1997; Graham, 1995; Isaji et al., 1994; Kinzler and 
Vogelstein, 1998; Martin et al., 1996), which indicates that the pathways 
of tissue regeneration by ISEMFs in Crohn’s disease are stringently 
controlled and can prove deleterious if dysregulated.
4.1.3) BM contributes to vascular lineages in inflamed and diseased 
tissues
Endothelial progenitor cells (EPCs) originating in the adult BM are 
involved in the remodelling of existing blood vessels by angiogenesis, 
and in the formation of new blood vessels by postnatal vasculogenesis, 
thereby playing a role in vascular repair and remodelling in specific 
physiological and pathological conditions (Asahara et al., 1997; Grant et 
al., 2002; Reyes et al., 2002; Sata et al., 2002; Shi et al., 1998). 
Endothelial cells and their surrounding vascular smooth muscle (mural) 
cells derived from EPCs have been reported in blood vessels in various 
ischaemic organs and tissues in both mice and humans (see Table 1.1). 
However, to date, there have been no reports of BM-derived vascular 
lineages in the colon, and the role of BM in tissue regeneration in IBD is 
poorly understood.
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4.2) Aim
In order to investigate the therapeutic relevance of BM cells in intestinal 
regeneration, we used the 2,4,6-trinitrobenzene sulfonic acid (TNBS) 
model of experimental colitis, a well-established model of T helper cell 
type l-mediated gut inflammation, with similarities to human Crohn's 
disease (Neurath et al., 1995). This model of intestinal inflammation was 
selected as it directly involves the ISEMFs, which we have confirmed can 
be derived from a population of cells in the BM (Brittan et al., 2002). 
Emerging data indicates that BM plasticity is enhanced in diseased 
tissues, although this has not yet been demonstrated in a model of IBD. 
Furthermore, increasing evidence suggests that transplanted BM cells 
can provide long-term remission of Crohn’s disease, which is as yet 
incurable, although the mechanism by which the BM cells alleviate colitis 
is poorly understood.
We now show that in TNBS colitis, transplanted BM cells significantly 
enhance their engraftment into the damaged colon, and give rise to 
ISEMFs of donor origin. Furthermore, we demonstrate that BM cells can 
form both endothelial and mural cells in blood vessels in the colon, again 
with a significant increase in colitis. Blood vessels were observed that 
were composed entirely of cells of BM origin, highlighting the possible 
role of BM in neovasculogenesis.
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4.3) Methods
Female Balb/C donor mice were given a lethal dose of irradiation followed 
by a whole BM transplant from male Balb/C donor mice (section 2.1). Six 
weeks post-transplant, experimental colitis was induced in the mice by 
intrarectal injection of 2 mg TNBS in 50% ethanol. Control animals were 
given an injection of 50% ethanol only. Animals were killed and colons 
were fixed and processed for analyses at 1, 4, 7, 8 and 14 days post- 
TNBS. Donor male cells were detected by in situ hybridisation with a Y 
chromosome-specific probe, which was combined with 
immunohistochemistry for specific antigens to determine the phenotype of 
the donor cells (section 2.3). Male and female mouse colons were used 
as positive and negative controls, respectively, for the in situ hybridisation 
protocol.
A more detailed description of the materials and methods used in this 
chapter is given in Chapter II, section 2.2.2.
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4.4) Results
4.4.1) TNBS-induced colitis
Previous studies have shown that TNBS-induced colitis is manifest as 
patchy lesions in the distal colon that gradually worsen throughout days 1 
- 8 (Higgins et al., 1999). Examination of H & E stained paraffin sections 
of the colons at all timepoints after TNBS administration, confirmed earlier 
reports and allayed our initial concerns that the pathology of TNBS colitis 
may be altered due to irradiation and BM reconstitution. Affected areas 
showed an acute transmural disease with inflammatory cell infiltration, 
oedema, ulceration, fibrosis, epithelial cell necrosis and loss of colonic 
crypts. Fourteen days after TNBS administration, the colons had almost 
entirely returned to normal (Figure 4.1 A -  E).
4.4.2) Identification of BM-derived cells by in situ hybridisation
As paraffin sections analysed by in situ hybridisation for Y chromosome- 
specific sequences were 4 jxm thick, the Y chromosome was not present 
in all nuclear profiles and the observed proportion of donor-derived cells 
in female colons following a male BM transplant was therefore 
underestimated. Approximately 69.2% of cell nuclei in colons from male 
control mice show a Y chromosome using the in situ hybridisation 
technique. Therefore, the observed values of donor cells in the female 
recipient tissues were divided by a factor of 0.692 to reflect total BM- 
derived cell populations.
4.4.3) BM-derived ISEMFs in ethanol-treated control colons
At all time-points, Y chromosome-positive cells were abundant throughout 
the lamina propria in colons of female control mice that received a male 
BM transplant and were given 50% ethanol only. Based upon previously
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established criteria, an ISEMF phenotype was attributed to those donor- 
derived cells that had a spindle-shape, resided in the subepithelial lamina 
propria, were immunoreactive for SMA (Figure 4.2A) and did not express 
the mouse macrophage marker F4/80 or the haematopoietic progenitor 
marker CD34 (section 3.4.3; (Sappino et al., 1990; Schmitt-Graff et al., 
1994)). Throughout the time-course, the contribution of transplanted BM 
to ISEMFs in this ethanol control group remained relatively constant 
(Table 4.1). Leucocytes throughout the lamina propria were also Y 
chromosome-positive, as expected.
4.4.4) BM-derived ISEMFs in undamaged mucosa of mice given 
TNBS
Due to the patchy nature of TNBS colitis, regions of lamina propria that 
displayed a typically normal morphology and no significant inflammation 
were assessed separately from the adjacent patches of colitis. In these 
regions of undamaged mucosa, donor-derived ISEMFs were identified at 
all timepoints (Figure 4.2B,C). In both ethanol-treated control colons and 
in the regions of undamaged mucosa in TNBS-treated animals, the 
ISEMFs were often present as rows of cells extending from the base of 
the crypt to the intestinal lumen, consistent with our previous 
observations (Figure 4.3; section 3.4.5). Approximately 24% of ISEMFs 
in the undamaged mucosa were derived from the transplanted BM 1 - 4 
days after TNBS administration, increasing to 26% by days 6 - 8 when 
the adjacent colitis was most severe. By day 14, parallel to the regression 
of colitis, the proportion and total number of donor-derived ISEMFs had 
decreased once more, with approximately 22% of ISEMFs having a Y 
chromosome (Table 4.1).
4.4.5) BM-derived ISEMFs in severely inflamed colons of mice with 
TNBS-induced colitis
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In regions of severe tissue injury surrounding ulcer beds in TNBS-treated 
animals, very large numbers of cells throughout the lamina propria, 
muscularis mucosa, submucosa, and muscularis propria had a Y 
chromosome, due to the high numbers of inflammatory cells in colitis. In 
these regions at 6 - 8 days post-TNBS, 39% of ISEMFs were derived 
from the transplanted BM (Figure 4.4; Table 4.1), and interestingly, 
donor-derived myofibroblasts at this timepoint were three-fold more 
numerous than in the ethanol-treated control colons. In the lamina 
propria surrounding regions of re-epithelialisation, the myofibroblasts 
assumed an activated phenotype with a large, rounded morphology 
(Figure 4.4). At 14 days post-TNBS there was no evidence of colitis.
4.4.6) BM-derived cells form vascular lineages in TNBS-induced 
colitis
We observed BM-derived vascular mural cells, confirmed by 
morphological criteria and their expression of a Y chromosome and 
immunoreactivity for SMA, at all timepoints studied in both the ethanol 
controls and in TNBS-treated animals (Figure 4.5). In colons showing an 
apparently normal morphology, and in non-inflamed regions of colons in 
TNBS-treated mice, BM-derived mural cells were frequently present as 
single cells, interspersed throughout the blood vessels. However, in 
patches of severe inflammation, vessels were observed that appeared to 
be composed largely, and even entirely, of BM-derived cells, thereby 
suggesting that BM is involved in the creation of entire new blood vessels 
via postnatal neovasculogenesis (Figure 4.6). In grossly inflamed 
regions, the tissue was highly vascularised containing small, leaky 
vessels, and BM-derived mural cells were frequently present in these 
structures (Figure 4.6B). The numbers of blood vessels containing BM- 
derived mural cells were calculated, revealing a 6.4-fold increase in 
TNBS-treated colons than compared to ethanol-treated controls (p = 
0.013; Table 4.2). Moreover, the total percentages of BM-derived mural 
cells within these blood vessels was calculated, showing an almost 2-fold
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increase in the contribution of BM to mural cells in colitis, compared to 
ethanol-control tissue (p = 0.017; Table 4.2).
BM cells also contributed to endothelial cells within blood vessels in 
inflamed colons, ascertained by their morphology and their co-expression 
of ICAM-1 and the Y chromosome (Figure 4.7). However, the transition 
of BM to endothelial cells appeared to occur less frequently than BM 
formation of mural cells, as BM-derived endothelial cells occurred only in 
vessels in grossly inflamed tissue i.e., at 6 - 8 days post-TNBS.
4.4.7) BM-derived ISEMFs and vascular cells do not express 
haematopoietic or macrophage markers
Following detection of the Y chromosome-positive ISEMFs and vascular 
lineages, immunohistochemical staining was performed for the 
haematopoietic marker CD34, or the macrophage marker F4/80, to 
establish whether BM-derived lineages were haematopoietic or 
macrophage cell types. We frequently observed cells of BM origin in the 
blood vessels that lacked expression of F4/80 (Figure 4.8) and CD34 
(Figure 4.9). Similarly, BM-derived cells were present in the lamina 
propria of both normal colons and in inflamed colons, which displayed a 
myofibroblast phenotype, but lacked expression of these markers (Figure 
4.10). Macrophages or haematopoietic cells derived from the BM were 
present within the lamina propria and blood vessels (Figure 4.8 - 4.10) 
and thereby provided an internal control for this experiment.
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4.5) Discussion
These data confirm my previous observations that BM forms ISEMFs in 
the lamina propria of the mouse gut (chapter III; (Brittan et al., 2002)). I 
now show that this phenomenon is significantly increased in murine 
colitis. I believe that this study presents a number of new observations: 
(1) BM contribution to ISEMFs is enhanced in colitis, (2) BM cells give 
rise to vascular lineages in the mouse colon and, (3) the role of BM cells 
in vasculogenesis is upregulated in colitis. These data indicate that BM 
has multiple therapeutic roles in colitis, in its production of both 
mesenchymal and vascular lineages that aid tissue regeneration and 
indirectly regulate intestinal epithelial stem cell behaviour, the implications 
of which will be discussed in the following sections.
4.5.1) Confirmation of a BM origin of ISEMFs in the mouse colon
I have verified my previous findings, that ISEMFs in the mouse colon are 
derived from a progenitor population of cells in the BM (section 3.6.1; 
(Brittan et al., 2002)). I also confirm my observations of cellular columns 
of BM-derived ISEMFs in the subepithelial lamina propria, spanning from 
the crypt base to the intestinal lumen (section 3.6.3; (Brittan et al., 2002)). 
It is tempting to speculate that this provides further evidence of a clonal 
nature of BM-derived ISEMFs surrounding individual crypts, although 
markers of cell proliferation are required to unequivocally demonstrate 
this. Furthermore, as expected from my previous results, numbers of 
BM-derived ISEMFs were high, even in apparently undamaged, non- 
colitic tissue, presumably due to the regenerative demand incurred by 
irradiation damage at the time of BM transplant (Naftalin, 2004).
4.5.2) BM formation of ISEMFs is significantly upregulated in colitis
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BM contribution to adult cells in non-haematopoietic tissues is 
upregulated in damage or disease (section 1.13), which we can now 
confirm, for the first time, also occurs in the inflamed colon. The 
observed increase in BM engraftment in the inflamed colons 
demonstrates an augmented BM contribution to differentiated lineages in 
the intestine during times of stress, and outlines the significance of 
ISEMFs in tissue regeneration in IBD. However, it is not known whether 
increased numbers of circulating BM cells are stimulated to engraft within 
the diseased colon and form ISEMFs after TNBS administration, or if pre­
existing BM-derived ISEMFs in the lamina propria become activated to 
divide and repopulate the damaged pericryptal sheath. Markers of cell 
proliferation could confirm the clonogenic potential of BM-derived 
ISEMFs.
ISEMF number is increased in Crohn's disease (Pucilowska et al., 2000), 
which is believed to be a result of the activation and differentiation of 
quiescent interstitial fibroblasts or pericytes, or the increased proliferation 
and/or decreased apoptosis of existing myofibroblasts (Adegboyega et 
al., 2002). However, my observations suggest a further contributory 
factor to this increase in myofibroblast number, as a substantial 
proportion of ISEMFs in colitis are derived from the BM.
4.5.3) BM forms multiple vascular lineages in the inflamed mouse 
colon
In addition to ISEMFs, we now show for the first time that transplanted 
BM cells form both mural cells and endothelial cells of blood vessels in 
the inflamed mouse colon. The “angiogenic switch” model describes the 
repopulation of damaged blood vessels by fully differentiated endothelial 
cells, which migrate to sites of injury from neighbouring blood vessels 
(Hanahan and Folkman, 1996). However, since the recent identification 
of a circulating EPC population in the BM (Asahara et al., 1997; Shi et al., 
1998), evidence for postnatal neovasculogenesis has increased. The 
contribution of BM-derived EPCs to neovascularisation in many
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inflammatory conditions is now well documented (Table 1.1), although 
despite this wealth of evidence, BM-derived vascular lineages have not 
previously been reported in IBD. Expression of the intracellular adhesion 
molecule, ICAM-3 (CD50), is upregulated in Crohn’s disease (Bretscher 
et al., 2000; Fawcett et al., 1992; Serrador et al., 1997; Vainer and 
Nielsen, 2000), and ICAM-3 has recently been shown to be expressed on 
BM-derived endothelial cells and to play a regulatory role in endothelial 
cell junction formation (van Buul et al., 2004), possibly supporting our 
evidence for neovasculogenesis by BM-derived endothelial cells in colitis.
There are numerous reports of BM-derived endothelial cells, although few 
studies describe BM-derived mural cells (Espinosa-Heidmann et al., 
2003; Orlic et al., 2001b). A recent report describes a BM origin of the 
periendothelial vascular mural cells, which are believed to be mural cell 
progenitors (Rajantie et al., 2004). It has not yet been possible to purify 
EPCs from the mouse BM, although it is suggested that they derive from 
a population of haematopoietic stem cells (HSCs) which express Flk-1, c- 
Kit, Sca-1, CD34, CD45, but lack markers of lineage differentiation (Lin-) 
(section 1.12.5; see also (Asahara and Kawamoto, 2004)). A population 
of mesenchymal stem cells (MSCs), termed multipotent adult progenitor 
cells (MAPCs), has been isolated from both murine and human BM and 
have also been shown to have endothelial differentiation potential, both in 
vivo and in vitro (section 1.12.4; (Jiang et al., 2002; Reyes et al., 2002). 
In our present study, since whole BM was transplanted, we cannot 
comment on the origins of our BM-derived cells.
4.5.4) BM-derived endothelial cells may directly influence intestinal 
epithelial stem cell behaviour
Paris and colleagues presented data showing that the initiating factor in 
radiation-induced crypt death in mice is apoptosis of the endothelial cells 
in the tissue stroma, which precedes intestinal epithelial stem cell 
dysfunction and crypt damage (Maj et al., 2003; Paris et al., 2001). The 
authors proposed that the endothelial cells are the primary targets of
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gamma radiation, and that the concurrent death of the epithelial stem 
cells is a secondary event caused by a loss of endothelial cell support. 
However, these claims have never been corroborated and were refuted 
due to the lack of tissue ischaemia and hypoxia that would be expected 
following such severe damage to the vasculature (Hendry et al., 2001; 
Suit and Withers, 2001). With respect to our current findings of BM- 
derived endothelial cells in the mouse colon, it is important to note that if 
the endothelial cells in the intestine are the primary targets of radiation- 
induced intestinal mucosal damage this implicates the BM with a further 
role in intestinal epithelial stem cell regulation, via the formation of 
endothelial cells.
4.5.5) BM transplantation as a therapy for Crohn’s disease
Crohn’s disease runs a chronic relapsing and remitting course with a 
significant disease-associated mortality rate of between 6 -  24% of 
patients observed within a 13 -  20 year follow-up (Cooke et al., 1980; 
Farmer et al., 1985; Trnka et al., 1982). Crohn’s disease responds to 
immunosuppressive medications and anti-inflammatory agents, although 
as yet, no curative therapy has been found. Several case studies 
showing long-term remission from Crohn’s disease following autologous 
(Kashyap and Forman, 1998; Soderholm et al., 2002) or allogeneic BM 
transplantation (Lopez-Cubero et al., 1998; Talbot et al., 1998) have been 
documented. Prior to BM transplant, a patient’s own BM is eradicated, 
and it is therefore possible that the observed remission of Crohn’s 
disease following BM transplant is due to the elimination of aberrant BM 
cells that play a critical role in the pathogenesis of Crohn’s disease. 
Furthermore, no immunosuppressive medication is required following BM 
transplantation in Crohn’s disease patients, indicating that the observed 
long-term remission is a direct result of the transplantation procedure 
(reviewed in (James, 1998)). We now suggest a possible mechanism by 
which BM cells provide remission from Crohn’s disease, by their 
formation of mesenchymal and vascular lineages in the inflamed colon, 
thereby contributing directly to tissue regeneration.
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4.6) Conclusion
In conclusion, transplanted BM cells contribute to myofibroblasts in the 
lamina propria of the mouse colon in both normal and diseased states. 
BM engraftment and ISEMF formation is enhanced with increasing 
disease severity, demonstrating a possible functional role of the BM- 
derived ISEMFs in colitis. Transplanted BM cells also form vascular 
lineages in the mouse colon, again with a significant increase in colitis, 
and whole donor-derived blood vessels were observed, suggestive of 
neovasculogenesis by BM cells. It is possible that a stem cell population 
present in adult BM can undergo multipotential differentiation to several 
specialised adult cell lineages in the gastrointestinal tract, although it is 
equally feasible that different stem cell populations exist in the BM, each 
differentiating to form a specific adult lineage (Ratajczak et al., 2004).
The formation of ISEMFs and vascular lineages by BM cells in the mouse 
colon shows that BM cells may have multiple indirect influences on 
epithelial stem cell behaviour, as both these differentiated intestinal 
lineages are known to regulate epithelial stem cell function (Bajaj-Elliott et 
al., 1997; Paris et al., 2001; Powell et al., 1999b).
Our results suggest a therapeutic potential for BM cells in the formation of 
mesenchymal and vascular lineages, which aid tissue regeneration in 
Crohn's disease. However, the underlying mechanisms of BM 
transformation to differentiated cell lineages within extraneous tissues 
requires further detailed understanding before such stem cell therapy is 
used in a clinical environment.
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Table 4.1) BM contribution to ISEMFs in ethanol-treated colons, in the 
normal-appearing mucosa adjacent to colitis in TNBS-treated colons, and 
in areas of colitis.■n
Days 1 -4  
(n = 7)
17 ± 1 24 ± 2.6 34.7 ±1.3
Days 6 -8
(n = 9)
20 ±1.3 26 ± 1.3° 38.7 ± 3 0,<l
Day 14
(n = 7)
19± 1.2 22 ± 0.8 No colitis
a Mean ± standard error of the mean percentage of ISEMFs that were 
BM-derived
b Significant increase in mean percentage of BM-derived ISEMFs in 
normal mucosa adjacent to regions of colitis in TNBS-treated animals 
compared to ethanol-treated controls to at 6 - 8 day timepoint (p = 0.012). 
c Significant increase in mean percentage of BM-derived ISEMFs in 
TNBS colitis compared to ethanol-treated control colons at 6 - 8 day 
timepoint (p = 0.0095).
d Significant increase in mean percentage of BM-derived ISEMFs in 
TNBS colitis compared to normal mucosa adjacent to regions of colitis in 
TNBS-treated animals, at 6 - 8 day timepoint (p = 0.013).
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Table 4.2) BM contribution to mural cells in normal colons compared to 
colitis, 6 - 8  days after ethanol or TNBS administration.
EtOH Control 
(n = 5)
4.2 ± 0.9 14 ±3.1
Normal mucosa in 
TNBS-treated mice 
(n = 9)
15 ±2.6 20 ± 3.6
TNBS Colitis 
(n = 9)
27 ± 6 c 27 ±1 a
a Mean ± standard error of the mean percentage of blood vessels 
containing BM-derived mural cells
b Mean and ± standard error of the mean percentage of mural cells 
derived from the BM in blood vessels
c Statistically significant increase in percentage of blood vessels 
containing BM-derived mural cells in ethanol controls, compared to 
regions of colitis (p = 0.013).
d Statistically significant increase in percentage of total BM-derived mural 
cells in ethanol controls compared to regions of colitis (p = 0.017).
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Figure 4.1
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Figure 4.1) Morphological characteristics of TNBS-induced colitis.
Haematoxylin and eosin-stained paraffin sections of colons at different 
timepoints following ethanol or TNBS administration, demonstrating the 
progression of TNBS-induced colitis in irradiated, BM reconstituted mice. 
Four days after ethanol administration, crypts appear to have a normal 
morphology (A). One day after TNBS, colons are relatively normal with 
some increased inflammation (B). At 8 days post-TNBS, colitis is most 
severe (C, D). By day 14 post-TNBS, the tissue has almost entirely 
regenerated and displays a normal morphology, with evidence of crypt 
fission, a key component of the regeneration process (E; arrows), inf, 
inflammatory cell infiltration; u, mucosal ulceration; f, fibrosis; n, epithelial 
cell necrosis and crypt death.
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Figure 4.2) BM-derived ISEMFs in the non-inflamed mouse colon.
BM-derived ISEMFs were identified by morphological criteria i.e., spindle- 
shaped cells in the lamina propria surrounding epithelial crypts, which 
have a nuclear Y chromosome (dark brown nuclear spot), and are 
immunoreactive for SMA (red cytoplasm). These cells were frequently 
identified at all timepoints in both ethanol-treated controls (A; arrow; 4 
days post-ethanol) and in the non-inflamed mucosa adjacent to regions of 
colitis in TNBS-treated mice (B, C; arrows; 8 days post-TNBS).
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Figure 4.3) BM-derived ISEMFs form cellular columns in the lamina 
propria.
BM-derived ISEMFs were present as cellular columns spanning from the 
base of the epithelial crypts to the intestinal lumen, at all timepoints 
studied in both ethanol controls and in the inflamed and non-inflamed 
mucosa of TNBS-treated mice. ISEMFs were identified by their Y 
chromosome expression (dark brown nuclear spot) and SMA 
immunoreactivity (red cytoplasm). This figure shows columns of BM- 
derived ISEMFs in the non-inflamed mucosa in ethanol-treated mice (A, 
and inset B, C; arrows; 6 days post-ethanol).
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Figure 4.4
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Figure 4.4) BM-derived ISEMFs display an activated phenotype in 
TNBS colitis.
Activated myofibroblasts in colitis were identified by their location in 
regions of fibrosis and by their large, flat shape (A -  C; arrows; 6 - 8  days 
post-TNBS). BM-derived cells were present in the lamina propria 
surrounding regions of mucosal re-epithelialisation, suggesting a potential 
role for BM-derived cells in mucosal regeneration (B, and high power 
inset C; arrows; 8 days post-TNBS). n, epithelial cell necrosis and crypt 
death; u, mucosal ulceration; f, fibrosis; re, re-epithelialisation.
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Figure 4.5) BM forms mural cells in blood vessels in TNBS colitis.
BM-derived mural cells were identified as smooth muscle-like cells 
surrounding the blood vessels that were immunoreactive for SMA antigen 
(red cytoplasm) and possessed a nuclear Y chromosome (dark brown 
nuclear spot). BM-derived mural cells were frequently interspersed 
throughout blood vessels in inflamed colons (A and high power inset, B 
and high power inset, C; arrows; 6 days post-TNBS).
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Figure 4.6) BM cells contribute to entire mural cell populations 
within blood vessels in TNBS colitis.
In inflamed tissue, blood vessels were observed in which the mural cell 
population appeared to be entirely derived from the transplanted BM 
cells, suggesting a role of BM cells in postnatal vasculogenesis in TNBS 
colitis (A, plus high power inset, C; arrows; 6 days post-TNBS). These 
cells displayed a Y chromosome (dark brown nuclear spot), and their 
mural cell phenotype was confirmed by their positive immunoreactivity for 
SMA (red cytoplasm). Interestingly, in grossly inflamed regions, the 
tissue was highly vascularised with small, leaky vessels, and BM-derived 
mural cells were frequently present in these structures (B; arrows; 8 days 
post-TNBS).
175
Figure 4.7
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Figure 4.7) BM contributes to endothelial cells in TNBS colitis.
BM-derived endothelial cells were identified in blood vessels in inflamed 
colons, indicating that BM contains progenitor cell populations that can 
produce multiple vascular lineages (A, B; arrows; 8 days post-TNBS). 
BM-derived endothelial cells were identified as cells that were ICAM-1- 
immunoreactive (red cytoplasm), and possessed a Y chromosome (dark 
brown nuclear spot).
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Figure 4.8) Some BM-derived cells in blood vessels do not express 
the macrophage marker F4/80.
Blood vessels in inflamed colons contained cells that displayed a Y 
chromosome (dark brown nuclear spot), but did not express the 
macrophage marker, F4/80 (A -  C; arrows; 6 days post-TNBS). 
Macrophages of BM origin were frequently observed i.e., cells that were 
immunoreactive for F4/80 (red cytoplasm) and displayed a Y 
chromosome (A, C; *), and provided an internal control for these 
experiments. Some cells lacked expression of F4/80 and expressed a Y 
chromosome, but were not believed to be either mural or endothelial cells 
due to their morphology and location (B; arrowheads).
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Figure 4.9) Some BM-derived cells in blood vessels do not express 
the haematopoietic cell marker CD34.
Blood vessels in inflamed colons contained cells that displayed a Y 
chromosome (dark brown nuclear spot), but did not express the 
haematopoietic marker, CD34 (A, B; arrows; 6 days post-TNBS). 
Haematopoietic cells derived from the transplanted BM were frequently 
observed i.e., cells that were immunoreactive for CD34 (red cytoplasm) 
and displayed a Y chromosome (A, B; *), and provided an internal control 
for these experiments.
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Figure 4.10
Figure 4.10) Some BM-derived cells in the lamina propria do not 
express the macrophage marker F4/80.
BM-derived cells in the subepithelial lamina propria, which were 
morphologically characteristic of ISEMFs, did not express the 
macrophage marker F4/80 (A, and high power inset B; arrows; 6 days 
post-TNBS). BM-derived cells were present in the submucosa that were 
morphologically characteristic of macrophages and were immunoreactive 
for F4/80 (A, and high power inset C; *).
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CHAPTER V
BM-derived keratinocytes in normal and wounded 
epidermis: evidence of proliferate competence in vivo and 
in vitro.
5.1) Introduction
5.1.1) The adult mouse epidermis has two stem cell populations
The stem cells of the adult mouse epidermis reside within two distinct 
locations, the epidermal proliferating units (EPU) in the basal layer of the 
IFE, and the bulge region of the hair follicles. The stem cells in the bulge 
are more numerous than those within EPUs, and can undergo multipotent 
differentiation to give rise to all the differentiated adult lineages in the hair 
follicles, sebaceous glands and IFE, whereas the stem cells within EPUs 
are unipotent and contribute solely to keratinocytes of the IFE (section
1.8).
As stem cells cycle more slowly than their differentiating counterparts, the 
majority of studies aimed at identification of the epidermal stem cells have 
utilised the slow cell cycle duration of these cells, and their resultant DNA 
label-retaining phenotype (section 1.8).
5.1.2) Markers of stem cells in the epidermis
Recent literature has highlighted several molecular markers that display 
an enriched expression in cells within the postulated epidermal stem cell 
niches, including the p1- and a6-integrin subunits (section 1.9.1) and the 
keratin proteins, K15 and K19 (section 1.9.2). CD34, previously believed 
to be restricted to early haematopoietic progenitor cells, was recently
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shown to be co-expressed in K15-, a6 integrin-positive keratinocytes in 
the follicular bulge (section 1.9.2).
5.1.3) BM cells contribute to adult epidermal lineages
It is now well validated that adult BM cells are not all lineage-restricted 
and can engraft within foreign tissues to produce functional non- 
haematopoietic cell types (section 1.13). Recent studies have shown that 
BM-derived cells of epithelial phenotype can be found in the epidermis 
(section 1.13.3; (Badiavas et al., 2003; Borue et al., 2004; Kataoka et al., 
2003; Korbling et al., 2002; Krause et al., 2001)), although the functional 
capacity of these cells is poorly understood and many questions remain 
to be answered. For example, do BM cells contribute to epidermal stem 
cell niches? Do BM-derived epidermal cells have the potential to 
proliferate and produce differentiated progeny? Is BM cell engraftment 
enhanced in cutaneous wound healing? And finally, since BM-derived 
cells appear to engraft in various tissues by either spontaneous fusion or 
by de novo cell generation, what is the mechanism of engraftment of BM 
cells in the epidermis?
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5.2) Aim
The following section of this project is an investigation into the 
contribution of transplanted BM cells to the cells of the normal and 
wounded mouse epidermis. Previous studies have shown that 
transplanted BM cells can engraft within the skin and assume a 
keratinocyte phenotype, and we therefore aimed to investigate whether 
these BM-derived cells; (1) are capable of engraftment into the 
keratinocyte stem cell niches, (2) have the potential to proliferate and 
form colonies in vivo and in vitro, (3) contribute to cutaneous wound 
repair and, (4) form epidermal lineages by de novo generation of new 
cells, or by fusion with an indigenous keratinocyte to form a heterokaryon.
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5.3) Methods
Female mice were lethally irradiated and rescued by a whole BM 
transplant from GFP-positive male donors (section 2.1). Six weeks post­
transplant, the dorsal skin of recipient mice was wounded by a 3 mm 
punch biopsy, and mice were killed at 4, 7 or 30 days post-wounding. 
Mice were injected with BrdUrd one-hour prior to sacrifice, to label cells in 
S-phase.
For the spontaneous fusion study, male mice were given a BM transplant 
from GFP-positive male donors, which permitted identification of the 
donor-derived keratinocytes by their co-expression of GFP and K14. In 
situ hybridisation was then performed to detect Y chromosome number 
within the BM-derived keratinocytes, to determine whether fusion of a 
male donor cell with an indigenous male keratinocyte had occurred.
Following BM transplant and cutaneous wounding, the skin was 
harvested and processed in a number of different ways depending on the 
method of analysis performed i.e., normal and wounded epidermis was 
fixed in NBF and paraffin-embedded for immunohistochemical and in situ 
hybridisation analyses of tissue sections, tissue wholemounts were 
prepared from the tail epidermis for immunofluorescence and confocal 
analyses, epidermal keratinocytes were isolated and grown in culture for 
immunofluorescence, and DNA was extracted from keratinocyte colonies 
for PCR.
The materials and methods used in this series of experiments are 
described in full in sections 2.2.3, 2.3 - 2.6.
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5.4) Results
5.4.1) BM-derived cells engraft within the epidermis and form 
keratinocyte-like cells
Six weeks after BM transplant, GFP-positive cells were frequently 
observed throughout the epidermis; in the IFE, the hair follicles including 
the bulge region, and in the sebaceous glands. Many of these donor- 
derived cells were characteristic of keratinocytes, as shown by their 
rounded, vesicular nuclei, abundant non-dendritic cytoplasm and 
epithelial cell-like morphology (Figure 5.1 -  5.3). Immunohistochemical 
controls confirmed a lack of non-specific binding by the GFP antibody 
(Figure 5.4).
BM-derived cells were also present in the dermis, and were believed to 
be circulating inflammatory lineages. Some cells of BM origin in the IFE 
displayed a dendritic phenotype and were likely to be epidermal 
Langerhans cells (Figure 5.2B), supported by evidence that BM contains 
Langerhans cell progenitors (Ogata et al., 1999; Reid et al., 1990). It is 
unlikely that these dendritic BM-derived cells are Merkel cells, as these 
cells are extremely rare in the back skin of mice (Moll et al., 1996).
5.4.2) BM-derived cells express markers of basal keratinocyte 
differentiation
The keratinocyte phenotype of the BM-derived cells in paraffin sections of 
non-wounded epidermis was established either by double 
immunofluorescence staining for both GFP and K14 (Figure 5.5), or by 
combining in situ hybridisation for the Y chromosome with 
immunohistochemistry for K14. The numbers of BM-derived 
keratinocytes were calculated in the hair follicles and in the IFE of non­
wounded skin at 6 weeks post-transplant, which revealed that 7.2% and
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7.7% of keratinocytes were of donor origin within each respective 
epidermal region (Table 5.1).
5.4.3) Effects of wounding on BM engraftment into the epidermis
Immunohistochemical detection of GFP revealed that BM-derived cells 
were abundant throughout the wounded epidermis and the dermis (Figure 
5.6A). The keratinocyte phenotype of the BM-derived cells in the 
wounded epidermis was established either by double 
immunofluorescence staining for both GFP and K14 (Figure 5.6B), or by 
combining in situ hybridisation for the Y chromosome with 
immunohistochemistry for K14 (Figure 5.7). BM-derived keratinocytes 
were commonly present as rows of adjacent cells in regions of re- 
epithelialisation (Figure 5.6B). At 4 days post injury, the fraction of BM- 
derived basal keratinocytes in the hyperproliferative region of the 
epidermis was 11.5%, a significant increase when compared 7.2% of 
keratinocytes in the surrounding non-wounded IFE (p = 0.0028; Table
5.1).
Double immunohistochemical staining for GFP with the macrophage 
marker, F4/80 (Figure 5.8A), or the neutrophil marker, Ly6G (Figure 5.8B- 
D) confirmed that many of the dermal cells in the wound bed were 
circulating inflammatory lineages, as expected.
5.4.4) BM-derived cells are present in the epidermal stem cell 
regions and can express CD34
Donor-derived cells were detected by in situ hybridisation for the Y 
chromosome, and this was combined with immunohistochemistry for the 
putative epidermal stem cell marker CD34. CD34-immunoreactive cells 
were concentrated in the region of the hair follicles just beneath the 
sebaceous glands. We observed BM-derived cells in this region that also 
expressed CD34 (Figure 5.9).
188
Rows of GFP-positive cells were observed in structures resembling EPUs 
in the regenerating IFE at 4 days post-wounding (Figure 5.10A). 
Interestingly, the cornified layer of dead cells shed from the surface of the 
epidermis above the GFP-positive EPU was also GFP-positive, whereas 
cells shed from regions of non-GFP-positive epidermis were not.
5.4.5) Epidermal wholemounts provide a 3-dimensional perspective 
of BM cell engraftment into the epidermis
We employed a novel method to examine BM-derived cell engraftment in 
the epidermis using wholemount preparations of tail skin from wild type 
mice transplanted with GFP-positive male BM. Confocal analyses of the 
wholemounts provided a three-dimensional perspective of the epidermis 
and a greater insight into the location of the engrafted BM-derived cells. 
Double immunofluorescence-labelling for GFP and K14 identified basal 
keratinocytes of donor origin. Our results confirmed our observations in 
paraffin sections, that BM-derived keratinocytes were frequently located 
in the hair follicle, just beneath the sebaceous gland (Figure 5.11).
5.4.6) BM-derived keratinocytes can incorporate BrdUrd
Transplanted mice were given a single pulse of BrdUrd one-hour prior to 
sacrifice. Approximately 4 - 6% of the total epidermal keratinocyte 
population, of both host and donor origin, incorporated BrdUrd following 
this pulse. Cells that were triple immunofluorescence-labelled for GFP, 
K14 and BrdUrd were observed in both the non-wounded and 
regenerating IFE, thus demonstrating that BM-derived keratinocytes were 
capable of proliferation (Figure 5.12).
In addition, large rows of GFP-positive cells were observed in the ORS of 
hair follicles 30 days post injury (Figure 5.1 OB), although these were not 
observed in the hair follicles of non-wounded skin, indicating the 
importance of wounding and that BM-derived cells are maintained in the 
epidermis when the tissue has regenerated.
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5.4.7) BM-derived keratinocytes undergo clonal expansion in vitro
Keratinocyte cultures were established from single cells isolated from the 
dorsal skin of transplanted mice, and were maintained in normal calcium- 
containing medium and grown on a feeder layer of fibroblasts. Cultures 
were double-fluorescence immunostained for GFP and K14. We 
observed 6 out of 600 colonies that expressed both GFP and K14 (Figure 
5.13), suggesting these colonies were each derived from a single BM- 
derived keratinocyte.
Furthermore, PCR analysis of both GFP and the Y chromosome of DNA 
extracted from the GFP-positive; K14-positive cell colonies, confirmed 
that the keratinocytes in these cultures derived from transplanted mice 
were of BM origin (Figure 5.14).
5.4.8) Spontaneous fusion is not detectable in BM-derived 
keratinocytes
Paraffin sections of epidermis from male wild-type hosts transplanted with 
male GFP-positive BM were analysed for the combined expression of 
GFP, K14, and the Y chromosome (5 mice, 200 cells from each mouse). 
Paraffin sections were 10 p,m thick to ensure incorporation of entire 
nuclei. On no occasion were multiple Y chromosomes observed within a 
keratinocyte. Moreover, GFP-positive, K14-positive cells that contained a 
single Y chromosome were seen (Figure 5.15), implying that transplanted 
BM cells can form keratinocytes without prior fusion with an indigenous 
cell.
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5.5) Discussion
My observations, that BM-derived cells can not only engraft with high 
frequency in known epidermal stem cell niches, but also show 
proliferative potential in vivo, and colony formation in vitro, were 
unexpected and call for a reconsideration of the possible source of adult 
stem cells within the epidermis.
5.5.1) BM-derived cells engraft within the epidermis and contribute 
to the stem cell niche
While much has been learned about the signals that regulate self-renewal 
and lineage commitment choices of epidermal stem cells (Fuchs and 
Raghavan, 2002; Niemann and Watt, 2002), one question that has not 
been addressed is the origin of adult epidermal stem cells. My 
observations of BM-derived keratinocytes in the hair follicles, IFE and 
sebaceous glands indicate that BM cells can engraft within the adult 
epidermis and undergo differentiation to form specialised epidermal cell 
lineages.
Engrafted BM-derived keratinocytes were frequently observed in 
epidermal stem cell niches i.e., the follicular bulge region and EPU-like 
structures in the IFE. Moreover, BM-derived cells in the bulge could 
express the putative stem cell marker CD34, raising the possibility that 
these cells may participate in epidermal homeostasis. BM-derived EPU- 
like structures appeared morphologically typical of indigenous EPUs, and 
were composed of approximately 10 cells in the basal epidermis. 
Furthermore, BM-derived EPU-like structures also appeared to be 
functioning normally, as the stratum corneum immediately above these 
structures was also GFP-positive, although surrounding cells in the 
stratum corneum did not express GFP. This is highly suggestive that BM- 
derived cells within an EPU show stem cell-like behaviour by producing
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differentiated progeny that migrate upward through each layer of the 
epidermis until they are shed from the skin surface.
5.5.2) BM-derived keratinocytes are significantly increased in 
regenerating epidermis
Tissue injury has been proposed to enhance engraftment of BM cells in 
many organs (section 1.13). To investigate whether this applies to the 
mouse epidermis, full thickness cutaneous wounds were applied to dorsal 
skin of transplanted mice, and wounded tissue was harvested at 4, 7 or 
30 days post-injury for histological analysis of BM cell recruitment. 
Cutaneous wound healing involves the temporal and spatial regulation of 
various cell types including infiltrating immune cells such as neutrophils, 
macrophages and fibroblasts, in addition to the processes of re- 
dermalisation and re-epithelialisation. The latter involves 
hyperproliferation and migration of epidermal keratinocytes from the edge 
of the wound to cover the neodermis.
The frequency of BM-derived cells was increased significantly in 
wounded skin (11.6%) compared with non-wounded skin (7.2%), and I 
commonly observed colonies of BM-derived keratinocytes in the wounded 
epidermis. These data imply a functional role for BM cells in epidermal 
regeneration, although it is not clear if BM engraftment is increased after 
wounding, or if BM-derived keratinocytes already established within the 
epidermis increase their proliferation following damage, or indeed if both 
scenarios occur.
Interestingly, I observed rows of BM-derived cells in the ORS of the hair 
follicles at 30 days post-wounding when the epidermis had regenerated, 
which demonstrates the sustained expression of BM-derived cells in the 
epidermis after injury, and also suggests that BM-derived keratinocytes 
can proliferate to produce daughter cells that can leave the stem cell 
niche and form differentiated cells in the hair follicle.
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5.5.3) BM-derived keratinocytes proliferate in vivo and can form 
colonies in vitro
BM-derived keratinocytes were observed in the non-wounded and 
regenerating epidermis that had incorporated a BrdUrd label and were 
therefore undergoing proliferation in vivo. This is the first observation of 
BM-derived keratinocytes in S-phase, and these data provide strong 
evidence for a functional role of BM-derived keratinocytes within the 
epidermis i.e., in the maintenance of the continual turnover of 
differentiated cells.
Furthermore, BM-derived keratinocytes formed colonies when cultured in 
vitro, thereby substantiating, for the first time, the capacity of BM cells to 
undergo clonal expansion and produce differentiated keratinocyte 
progeny.
5.5.4) BM-derived keratinocytes appear to form with no evidence of 
fusion
The regulatory mechanisms of BM cell differentiation, and the role of BM 
in epidermal regeneration are not known. Recent literature suggests that 
in some tissues, manifestation of a differentiated phenotype by ingressing 
adult stem cells is a result of cell fusion with a pre-existing adult cell to 
form a heterokaryon, although evidence also exists to show the de novo 
generation of cells from BM with no evidence of fusion (section 1.14). My 
results advocate the hypothesis that BM cells can form differentiated 
adult lineages in the epidermis, and indicate that BM-derived epidermal 
cells are unlikely to be a product of cell fusion. My data correlates with 
very recently published work suggesting the same (Harris et al., 2004). It 
is possible that BM-derived epidermal cells shed super-numerary nuclei, 
although this is deemed unlikely because heterokaryons appear stable for 
long periods of time (Weimann et al., 2003b).
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5.6) Conclusion
I believe that this study establishes that BM cells engraft into the 
epidermal stem cell niche and participate in tissue regeneration, and can 
form epidermal cells without fusion. I have also demonstrated for the first 
time, that BM-derived keratinocytes are capable of initiating cell 
proliferation in vivo and can divide to produce differentiated keratinocyte 
colonies in vitro.
Although beyond the scope of this report, these data raise some 
important questions regarding BM-derived stem cells in the epidermis. 
For example, how do BM cells ‘home’ to the bulge and epidermis? What 
are the stimuli to enhance BM-derived cell engraftment within wounded 
skin? Will a clearer understanding of the mechanisms of BM cell 
plasticity highlight the potential roles of BM-derived cells in the 
epidermis? The underlying principal, that transplanted adult BM cells 
assume the phenotype of their host tissue with an emphasis in diseased 
or damaged tissue, cannot be overlooked. Moreover, given that the 
results raise the possibility that BM may be a source of proliferating 
epidermal stem cells, the use of BM in the treatment of human skin 
disease becomes an important option. Further analyses of the 
mechanisms a cell employs to acquire a differentiated epidermal cell 
phenotype will be required prior to clinical application.
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Table 5.1) Donor-derived keratinocytes in normal and wounded 
epidermis of BM transplanted mice3.
Mouse ID Normal IFE Hair Follicle Wound
10410/01 15/266 (5.6%) 39/398 (9.8%) 101/1035 (9.8%)
10411/01 17/260 (6.5%) 24/287 (8.3%) 101/845 (11.9%)
10407/01 62/738 (8.4%) 65/824 (7.9%) 114/840(13.6%)
3210/02 18/361 (4.9%) 39/492 (7.9%) 49/369 (13.2%)
5425/02 57/614 (9.2%) 33/705 (4.6%) N/D
10406/01 36/413 (8.7%) 25/456 (5.4%) 37/417 (8.8%)
X + SEM D 7.2 + 0.7 7.3 + 0.8 11.5 + 0.9 c
3 For staining protocol please refer to the Materials and Methods section 
(Chapter II).
b Mean and standard error of the mean (SEM) percentage of Y-positive 
keratinocytes.
c Statistically significant increase in Y chromosome-positive keratinocytes 
in wounded compared to non-wounded epidermis (p = 0.0028; one-tailed 
t-test).
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Figure 5.1) BM-derived cells engraft into the hair follicles in non- 
wounded epidermis
BM-derived cells were detected by GFP immunoreactivity (dark brown 
stain) and were frequently identified within hair follicles, and also in the 
region of the bulge (A -  D; arrows). These cells were morphologically 
characteristic of keratinocytes. The bulge is identified as the lowest point 
of the upper, permanent portion of the follicle, beneath the sebaceous 
glands and directly below the point of insertion of the arrector pili muscle, 
hs, hair shaft; s, sebaceous gland; ap, arrector pili muscle.
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Figure 5.2) BM-derived cells engraft within the non-wounded IFE.
GFP-immunoreactive, BM-derived cells (brown stain), morphologically 
characteristic of keratinocytes, were observed throughout the 
interfollicular epidermis (A, B; arrows). GFP-positive cells were observed 
in the epidermis that displayed a dendritic morphology, possibly 
Langerhans cells (B; *). d, dermis; hs, hair shaft; ife, interfollicular 
epidermis. Scale bar = 50 i^m.
Figure 5.3) Transplanted BM cells can form sebocyte-like cells.
GFP-positive (brown stain) sebocyte-like cells (arrow) were present in 
sebaceous glands, outlined in this figure by a white dashed line in a 
cross-section of a hair follicle in non-wounded mouse epidermis 6 weeks 
after transplant of male GFP-positive whole BM cells, hs, hair shaft.
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Figure 5.4) Immunohistochemical controls.
Lack of non-specific binding, which would be indicated by a brown stain, 
in epidermis from GFP transgenic mice probed with isotype-matched IgG 
control (A). Interfollicular epidermis and hair follicles in epidermis from 
wild-type mice incubated with the anti-GFP antibody also show lack of 
non-specific binding (B, C).
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Figure 5.5
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Figure 5.5) BM-derived keratinocytes were present in hair follicles in 
non-wounded epidermis.
Confocal image of a paraffin section of non-wounded female mouse 
epidermis at 6 weeks post-transplant, showing BM-derived keratinocyte 
cells. The section was labelled for both K14 (Cy5 label, blue) and GFP 
(Cy3 label, red), and cells that co-expressed both K14 and GFP were 
observed as pink. Multiple, adjacent BM-derived keratinocytes were 
often observed (arrow). GFP-positive cells were present in the dermis, as 
expected, that did not express K14 and therefore displayed a red signal 
and not a pink signal (arrowheads), d, dermis; ife, interfollicular 
epidermis; hs, hair shaft; s, sebaceous gland.
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Figure 5.6) BM-derived epidermal cells express K14, and their 
engraftment is enhanced in wounded epidermis.
An abundance of GFP-positive BM-derived cells (brown signal) were 
detected in the hyperproliferative region of the regenerating epidermis 
(A). Most of the keratinocytes just outside this region did not express 
GFP (A; arrowheads; 4 days post-wounding). BM-derived keratinocyte 
engraftment increased in response to wounding, shown by multiple 
adjacent GFP- (Cy5 label, blue), and K14- (Cy3 label, red) doubly positive 
cells (B; arrows; 4 days post-wounding), ife = interfollicular epidermis, d = 
dermis. Scale bars = 25pm.
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Figure 5.7) High power view of a BM-derived keratinocyte in the 
regenerating epidermis.
Confocal image of a paraffin section of epidermis, 4 days post-wounding, 
when re-epidermalisation is taking place. Arrow points to a Y 
chromosome in the cell nucleus, detected by a FITC-conjugated probe 
(green), confirming the donor origin of this cell. The keratinocyte 
phenotype of the cell is demonstrated by positive immunoreactivity for 
K14 (red cytoplasmic stain).
c
Figure 5.8) Inflammatory cell lineages in the dermis are BM-derived.
GFP-positive cells (Cy5 label, blue) that expressed the macrophage 
marker, F4/80 (Cy3 label, red), were identified by a pink signal (A, and 
inset; e.g., arrows). Many cells in the dermis co-express the neutrophil 
marker, Ly6G (B; Cy3 label, red), and GFP antigen (C; Cy5 label, blue), 
merge of B and C (D; e.g., arrows), hf, hair follicle; d, dermis; m, muscle. 
Scale bars = 50|xm.
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Figure 5.9
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Figure 5.9) BM-derived cells are located in the bulge region of the 
hair follicles and can express CD34.
In female mice transplanted with male GFP-positive BM, cells were 
observed in the bulge region of the hair follicles that expressed a Y 
chromosome (dark brown nuclear spot) and CD34 (red cytoplasm), 
suggesting that BM-derived cells are located in the putative stem cell 
zones and express an epidermal stem cell marker. This figure shows 
BM-derived, CD34-immunoreactive cells in a longitudinal section (A), and 
in a cross section (B) of hair follicles, hs, hair shaft; d, dermis; s, 
sebaceous gland; b, bulge region.
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Figure 5.10) BM-derived cells form EPU-like structures in the 
regenerating epidermis, and BM-derived cellular columns were 
observed in hair follicles, in vivo.
Multiple adjacent GFP-positive cells (brown stain), resembling an EPU in 
the interfollicular epidermis, 4 days post wounding (A). The cornified 
layer of cells at the surface of the GFP-positive, EPU-like structure also 
expressed GFP (A; **), whereas cells from adjacent GFP-negative 
regions of epidermis did not (A; *). Columns of GFP-positive cells were 
observed in the outer root sheath (ORS), shown at 30 days post 
wounding (B). Note that some of the cells in the inner root sheath (IRS) 
and matrix are GFP-negative. Scale bar = 25 i^m.
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Figure 5.11
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Figure 5.11) BM-derived keratinocytes were identified in epidermal 
wholemounts.
Co-localised GFP (Cy3-labelled, red) and K14 expression (Cy5-labelled, 
blue) resulted in a pink signal, and was detected in the interfollicular and 
follicular epidermis in tail epidermal wholemounts of control GFP 
transgenic mice (A, B). Control wild type epidermal wholemounts stained 
for both K14 and GFP displayed K14 expression but not GFP (C). In wild 
type mice transplanted with GFP-positive BM, keratinocytes of donor 
origin were identified by their co-expression of GFP and K14, and were 
frequently observed in the bulge region of hair follicles (D, and high power 
inset, E; arrows). K14-negative cells that expressed GFP were also 
observed and were believed to be inflammatory cells, shown here in the 
bulge region (E; *). s = sebaceous glands, ife = interfollicular epidermis, 
hf = hair follicle, the follicular bulge region is within dotted boundary. 
Scale bars = 50jxm.
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Figure 5.12) BM-derived keratinocytes can proliferate in vivo.
Mice transplanted with GFP-positive BM were injected with BrdUrd one 
hour prior to sacrifice, and skin was immunostained to identify K14 (Cy5- 
label, blue), GFP (Cy3-label, red), and BrdUrd incorporation (FITC label, 
green). GFP and K14 (A), BrdUrd and K14 (B), merge of A and B (C), 
and inset (D), illustrating a BM-derived, BrdUrd-positive keratinocyte in 
non-wounded epidermis 6 weeks post-transplant (arrows).
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Figure 5.13) BM-derived keratinocytes can expand in vitro. 
Keratinocytes were isolated from the epidermis, grown in culture for 3 
weeks, and immunostained for GFP (FITC label, green) and K14 (Cy3 
label, red). Those cells derived from wild type mice did not express GFP; 
those from GFP transgenic mice did express GFP, as expected. Some 
keratinocyte colonies from wild type animals transplanted with male GFP- 
positive BM cells, expressed GFP. All keratinocyte cultures express K14.
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Figure 5.14) PCR analysis.
PCR analysis of GFP expression confirmed that GFP-immunoreactive 
keratinocyte colonies from wild type animals transplanted with male GFP- 
positive BM (trans) expressed GFP; wild type (wt) samples were negative 
for GFP; and GFP-positive (GFP+) cell samples were positive for GFP. 
In addition, PCR for Y chromosome expression showed that keratinocyte 
colonies from female wild type animals transplanted with male GFP- 
positive bone marrow (trans) were positive for the Y chromosome; 
keratinocytes from female wild type mice were negative; and keratinocyte 
colonies from male mice were strongly positive (PCR reactions were 
performed by Kairbaan Hodivala-Dilke).
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Figure 5.15) Transplanted BM cells engraft within the epidermis and 
form keratinocytes with no evidence of cell fusion.
Confocal analyses of epidermis (10 paraffin section) from male wild 
type mice transplanted with male GFP-positive BM cells, showed cells 
that express GFP (Cy5 label, blue) and K14 (Cy3 label, red), with a single 
Y chromosome (FITC label, green probe in nucleus), indicating that 
transplanted cells can form keratinocytes without evidence of fusion (A, 
B; arrows). No evidence of BM-derived keratinocytes with multiple Y 
chromosomes was observed.
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CHAPTER VI
Discussion
6.1) General Summary
Adult stem cells were fundamentally believed to be restricted to the 
production of differentiated lineages within their native tissue. However, 
with the emergence of a wealth of evidence over recent years, it is 
becoming increasingly accepted that adult stem cells have the capacity to 
cross lineage boundaries and form adult lineages within multiple 
extraneous tissues. In this thesis I have shown that transplanted BM 
cells retain a large degree of plasticity and can give rise to multiple 
differentiated lineages in the mouse and human gastrointestinal tract and 
in the mouse epidermis.
In chapters III, IV and V, I have presented a number of novel 
observations and have established that:
(1) Transplanted BM cells can give rise to an extensive proportion of 
ISEMFs in the mesenchymal lamina propria of the mouse and human 
small intestine and colon following lethal irradiation.
(2) The number of BM-derived ISEMFs is significantly increased in a 
mouse model of colitis.
(3) Transplanted BM contains progenitors cells that can form endothelial 
cells and mural cells in the mouse colon.
(4) The number of BM-derived vascular-associated cells is significantly 
increased in a mouse model of colitis.
(5) Transplanted BM cells can form epidermal cell lineages in the hair 
follicles, IFE and sebaceous glands of the mouse skin.
(6) The number of BM-derived keratinocytes is significantly increased in 
the regenerating epidermis.
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(7) BM-derived keratinocytes can proliferate in vivo and can form colonies 
in vitro.
(8) BM-derived keratinocytes can form without fusing to an indigenous 
keratinocyte.
Based upon these results, I have also postulated the following, although 
further studies will be essential to validate these points:
(1) BM-derived ISEMFs appear to be functional, as they exist in an 
interconnected cellular network in the lamina propria that spans from the 
base of the crypt to the intestinal lumen, thereby suggesting a 
proliferative capacity of these cells.
(2) BM-derived ISEMFs may contribute to the intestinal epithelial stem 
cell niche and assist in the maintenance of intestinal homeostasis by the 
paracrine secretion of specific growth factors and cytokines.
(3) BM cells may be therapeutic in the treatment of IBD via their formation 
of activated ISEMFs, which influence mucosal regeneration and 
remodelling.
(4) BM cells may be involved in neovasculogenesis in the inflamed 
mouse colon by differentiating to produce entire new blood vessels, and 
BM cells also appear to aid angiogenesis by contributing endothelial cells 
and mural cells to damaged blood vessels.
(5) My observation that transplanted BM cells frequently engraft within the 
postulated stem cell regions of the IFE and hair follicles, and can express 
a putative epidermal stem cell marker, suggests that BM cells contribute 
to the epidermal stem cell niche.
(6) BM cells may be therapeutic in re-epithelialisation of the wounded 
epidermis via their enhanced formation of keratinocytes in stressed 
tissue.
215
6.2) BM contribution to cells in the normal and inflamed 
gut
The intestinal stem cell is an empowering force, regulating homeostasis 
by altering the rate of cell proliferation and differentiation as regenerative 
demand dictates it. The intestinal stem cell can undergo self-renewal and 
programmed cell death and a constant stem cell number is therefore 
maintained in the base of the intestinal crypts to assure optimal 
gastrointestinal function. However, this cell does not act alone and the 
underlying mesenchymal cells and their secreted basement membrane 
factors in the subepithelial lamina propria are believed to directly regulate 
intestinal epithelial stem cell function by forming and maintaining the stem 
cell niche, and influencing the stem cells via the paracrine secretion of 
specific growth factors and cytokines. Little is understood about the 
origins of the intestinal epithelial stem cells and the underlying 
mesenchymal cells in the lamina propria, and therefore I have 
investigated the role of BM cells in their contribution to intestinal lineages, 
and the regenerative potential of BM-derived intestinal cells in a disease 
affecting gastrointestinal function.
6.2.1) Lack of BM-derived intestinal epithelial cells
BM cells have been reported to engraft within the mouse and human 
gastrointestinal tract and form cytokeratin-expressing epithelial cells in 
the gastric glands and the intestinal crypts and villi (Jiang et al., 2004; 
Korbling et al., 2002; Krause et al., 2001; Okamoto et al., 2002; 
Spyridonidis et al., 2004). I did not observe BM-derived epithelial cells in 
mouse or human gastrointestinal tissues, and so failed to reproduce 
these previous findings. In the mouse, this may be due to differences in 
the methods used i.e., transplantation of different sub-populations of 
fractionated BM, time elapsed between transplant and tissue analysis, the 
mouse strain used or experimental methods of donor cell detection.
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Likewise, in the human, differences in the methods of tissue fixation, the 
degree of GvHD at the time of tissue biopsy, and differences in the time 
elapsed between transplant and biopsy may cause these variations in 
results.
6.2.2) BM-derived ISEMFs in the normal and inflamed colon
My observation that BM can form a large proportion of ISEMFs in the 
mouse and human small intestine and colon is a novel discovery (Brittan 
et al., 2002), although the ability of BM to differentiate to form 
myofibroblasts has subsequently been shown in several other tissues 
including the mouse lung, stomach, oesophagus, skin, kidney, adrenal 
glands and pancreas (Direkze et al., 2003; Direkze et al., 2004; Poulsom 
et al., 2001), and the human liver (Forbes et al., 2004). This data also 
supports recent studies showing that human MSCs can differentiate to 
myofibroblast-like cells in vitro (Ball et al., 2004; Emura et al., 2000; 
Kadner et al., 2002).
I also report, for the first time, that BM formation of ISEMFs within the 
mouse colon is enhanced in a model of colitis. This is supported by 
subsequent observations that BM upregulates its formation of 
myofibroblasts in models of disease and injury in other tissue systems 
(Direkze et al., 2003; Direkze et al., 2004; Forbes et al., 2004).
6.2.3) BM-derived vascular cells in the normal and inflamed colon
The contribution of BM cells to vascular lineages in several models of 
tissue injury and disease is well documented (section 1.12.5; Table 1.1), 
although I believe that this is the first report of a BM origin of vascular 
lineages in the mouse colon. Moreover, I report a statistically significant 
increase in the number of BM-derived vascular cells in a mouse model of 
experimental colitis, which further supports a therapeutic role of 
transplanted BM cells in inflammatory bowel disease, possibly by 
contributing to postnatal neovasculogenesis.
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Emerging data shows that BM can provide long-term remission for 
patients with Crohn’s disease (Kashyap and Forman, 1998; Lopez- 
Cubero et al., 1998; Soderholm et alM 2002; Talbot et al., 1998), which is 
supported by my own results. I also provide the first insight into the 
mechanisms by which BM cells may provide this remission from disease, 
namely in their formation of mesenchymal and vascular lineages to aid 
tissue regeneration.
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6.3) BM-derived keratinocytes in the mouse epidermis
Several studies have reported a BM origin of keratinocytes in the 
epidermis of both mice and humans (Badiavas et al., 2003; Borue et al., 
2004; Kataoka et al., 2003; Korbling et al., 2002; Krause et al., 2001), and 
an enhanced engraftment of BM cells within the regenerating mouse 
epidermis (Badiavas et al., 2003; Borue et al., 2004). My data support 
these observations of an increased number of BM-derived keratinocytes 
within the regenerating epidermis (chapter V; (Brittan et al., 2004)).
In addition, I report for the first time that BM-derived keratinocytes have 
the ability to proliferate both in vivo and in vitro. The therapeutic 
implications for this proliferative capacity of BM-derived cells are 
profound, as this confirms that transplanted BM cells can divide to 
produce daughter cells and thereby actively assist in tissue homeostasis 
and regeneration.
I have also shown that BM-derived keratinocytes can engraft within 
known epidermal stem cell niches in the IFE and hair follicles, which is 
evidence, albeit circumstantial, that BM-derived cells become located 
within the region of epidermis where they are encompassed by a 
regulatory, protective niche environment and are most likely to divide and 
differentiate to produce keratinocyte progeny. Furthermore, I have 
verified the expression of a putative epidermal stem cell marker, namely 
CD34, by BM-derived cells in the follicular bulge region.
The mechanism by which BM cells assume a differentiated non- 
haematopoietic cell phenotype is currently a matter of some debate, with 
claims that BM cells do not differentiate to produce non-haematopoietic 
lineages, but simply fuse with pre-existing adult cells within a tissue to 
form a heterokaryon (section 1.14). By analysing chromosomal content 
within BM-derived keratinocytes, I provide evidence that BM cells can 
form epidermal keratinocytes by de novo cell production, and do not
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appear to fuse with an indigenous keratinocyte. Of all keratinocytes 
analysed (5 mice, 200 cells from each mouse), no cells were observed to 
contain an aberrant chromosome number indicative of cell fusion, and 
therefore I deem heterokaryon formation by transplanted BM cells in the 
mouse epidermis to be highly unlikely. However, cell fusion cannot be 
entirely discounted due to restrictions in the technique, although these 
restrictions may be overcome in the future by use of the Cre/lox 
recombinase system. Recent evidence showing BM cell fusion with cells 
in the liver, heart and brain is highly convincing (Alvarez-Dolado et al., 
2003; Vassilopoulos et al., 2003; Wang et al., 2003; Weimann et al., 
2003a; Weimann et al., 2003b), and I suggest that the mechanism of BM 
cell plasticity may be tissue-specific. A recent study has verified my own 
results that BM-derived keratinocytes can form in the mouse epidermis 
without fusion (Harris et al., 2004).
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6.4) Future directions
The newly emerging science of adult stem cell plasticity and the potential 
for vast and diverse tissue regeneration by these cells is hugely exciting. 
The discovery that adult bone marrow stem cells can produce functional 
non-mural lineages with the potential to divide and form differentiated 
progeny highlights future aspirations for the use of adult stem cells in the 
treatment of pathological conditions. In this study I have shown that bone 
marrow stem cells may be therapeutic in the treatment of skin disease 
and in inflammatory bowel disease, which can lead to the development of 
colon cancer.
It is becoming clear that the degree of regenerative pressure within a 
tissue has a major influence on the level of BM cell engraftment and 
contribution to adult cells of that tissue (section 1.13). I have confirmed 
that BM engraftment into the mouse colon and epidermis is significantly 
enhanced in disease or injury using models of experimental colitis and 
cutaneous wounding, respectively, and it is therefore possible that BM 
cells are involved in the regeneration of these damaged tissues.
In the lamina propria of both the non-inflamed and inflamed colon, BM- 
derived ISEMFs were frequently present in cellular columns spanning 
from the base of the crypt to the intestinal lumen, which is highly 
suggestive that these cells divide to produce differentiated progeny. 
Unfortunately, due to restrictions in the Home Office Project licence used 
in this study, it was not possible to inject the TNBS-treated mice with 
BrdUrd to label the dividing cells and therefore investigate the 
proliferative capacity of BM-derived cells in colitis. However, a new 
project licence has recently been written outlining the above experiment, 
which will be investigated within the Histopathology Unit at CRUK in the 
near future.
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Future studies should involve elucidation of the stimulatory factors and 
molecular pathways that influence a BM cell to travel to and engraft within 
a tissue, and differentiate to form a defined lineage. It is likely that BM 
cells respond to aberrant levels of secretion of specific growth factors or 
chemokines by a tissue in disease or injury. For example, the intestinal 
myofibroblasts are a source of many pro-inflammatory cytokines and 
growth and differentiation factors, and are considered to be major role 
players in the initiation and regulation of intestinal immunity in normal and 
inflammatory conditions, including Crohn’s disease (Fiocchi, 1997; Otte et 
al., 2003; Pang et al., 1994; Roberts et al., 1997; Strong et al., 1998). 
Therefore, the intestinal myofibroblasts appear to be likely candidates for 
the cells that stimulate the cells of the BM to home-to and engraft within 
the inflamed gut, and aid tissue regeneration by initiating a T-cell 
response, and as my data suggests, by differentiating to form both 
mesenchymal and vascular lineages.
It is important to define the specific subpopulations of cells present in the 
BM that can form each specific lineage in adult tissues. At the moment it 
is not clear if the BM contains a single primitive stem cell population that 
can produce multiple adult lineages within numerous tissues, or whether 
multiple stem cell populations are present within the BM each pre­
programmed to differentiate and form cells within a specific tissue. It is 
possible that BM cells respond to external cues from a tissue in stressed 
conditions, and then migrate to and engraft within this tissue whereupon 
they initiate differentiation to a required cell type. Future studies involving 
purification and transplantation of distinct BM stem cell populations will 
assist the identification of innate differentiation pathways, and will shed 
light upon the above problem. Indeed, in the Histopathology Unit at 
CRUK, studies wherein mouse BM is sorted into defined haematopoietic- 
and mesenchymal-expressing populations prior to transplantation into an 
irradiated host are currently underway.
Knowledge of the distinct progenitor cells within the BM will also permit 
the manipulation of these cells by introduction of therapeutic genes that
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can then be targeted directly to a specific diseased tissue. For example, 
the pro-inflammatory cytokines interleukin-1 p and tumour necrosis factor- 
a (TNFa) are upregulated in Crohn’s disease (Mahida et al., 1989; 
Reinecker et al., 1993), and these have been shown to drive the 
proliferation of human colonic myofibroblasts in vitro (Jobson et al., 
1998), which can lead to fibrosis and scarring (Aigner et al., 1997; 
Graham, 1995; Isaji et al., 1994; Kinzler and Vogelstein, 1998; Martin et 
al., 1996). It would therefore be interesting to transplant BM cells that 
have been genetically-modified to express anti-inflammatory cytokines 
such as interleukin-10 or anti-TNFa antibodies, and investigate whether 
these cells can differentiate to form ISEMFs with anti-inflammatory 
properties in our model of TNBS colitis, and thereby alleviate the disease.
So, to summarise, I believe that the results presented in this thesis are a 
further step forward in the understanding of the functional relevance of 
adult stem cell plasticity. The BM proves an excellent source of readily 
accessible adult stem cells, and I have now ascertained that adult BM 
contains progenitor cells for multiple non-haematopoietic lineages, 
namely, the intestinal myofibroblasts, the endothelial cells and mural cells 
within blood vessels, and the keratinocytes and sebocytes of the 
epidermis. Transplanted BM may prove therapeutic in the treatment of 
pathological conditions of the skin and inflammatory disease of the 
intestine.
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